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Abstract 
Ventilator-associated lung injury (VALI) describes the process by which 
mechanical ventilation of the lungs causes systemic injury. Cyclic Mechanical 
Strain (CMS) of alveolar epithelial cells induces cytokine release, suggesting 
that mechanotransduction of force into injurious biological signaling occurs in 
the alveolar epithelium. The work in this thesis investigated the role of integrin 
and cytoskeletal signalling in CMS-induced cytokine release in these cells. 
Specifically, the roles of RhoA-Rho associated protein kinase (ROCK) 
signaling and the integrin-associated protein, CD98hc, were assessed.  
Inhibition of ROCK and non-muscle myosin II (NMII), and knockdown of 
CD98hc abrogated CMS-induced IL-8 release. Preliminary data obtained 
using FRET probes indicated that CD98hc knockdown reduced baseline 
RhoA activity. To investigate these pathways upon CMS-induced injury in 
intact human lung, and to generate translational data, we established a model 
of CMS using precision-cut lung slices (PCLS). CMS induced cytokine release 
in both murine and human PCLS and there was also an indication that cells 
spatially correlating with ATII proliferated in response to CMS.  
These data suggest a key role for the RhoA-ROCK-NMII axis in the 
mechanotransduction of CMS in the alveolar epithelium. CD98hc may 
modulate baseline RhoA expression and CMS-induced injurious signalling by 
affecting baseline cellular pre-stress. PCLS respond to CMS thereby enabling 
mechanotransduction studies in human tissue with near physiological 
conditions. This will potentially facilitate future translational research in VALI. 
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1.1 Mechanobiology of the lung 
The lung is subjected to distending mechanical forces which regulate its 
development, maturation and repair, but can also promote disease and lead 
to injury. Mechanical ventilation of critically ill patients is life-saving, but can 
also induce pulmonary and systemic injury. Mechanical distension of the 
alveolar epithelium, particularly in the context of lung injury, can lead to 
injurious biological signalling that promotes multi-organ failure, long-term 
morbidity and death. Understanding the molecular signalling processes that 
underlie mechanotransduction in the lung is critical not only to improve 
outcomes for mechanically ventilated patients, but also to advance research 
in lung development, regeneration and repair. 
1.1.1 Ventilator-associated lung injury (VALI) 
Ventilator-associated lung injury (VALI) describes the process by which 
mechanical ventilation of the lung exacerbates pulmonary and systemic injury 
(Salman et al. 2013). The pathological appearances of VALI and the Acute 
Respiratory Distress Syndrome (ARDS) (The ARDS Definition Task Force 
2012), are indistinguishable. VALI is a key component of ARDS and the vast 
majority of patients with the latter require mechanical ventilation (Pinhu et al. 
2003). Whilst it was known that mechanical ventilation can cause ARDS in 
animal models (Dreyfuss & Saumon 1998), the concept that mechanical 
ventilation strategy is a key determinant of survival in ARDS was confirmed 
by the landmark ARMA ARDS Network trial in 2000 (ARDS Network 2000). 
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Patients with ARDS were randomised to either ventilation with the traditional 
tidal volumes used at the time of the study (12ml/kg predicted body weight) or 
with lower volumes of 6ml/kg. The latter group not only had reduced 
concentrations of circulating inflammatory mediators and indices of extra-
pulmonary organ failure, but crucially had a 9% absolute survival benefit. 
Therefore, modulation of mechanical force in the lung is not only critical for 
reducing lung injury, but also affects the ability of the lung to mediate extra-
pulmonary organ damage. 
Importantly, high tidal volume ventilation can induce injury in previously 
‘healthy’ lungs, suggesting that mechanical force can have a direct, rather 
than additive, effect (Guay & Ochroch 2015; Guo et al. 2016; Sutherasan et 
al. 2014; Serpa Neto et al. 2012; Pinheiro de Oliveira et al. 2010) and 
reduced tidal volume ventilation can improve clinical outcomes for patients 
undergoing abdominal surgery (Futier et al. 2013; Futier & Jaber 2014).  
Moreover, injury sustained from injurious mechanical ventilation can 
impact mortality and morbidity in the long term (Needham et al. 2012). ARDS 
affects approximately 190,000 patients each year in the Unites States alone 
with a mortality of around 40% (Rubenfeld & Herridge 2007), and reducing 
VALI is predicted to not only save 10 lives a day, but also to be cost effective 
even if $10,000 were spent to reduce tidal volumes per patient with ARDS 
(Cooke et al. 2009). Despite this, implementation of lower tidal volume 
ventilation into widespread clinical practice has been difficult (Young et al. 
2004), and no disease modifying agent has yet been developed to reduce the 
injury induced by mechanical ventilation. 
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Distension of the lung, as opposed to high pressures, is thought to 
mediate injury (de Prost et al. 2011). Rodents ventilated with high pulmonary 
pressures developed less pulmonary oedema where thoraco-abdominal 
strapping was used to reduce chest expansion (Hernandez et al. 1989). 
Over-distension, such as in VALI, is associated with increased pulmonary 
(Wilson et al. 2003) and systemic cytokine release (Chiumello et al. 1999), 
such as interleukin (IL)-8, IL-6 and Tumour Necrosis Factor (TNF)-α (Ranieri 
et al. 1999) in a process whereby the lung becomes an ‘engine’ of 
inflammation (Figure 1-1). Conversely, decreasing tidal volumes abrogates 
this effect (Slutsky 2005). Because high tidal volume ventilation increases 
expression of IL-6 and TNF-α messenger RNA (mRNA) by the alveolar 
epithelium (Tremblay et al. 2002), investigations into VALI have focussed 
here but many cells isolated from human lung parenchyma produce 
inflammatory mediators in response to mechanical strain (Pinhu et al. 2003). 
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Figure 1-1 Ventilator-associated lung injury (VALI) 
Image adapted and reproduced with permission from (Slutsky & Ranieri 2013), copyright 
Massachusetts Medical Society. Overdistention of the lung can lead to increases in alveolar–
capillary permeability and subsequent pulmonary oedema. The injured lung releases 
mediators that recruit neutrophils to the lung and propagate further injury. Translocation of 
inflammatory mediators and bacteria into the systemic circulation can occur, leading to multi-
organ dysfunction (biotrauma).  
IL – interleukin, PMN – polymorphonuclear leukocyte, TGF β -  transforming growth factor-β, 
TNF -  tumour necrosis factor 
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1.1.2 Distending forces in the lung in health and disease 
The alveoli form a three dimensional, interconnected network, where 
neighbouring alveoli share structural walls and are interdependent (Mead et 
al. 1970). Therefore, this complex structure expands non-uniformly, with 
external stresses transmitted throughout the structure and the lung 
parenchyma in particular (Waters et al. 2012). During normal tidal breathing, 
an increase in the transpulmonary pressure (the difference between the 
pressure in the pleural space (PPL) and the alveolus (PALV)) causes the lungs 
to expand. Air flows into the lungs providing that PALV is less than 
atmospheric pressure (PATM). Load is applied to the alveoli from the surface 
tension of air-fluid interfaces, elastic recoil of tissue, interdependence 
between neighbouring alveolar units, and PALV (Roan & Waters 2011). Forces 
acting on the pleura from the respiratory muscle and chest wall are also 
transmitted throughout the lung parenchyma (Macklem et al. 1983). 
The physiological changes experienced by alveoli during distension are 
not completely understood (Roan & Waters 2011). Alveoli from isolated rat 
lungs appear to distend at low pressures by unfolding and re-folding of 
alveolar septa (pleating), but at higher distending volumes, there is stretching 
of septal tissue (Tschumperlin & Margulies 1999). During normal tidal 
breathing, the alveolar basement membrane, composed of load-bearing 
collagen, elastin and proteoglycans (Suki et al. 2005), is estimated to distend 
linearly by 4% (Forrest 1970; Roan & Waters 2011) whereas higher tidal 
volume ventilation may distend the epithelial basement membrane surface 
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area to approximately 40% (Tschumperlin & Margulies 1999). As a 
consequence, the distending stresses required increase in a non-linear 
fashion from very low at residual volume, to approximately 5 cmH2O at 
functional residual capacity (FRC), and 30 cmH2O at total lung capacity 
(Waters et al. 2012). 
The heterogeneous nature of the injured lung tends to spread the load 
of mechanical strain unevenly. The presence of oedema-filled alveoli both 
decreases the volume of compliant lung subjected to distending forces (the 
baby lung) (Gattinoni et al. 1993), and examination of the mechanics of a 
single alveoli suggested that collapsed or fluid-filled lung units increase the 
interfacial stresses experienced by neighbouring lung units (Perlman et al. 
2011). This over-distension of air-filled lung units (volutrauma) is 
compounded by the injurious effects of repetitive opening and closing of lung 
units (atelectrauma) (Dreyfuss et al. 1988), associated with surfactant 
dysfunction. Although not comprehensively characterised (Hubmayr 2002), 
atelectrauma may not contribute significantly to lung (Güldner et al. 2016) or 
systemic (Wakabayashi et al. 2014) injury, but is still taken into consideration 
when considering mechanical ventilation strategies for patients.  
1.2 Mechanobiology of the alveolar epithelium 
1.2.1 The alveolar epithelium 
The alveolar epithelium comprises a diverse array of cell types working 
as a unit both to establish a barrier to the external environment, and to enable 
gas exchange (Zemans et al. 2015). This epithelial barrier is composed of two 
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key cell types. Flat and broad alveolar type I cells (ATI), which cover the 
majority of the luminal surface of the alveolar structure, are more sensitive to 
injury, possibly due to their size and subsequent exposure to insults, and an 
inability to self-repair (Herzog et al. 2008; Mason 2006). Cuboidal alveolar 
type II cells (ATII), although more numerous than ATI, cover the remaining 5% 
of the epithelial surface (Mason 2006). Morphologically, ATII can be 
characterised by apical microvilli and lamellar bodies (Fujino et al. 2010) 
(Figure 1-2). Functionally, there are three primary roles of the ATII.  
First, they are responsible for the production of pulmonary surfactant to 
decrease alveolar surface tension (Andreeva et al. 2007). Second, they act as 
progenitor cells of the alveolar epithelium (Barkauskas et al. 2013). Indeed, 
following damage to ATI early in the course of lung injury, ATII de-differentiate 
to ATI-like cells to restore the epithelium (Evans et al. 1975; Desai et al. 
2014). Finally, ATII are responsible for the majority of fluid transport across 
the epithelium, actively transporting sodium from the apical to basolateral 
surface and clearing fluid from the alveolar space (Mason et al. 1982; Matthay 
2005). For these reasons, along with the capacity of the ATII to regulate 
innate immunity in the lung (Chignalia et al. 2015), ATII have been described 
as the ‘defender’ of the alveolus (Mason et al. 1982; Mason 2006). 
However, this picture may be incomplete. Whereas both ATI and ATII 
are thought to derive from a bipotent progenitor lineage (Desai et al. 2014), 
the concept that ATI represent a terminally differentiated cell that can be 
repopulated by differentiation of ATII is challenged by recent observations that 
suggest differentiated ATI expressing the homeodomain-containing protein 
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Hopx can both self-renew and generate ATII in the post-pneumonectomy lung 
(Jain et al. 2015), suggesting a bidirectional relationship and plasticity 
between the two cell types in lung regeneration and repair (Figure 1-2).  
 
Figure 1-2 The alveolar epithelium 
Image reproduced and adapted (McElroy & Kasper 2004) with permission of the © ERS 2004.  
European Respiratory Journal Oct 2004, 24(4)664-673;DOI: 10.1183/09031936.04.00096003. 
The alveolar epithelium is populated by thin and numerous ATI, and cuboidal ATII cells 
containing lamellar bodies and apical microvilli. Following injury, ATII proliferate and 
transdifferentiate to ATI via intermediate cells, although the relationship may be bi-directional. 
ATI- alveolar epithelial type I cell, ATII – alveolar epithelial type II cell 
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1.2.2 Alveolar epithelial responses to stretch  
1.2.2.1 Force-induced lung maturation and cell differentiation 
The vast surface area of the alveolar epithelium is exposed to cyclic 
stretching forces from as early as in utero, when foetal breath movements 
influence its development (Wigglesworth & Desai 1979). Transection of the 
spinal cord of foetal rabbits above the level of the phrenic nerve, which 
ablates diaphragmatic-derived foetal breath movements, decreased lung 
growth by 70% when compared to controls. Indeed, distension of the foetal 
lung through tracheal obstruction demonstrably increased lung growth 
(Moessinger et al. 1990), and cellularity (Nardo et al. 2000). Similarly, foetal 
alveolar epithelial distension also promoted ATII to ATI cell differentiation 
(Flecknoe et al. 2000; Flecknoe et al. 2002). Cyclic strain of foetal ATII in vitro 
promoted surfactant-protein (SP) B and C gene expression and surfactant 
protein production, indicating that alveolar epithelial cell maturation and 
function is directly related to mechanical stimulation (Sanchez-Esteban et al. 
2001). In fact, previous studies demonstrated that a single stretch of cultured 
primary ATII was enough to increase intracellular calcium and surfactant 
secretion (Wirtz & Dobbs 1990).  
However, the relationship between strain and cell differentiation or 
surfactant release is not linear. Decreases in alveolar distension following 
birth, due to clearing of alveolar fluid, alter the relative proportions of ATI and 
ATII further, promoting decreases in ATI and increasing the ATII population 
(Flecknoe et al. 2003). Therefore, there is a relationship between mechanical 
force and alveolar epithelial cell differentiation and function, but the precise 
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nature of this interaction is yet to be determined (Waters et al. 2012). 
Furthermore, the mechanosensitive component of foetal alveolar epithelial 
cells has recently been localised to the integrin-cell matrix interface, where 
depletion of epithelial-specific β1 integrin in embryonic mice was associated 
with impaired alveolarisation and epithelial cell differentiation, and altered 
lung branching morphogenesis (Plosa et al. 2014). 
Examples of mechanical force-induced cellular differentiation have been 
demonstrated in other cell types, such as in mesenchymal stem cells (MSC), 
in which shear stresses induced osteogenesis (Sonam et al. 2016). Crucially, 
different degrees of force and cell contractility direct cell fate. MSCs cultured 
on soft matrices undergo neurogenesis, whereas those cultured on stiff 
matrices adopt myogenic fates, and those on rigid matrices, osteogenic fates 
(Engler et al. 2006). These force-induced differentiation cues are dependent 
on myosin II-mediated cell contractility, and abrogated by the non-muscle 
myosin II (NMII) inhibitor, blebbistatin. Furthermore, only cells with higher 
contractility responded to force by altering fate (Sonam et al. 2016), and 
when actomyosin contractility was inhibited, force-induced differentiation did 
not occur, confirming previous observations that RhoA-mediated cell 
contractility directs force–induced differentiation (McBeath et al. 2004). 
Therefore, there are precedents in other cell types that mechanotransduction 
drives cellular differentiation in a RhoA-myosin II-dependent manner, and that 
these may be relevant to the alveolar epithelium.  
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1.2.2.2 Force-induced cell proliferation in the lung 
Following birth, the lung, and the alveolar epithelium in particular, 
continue to show responses to mechanical forces. For example, the capacity 
of the lung to grow following partial pneumonectomy has been demonstrated 
(Rannels 1989) in dogs (Hsia et al. 1994), guinea pigs (Hsia 2004), rabbits 
(Thurlbeck & Langston 1989), rats (Buhain & Brody 1973) and mice (Liu et al. 
2014) and is attributed to the increase in distension force in the remaining 
lung, as prevention of such over-distension by the insertion of prosthetic 
material to fill vacant area inhibits re-growth (Hsia et al. 2001; Hoffman et al. 
2010). This effect has been demonstrated in humans, with evidence of 
increased lung mass and new alveolar units following pneumonectomy 
(Butler et al. 2012).  Furthermore, alveolar epithelial regrowth comprises a 
major component of compensatory growth of the lung (Hsia et al. 2001), and 
there is evidence that proliferation of ATII is implicated (Brody et al. 1978) 
although the mechanism for this is unclear. 
Early observations suggested that Cyclic Mechanical Strain (CMS) 
increased proliferation of foetal ATII in vitro via mechanisms involving platelet 
derived growth factor (Liu et al. 1995) or stretch activated calcium channels 
(Liu et al. 1994). Alveolar epithelial cells in culture proliferate in response to 
low degree CMS for periods greater than 24 hours (Chaturvedi et al. 2006) 
and recent evidence indicated that mechanical ventilation induced cell cycle 
entry in murine ATII (Chess et al. 2010). Furthermore, evidence of CMS-
induced proliferation has been demonstrated in other cell types, such as 
airway epithelial cells (Savla et al. 2004), vascular smooth muscle cells 
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(Mantella et al. 2015), fibroblasts (Cui et al. 2015) and MSCs (Ghazanfari et 
al. 2009). 
Two mechanistic pathways of stretch-induced proliferation have recently 
gained traction. First, in fibroblasts (Cui et al. 2015) and epithelial cells 
(Aragona et al. 2013), Yes-associated protein (YAP) and transcriptional co-
activator with PDZ-binding motif (TAZ) were activated in response to stretch 
which promoted entry to S-phase. Furthermore, in epithelial cells, this was 
dependent on expression of β-catenin and E-cadherin extracellular 
engagement (Benham-Pyle et al. 2015). Second, CMS activated the 
transmembrane protein Piezo1 to drive cell cycle entry from G2 (Gudipaty et 
al. 2017) via calcium-dependent activation of extracellular signal related 
kinase (ERK) signalling. Finally, the small GTPase Rho is implicated in 
matrix-rigidity driven cell proliferation (Provenzano & Keely 2011), such as in 
the breast cancer microenvironment (Provenzano et al. 2009). That YAP and 
TAZ activation in response to mechanical force require Rho GTPase activity 
and actomyosin contractility (Dupont et al. 2011) provides exciting evidence 
of an emerging pathway of mechanotransduction and proliferation that may 
be applicable to the alveolar epithelium. 
1.2.2.3 Force-induced injury in the lung 
1.2.2.3.1 Physical disruption  
Although ventilation at high tidal volumes induces macroscopic lung 
injury (Ricard et al. 2003; de Prost et al. 2011) and alveolar damage, how this 
is mediated at the level of the alveolar epithelium is not clear. One 
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hypothesised method of CMS-induced alveolar epithelial cell injury is via 
direct rupture of the plasma membrane. Electron microscopy of rabbit lungs 
exposed to high tidal volume ventilation demonstrated plasma membrane 
disruption (Costello et al. 1992) and the suggested method of damage is 
through excessive unfolding of the membrane followed by stretching of 
plasma membrane lipids and further lipid trafficking (Vlahakis & Hubmayr 
2000; Vlahakis & Hubmayr 2005; Vlahakis et al. 2002). A rat model of VALI 
suggested that the majority of plasma membrane wounds in alveolar 
epithelial cells are sealed following injury, (Gajic et al. 2003), possibly through 
tripartite motif-containing protein (TRIM)72-mediated endocytosis and rapid 
lipid trafficking (Nagre et al. 2016) followed by re-polymerisation of the actin 
cytoskeleton (Godin et al. 2011). However, plasma wounding in itself may 
contribute to CMS-induced inflammatory signalling, for example through c-
Fos signalling (Grembowicz et al. 1999).  
Either due to plasma membrane failure, or independently, CMS may 
induce alveolar epithelial cell apoptosis or necrosis. Mechanical ventilation of 
pre-term infants induced alveolar epithelial cell apoptosis (Lukkarinen et al. 
2003), and this effect was seen experimentally following mechanical 
ventilation of pre-term mice (Mokres et al. 2010). High magnitude CMS at 
17% elongation induced apoptosis of foetal ATII via increased expression of 
Fas ligand (FasL) and cleaved caspases (extrinsic pathway) (Kroon et al. 
2013). Similar effects have also been seen in mature ATII, where CMS 
increased the number of dead cells in a magnitude-dependent manner 
(Tschumperlin & Margulies 1998; Arold et al. 2009). High amplitude stretch 
also significantly increased the apoptotic index of rat ATII (Crosby et al. 
 38 
2011), in a mechanism thought to occur via impairment of bradykinin-
mediated stimulation of phosphoinositide 3-kinase (PI3K)-B-cell lymphoma 
(BCL) signalling (Hammerschmidt et al. 2007), and more recent evidence has 
indicated a role for the intrinsic (mitochondrial) apoptosis pathway (Kuhn et 
al. 2017). 
1.2.2.3.2 Mechanotransduction 
VALI is a systemic disease, and CMS-induced injury of alveolar 
epithelial cells is thought to propagate diffuse injury through transduction of 
force into injurious biological signalling, such as cytokine release (Belperio et 
al. 2006). CMS of alveolar epithelial cells induced inflammatory cytokine 
signalling in vitro (Vlahakis et al. 1999) and, several possible upstream 
signalling pathways have been investigated.  
First, CMS induced activation of extracellular signal related kinase 
(ERK) within 5 minutes in primary rat alveolar epithelial cells via G-protein 
signalling, and independent of stretch-activated ion channels (Correa-Meyer 
et al. 2002). Furthermore, CMS of foetal ATII induced ERK and Nuclear 
Factor Kappa-light-chain-enhancer of activated B cells (NF-κB) mediated IL-6 
and macrophage inflammatory protein (MIP)-2 (chemokine (C-X-C motif) 
ligand 2 CXCL2) (Copland & Post 2007), but these responses were 
downstream of, and dependent on, calcium mobilisation. Previous results 
from our group suggested that CMS-induced IL-8 release in A549 cells was 
inhibited by blockade of ERK signalling with U0126, and that CMS-induced 
ERK activation was independent of stretch-activated cation channels (Pinhu 
2008). 
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Another putative mechanism of CMS-induced cytokine generation is via 
redox and NF-κB signalling. CMS induced reactive oxygen species (ROS) 
generation in ATII at low and high magnitudes of stretch (Chapman et al. 
2005), and CMS-induced IL-8 release was abrogated by augmentation of 
intracellular glutathione, an oxidant scavenger (Jafari et al. 2004).  
Furthermore, CMS of rat ATI induced superoxide and nitric oxide generation 
in an NF-κB-dependent manner, and was associated with increased epithelial 
permeability which was abrogated by the superoxide scavenger, Tiron (Nurit 
Davidovich et al. 2013). Similarly, high magnitude CMS applied to precision 
cut lung slices (PCLS) induced superoxide generation associated with tight 
junction dissociation, and these effects were abrogated by the use of Tiron 
(Song et al. 2016). Indeed, pre-treatment with an antioxidant improved 
parameters of oxidative stress, inflammation and pulmonary epithelial 
integrity in a mouse model of VALI (Fu et al. 2011), but use in a clinical trial in 
patients undergoing one-lung ventilation failed to show any positive effect in 
clinical outcomes (Bastin et al. 2016).  
Pharmacological inhibition of mitochondrial electron transport chain 
function by rotenone abrogated CMS-induced oxidative stress in A549 cells, 
and mitochondrial-free A549 cells did not generate IL-8 or show activation of 
NF-κB in response to CMS, although IL-8 generation was intact following 
chemical stimulation (Pinhu 2008). Although no overlap could be found 
between the ERK and mitochondrial ROS signalling pathways in CMS-
induced injury in these studies, mitochondrial ROS generation is clearly part 
of a multifaceted cellular response to CMS (Figure 1-3). 
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Figure 1-3 Proposed mechanotransduction pathways in VALI 
CMS is proposed to induce injurious signalling via mitochondrial reactive oxygen species 
(ROS) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB). 
Alternatively, extracellular related kinase (ERK) signalling is activated, but no overlap 
between the two pathways has yet been found. 
AKT  - protein kinase B, FAK – focal adhesion kinase, IKK - inhibitor of kappa B kinase, NOS- 
nitric oxide synthase, PI3-K –phosphoinsitide 3-kinase 
 
1.3 Studying mechanotransduction in the alveolar epithelium 
1.3.1 in vivo models 
Animal models have been invaluable in the research of lung injury, 
However, translation of observations from these models into human disease 
are limited by fundamental differences in anatomy (Shapiro 2006), alveolar 
epithelial biology (Sakuma et al. 1997) and proteomics. Only 21 homologous 
proteins were identified in a comparative analysis of broncho-alveolar lavage 
fluid (BALF) from a murine model and a patient with lung injury (Gharib et al. 
2010). Although in vivo models of human lung injury exist, such as the 
inflammation induced during one lung ventilation (Bastin et al. 2016), ex vivo 
models offer the prospect of progress in VALI research (Proudfoot et al. 
2011). These are comprised of the ventilation and perfusion of consented 
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donor lungs unsuitable for transplant. The ex vivo lung perfusion (EVLP) 
method is used to re-condition such organs to increase their suitability for 
transplant (Cypel et al. 2011), and VALI associated with cytokine release can 
be induced in these lungs (Terragni et al. 2016). This method therefore 
provides a novel and exciting platform in which to investigate VALI and 
targeted therapies in human lungs (Tane et al. 2017). 
1.3.2 in vitro models 
1.3.2.1 Application of CMS 
The application of strain to alveolar epithelial cells in vitro facilitates 
investigation of mechanistic responses. Stretching devices developed for this 
purpose can apply uniaxial (pulling at opposite ends) (Moretti et al. 2004) and 
biaxial (pulling in all directions) (Banes et al. 1985) stretch forces on a flexible 
cell culture surface. Biaxial stretch has been applied by generating a vacuum 
beneath a clamped cell culture surface, but this method is limited by 
heterogeneity of the strain field (Williams et al. 1992), with true equibiaxial 
strain present at the centre of the well only (Waters et al. 2012). These issues 
are partially overcome by the use of thinner cell culture membranes (Winston 
et al. 1989), using an indenter to push into the centre of a well (Hung & 
Williams 1994), or pulling on the four sides of a cruciform membrane (Waters 
et al. 2001).  
The commercially available Flexcell system uses a vacuum to deform 
membranes down: either across a loading post, leading to validated 
homogenous equibiaxial strain fields in the central area covering the post; or 
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without a post (Figure 1-4). However, evidence that substrate strain does not 
necessarily correlate with cellular strain (Wall et al. 2007) and that the 
mechanical properties of the membrane material change over time present 
on-going issues with these techniques (Bieler et al. 2009). Therefore, studies 
of cellular mechanotransduction will be limited until methodical improvements 
can be made.  
 
Figure 1-4 Flexcell mechanism of equibiaxial cell strain 
Cells are plated on deformable silicone (Bioflex™) membranes. A vacuum exerted beneath 
the well distorts the membrane, causing equibiaxial strain of the cells. 
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1.3.2.2 Towards physiologically-relevant systems of in vitro 
stretch 
 Such in vitro systems are further limited by their physiological 
relevance. Although technically challenging and limited by availability of 
human tissue, isolation and culture of human ATII cells is feasible (Witherden 
& Tetley 2001; Mao et al. 2015) although they trans-differentiate to an ATI 
phenotype after 8-10 days (Fuchs et al. 2003). The human lung 
adenocarcinoma cell line, A549, was established in 1972 from explant culture 
of tissue from a 48 year-old Caucasian male (Giard et al. 1973). They contain 
cytoplasmic inclusion bodies typical of ATII, and synthesise phospholipids in 
a pattern concordant with surfactant production (Lieber et al. 1976). Recent 
micro-array analysis suggests that this cell line may further develop ATII 
characteristics, including multi-lamellar body (MLB) development, in long term 
culture (Cooper et al. 2016). The recent development of a stable cattle ATII 
cell line by over-expression of human telomerase reverse transcriptase 
(HTERT) may facilitate in vitro alveolar epithelial cell work further (Su et al. 
2013). 
However, in vitro mechanotransduction studies of a monolayer of 
alveolar epithelial cells are limited given that the cellular repertoire, polarity, 
cell-cell and cell-matrix adhesions and composition of extracellular matrix in 
vivo are fundamentally different. Focal adhesions of fibroblasts in three 
dimensional tissue environments did not resemble those seen in culture on 
flat surfaces, showing the absence of distinct focal and fibrillar adhesions, 
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with different rates of migration and proliferation (Cukierman et al. 2001) 
(Figure 1-5).  
A better method of replicating the in vivo physiological environment in 
mechanotransduction studies of the alveolar epithelium is to use ‘micro-
stretchers’ to apply CMS to air lung interface (ALI) cultures of cells on ‘lung 
on a chip’ systems (Huh et al. 2010). In this case, epithelial and endothelial 
cells are seeded on opposite sides of a porous membrane, where the 
epithelial surface is exposed to air, and the endothelial surface is perfused. A 
vacuum produced around the membrane induces uniaxial strain.  
Another approach is through the use of PCLS. Human or animal lung 
tissue that has been agarose-inflated and sliced to under 500 µm thickness 
can survive for several days in culture and retains alveolar epithelial cellular 
characteristics (Alçada et al. 2014; Uhl et al. 2015). Furthermore, the in vivo 
cellular microenvironment is retained (Sanderson 2011). By stitching (N 
Davidovich et al. 2013; Song et al. 2016) or clamping the slice (Dassow et al. 
2010) to a flexible substrate, equibiaxial CMS can be applied. Transient 
expression of focal adhesion markers allows for the real-time investigation of 
cell-matrix and cell-cell interactions in living human tissue (Burgstaller et al. 
2015), and coupled with progress in live cell imaging during CMS (Rápalo et 
al. 2015), this method presents exciting opportunities for cellular 
mechanobiology research. 
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Figure 1-5 Focal adhesions in 3-dimensions do not resemble those seen in culture on 
flat surfaces 
Adapted from (Cukierman et al. 2001) Reprinted with permission from the American Society 
for the Advancement of Science (AAAS). Panels A-E represent confocal microscopic images 
of murine fibroblast in vitro on a fibronectin-coated cover slip whereas panels F-J represent 
transverse cryostat craniofacial mesenchyme sections of an E13.5 mouse embryo. α5 integrin 
(green) and paxillin (red) colocalize in a fibrillar structure in the mesenchymal tissue [(H), but 
not in the plated cells in vitro (C). Similarly, fibronectin (blue] localises to the in vivo fibrillar 
structures (J) 
 
1.3.3 Measuring forces in mechanotransduction  
The repertoire of methods used to study cell adhesion forces, such as 
atomic force microscopy (AFM) (Charras & Horton 2002), traction force 
microscopy (TFM) (Sabass et al. 2008) and magnetic twisting cytometry 
(Mijailovich et al. 2002), have traditionally either required a force to be applied 
to proteins, or measure micrometre-scale deformation of extra-cellular matrix 
(ECM) in vitro (Jurchenko & Salaita 2015). However, investigation of 
mechanotransduction events in vivo has been facilitated by the advent of 
fluorescence molecular tension-sensing probes which can measure 
deformation on a nanometre scale. Förster Resonance Energy Transfer 
(FRET) describes the non-radiative transfer of energy from a donor 
fluorophore to an acceptor, depending on the proximity between the two 
(Jurchenko & Salaita 2015). The Förster distance, at which energy transfer 
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between a spectrally overlapping donor and acceptor pair is approximately 
50%, is generally between 4 to 7 nm. Therefore, this technology has been 
used to investigate conformational dynamics of single molecules, such as 
measuring activation of RhoA using a FRET probe (Pertz et al. 2006; 
Heasman et al. 2010). In respect to measuring forces between cells, and cells 
and their environment, two main classes of FRET tension probes have 
emerged.  
One group consists of an immobilised fluorophore anchored to a 
substrate, whereby its fluorophore pair bound to a biological cell-ligand 
extends a flexible linker between the two (Jurchenko & Salaita 2015). The 
second consists of genetically engineered fluorophore pairs, split by a flexible 
linker, encoded within proteins and expressed in the living cell. In both cases, 
FRET between fluorophores is at its greatest when there is minimal tension 
between the two, but there is generally some degree of donor-acceptor 
separation even at this stage (Jurchenko & Salaita 2015). The 2010 tension 
sensor module (TSMod) consists of an mTFP1 and Venus FRET pair, joined 
by a 40 amino-acid flexible linker derived from spider silk protein (Grashoff et 
al. 2010). Calibrated using optical tweezers, when incorporated into vinculin 
the sensor revealed an average tension across vinculin of 2.5pN and an 
increase in tension at the protruding edges of the cell. This sensor has been 
used more recently to investigate the tension applied across E-cadherin 
(Borghi et al. 2012) and platelet endothelial cell adhesion molecule (PECAM) 
(Conway et al. 2013) in cell-cell adhesion studies. 
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AFM and traction force measurements of alveolar epithelial cells have 
been used to indicate their tensile forces (Alcaraz et al. 2003; Waters et al. 
2012) and pre-stress values (Sunyer et al. 2009) in comparison to those from 
fibroblasts and airway smooth muscle cells. The fact that these values were 
generally low, in the context of the in vitro environment, has lent credence to 
the theory that the ECM and air-liquid interfaces are responsible for bearing 
the majority of the load applied to the lung (Waters et al. 2012). 
1.4 Cellular mechanotransduction: how cells transduce 
forces into biological signalling 
Alveolar epithelial cells have specialised and flexible basement 
membrane consisting of laminin and collagen, and the cells are bound to this 
ECM via cell-matrix interactions (Roan & Waters 2011). The response of cells 
to mechanical forces acting through cell-matrix attachments is regulated by 
discrete cellular signalling, depending on the nature, magnitude and duration 
of applied force. Tension applied to integrins using magnetic microbeads 
induced either early visco-elastic responses or adaptive strengthening, or late 
cellular stiffening and increased countering traction forces to sustained force 
application (Matthews et al. 2006). The early and late responses were 
dependent on Rho-associated protein kinase (ROCK) signalling, but also on 
functioning mechanosensitive ion channels, indicating that cell-matrix forces 
activate specific and conserved cell signalling pathways.  
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1.4.1 The integrin-focal adhesion complex  
The cellular machinery of mechanotransduction can be thought of as 
comprising a load bearing structure, the cytoskeleton, which acts through and 
in response to the mechanosensory apparatus of the integrin-focal adhesion-
ECM complex. The latter acts as the hub through which cells sense the 
rigidity or stiffness of their external environment (Discher et al. 2005), and in 
response, determine cytoskeletal force to exert traction forces on the ECM 
(Plotnikov et al. 2012). This finely tuned and dynamic force-feedback loop 
determines cell adhesion and motility (Hoffman et al. 2011; Sun et al. 2016; 
Li, Lee, et al. 2016) and also determines key cellular behaviours, such as 
migration (Lo et al. 2000) (Plotnikov et al. 2012), proliferation and 
differentiation (Engler et al. 2006; Dupont et al. 2011).  
1.4.2 Integrin-mediated mechanotransduction 
 Integrins, the heterodimeric transmembrane receptors that link the 
cellular cytoskeleton to the ECM (Tamkun et al. 1986), are the primary 
cellular mechanosensitive machinery (Puklin-Faucher & Sheetz 2009). The 
heterodimers are composed of one of 18 α subunits non-covalently bound to 
one of 8 β subunits (Hynes 2002). Thus, 24 different mammalian integrins 
can be formed, each one specified for a particular ECM ligand (Hynes 2002; 
Sun et al. 2016; Campbell & Humphries 2011) (Table 1-1). Integrins are bi-
directional signal transducers: they can mediate the transmission of force 
from the cytoskeleton onto the ECM (inside-out signalling), or from the ECM 
to the cell (outside-in signalling) (Springer & Dustin 2012).  
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ECM ligand Integrin 
Laminin α3β1, α6β1, α1β1, α2β1, α10β1, 
α7β1, α6β4 
Collagen α10β1, α2β1, α1β1, α11β1 
Fibronectin αVβ1, α5β1, α8β1, αVβ6, αVβ3, 
α11bβ3 
ICAM αXβ2, αMβ2, αLβ2, αDβ2 
E-cadherin αEβ7 
Table 1-1 Major classes of integrin-ligand partners 
Based on (Humphries et al. 2006). Throughout the normal lung, integrin subunits α1, α2 and 
α3 are found in epithelial and endothelial alveolar layers, and α6 is present at the basolateral 
alveolar surface. Normal adult alveolar epithelium shows strong expression of β1 integrins 
(Koukoulis et al. 1997). The alveolar epithelial basement membrane is composed of laminin, 
types IV and V collagen, entactin, chondroitin sulphate and heparin sulphate proteoglycans 
(Dunsmore & Rannels 1996). 
ICAM – Intercellular Adhesion Molecule 
Both directions of signalling transduction mediate a change in 
conformation of the integrin heterodimer from a bent structure with low affinity 
for ECM ligand, to structures with intermediate or high ligand affinity (Luo & 
Springer 2006). The bent conformation consists of a closed ectodomain 
headpiece (Takagi et al. 2002; Springer & Dustin 2012), whereas the 
intermediate or high affinity states consist of either extension of the 
ectodomain alone in the former (Luo et al. 2007), or extension together with 
swinging open of the headpiece in the latter (Takagi et al. 2002) (Figure 1-6). 
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Figure 1-6 Conformation of integrins 
Adapted from (Springer & Dustin 2012) (Current opinion in cell biology, vol:24, T.Springer, 
M.Dustin, Integrin inside-out signalling and the immunological synapse, pgs: 107-15 Copyright 
(2012), with permission from Elsevier. In the low affinity, bent conformation, the integrin has a 
closed headpiece. Extension at α- and β-knees leads to an extended-closed conformation but 
with low affinity. The hybrid domain swings out at the interface with the βI domain and the βI 
interface connects with the β-propeller domain that increases affinity for ligand in the extended-
open conformation. In αI integrins, activation of a binding site for the internal ligand Glu310 in 
αL, pulls down the αI domain to activate an increase in affinity of the αL I domain for the ligand 
ICAM-1. The lower β-legs are also highly flexible, as shown by the dashed lower β-leg. 
Therefore, only large separations between α and β transmembrane (TM) domains such as from 
lateral motion of β when its cytoplasmic domain is in association with the actin cytoskeleton, 
can be transmitted through the floppy β-leg to stabilize the high-affinity conformation with open 
headpiece 
 
 51 
1.4.2.1 Inside-out signalling 
Forces generated from by the cytoskeleton can be transmitted through 
the integrin-focal adhesion complex onto the ECM. However, the cytoplasmic 
domains of integrins do not contain actin binding sites, therefore linkages with 
the actin cytoskeleton are co-ordinated via adaptor proteins such as talin and 
kindlin (Calderwood et al. 2013). Although in an auto-inhibited conformation 
when in the cytoplasm (Yang et al. 2014), talin consists of an N-terminal head 
domain which interacts with β1-integrin cytoplasmic tails. Actin binding sites 
in the head and rod complete the linkage with the F-actin cytoskeleton 
(Calderwood et al. 2013; Ye et al. 2014). For example, binding to F-actin 
initiates contact, with subsequent force stretching the talin rod to expose 
cryptic binding sites for the critical focal adhesion protein, vinculin (del Rio et 
al. 2009; Sun et al. 2016).  
Vinculin binding reinforces talin-actin engagement, exposing more 
vinculin binding sites, promoting further linkage with actin (Atherton et al. 
2015; Yao et al. 2016). Nuclear magnetic resonance (NMR) spectroscopy 
studies revealed that talin-integrin association promotes integrin activation by 
unclasping association between the α and β cytoplasmic tails (Vinogradova et 
al. 2002). Therefore, inside-out force transmission from actin, and in 
particular, lateral force as provided by moving actin filaments, induces 
integrin affinity for ECM ligand (Zhu et al. 2008), and regulates force across 
the integrin complex (Nordenfelt et al. 2016). 
The integrin co-activator, kindlin, also directly binds β-integrin tails, but 
much less is known about kindlin interactions in the actin-talin-integrin 
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complex (Calderwood et al. 2013), although it is possible that the talin head 
forms a complex together with kindlin and β-integrin tails. Recently, it has 
been shown that kindlin directly binds actin to mediate force transmission 
(Bledzka et al. 2016), and pull-down experiments in fibroblasts have 
demonstrated that kindlin binds and recruits a further focal adhesion protein, 
paxillin, which recruits the tyrosine kinase, focal adhesion kinase (FAK), to 
the signalling complex (Theodosiou et al. 2016). 
1.4.2.2 Outside-in signalling 
Whereas inside-out force transmission from the actin cytoskeleton 
regulates integrin-ECM binding affinity, ligand binding also drives and 
stabilises integrin headpiece opening (Du et al. 1991; Takagi et al. 2002), and 
increases integrin clustering (Welf et al. 2012), to promote outside-in force 
transmission. The precise steps leading from changes in ECM-induced 
integrin affinity to activation of talin are not completely understood (Ginsberg 
et al. 2005), but it is thought that both conformational change and integrin 
clustering drive the recruitment of effector proteins, such as focal adhesion 
kinase (FAK) and Proto-oncogene tyrosine-protein kinase sarcoma (Src 
kinase) (Arias-Salgado et al. 2003; Hu & Luo 2013), to the integrin tail, 
triggering further downstream signalling. It is likely that the bi-directional 
signalling processes are not mutually exclusive, and are closely linked to 
each other (Shattil et al. 2010) to regulate cell sensing and response (Puklin-
Faucher & Sheetz 2009). 
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1.4.3 Focal adhesion maturation 
Talin-mediated integrin activation and integrin clustering promote the 
formation of protein complexes at the integrin cytoplasmic tail, through which 
mechanotransduction is finely tuned. These complexes show dynamic 
variation in their size, mechanical properties, and role in 
mechanotransduction (Schiller & Fässler 2013; Sun et al. 2016). The initial 
‘nascent’ adhesion, or focal complex, is constructed at the cell leading edge, 
following integrin, talin, actin, vinculin and paxillin assembly (Zaidel-Bar et al. 
2003). The maturation of these nascent complexes to larger adhesions 
depends on actin flow (Alexandrova et al. 2008), the recruitment of other 
proteins such as zyxin (Zaidel-Bar et al. 2003), tyrosine phosphorylation of 
paxillin and FAK (Zaidel-Bar et al. 2006; Ballestrem et al. 2006) and integrin 
clustering (Roca-Cusachs et al. 2009). 
1.4.4 Mechanical force promotes integrin-dependent focal 
adhesion maturation and reinforcement 
Increased force across the ECM-integrin-focal adhesion-cytoskeleton 
interface matures and strengthens focal adhesions. For example, integrins 
show increased clustering in response to increased ECM rigidity (Paszek et 
al. 2009), whereas the opposite trend is seen in soft matrices (Qian et al. 
2010). Integrin clustering reinforces cell matrix adhesions (Roca-Cusachs et 
al. 2009).  When integrins are subjected to external force, or interact with stiff 
matrices, a corresponding increase in focal adhesion size and strength is 
observed (Sniadecki & Chen 2007; Provenzano & Keely 2011). 
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At a focal adhesion level, maturation in response to force has been 
comprehensively demonstrated (Oakes et al. 2012); micropipette-induced 
force at adhesions promotes focal adhesion elongation (Riveline et al. 2001), 
stretching of single talin rods leads to exposure of vinculin binding sites (del 
Rio et al. 2009), and binding of vinculin stabilises the adhesion by preventing 
refolding of talin into an auto-inhibited conformation (Yao et al. 2014). At a 
cellular level, this response to increased matrix rigidity can increase the 
capacity of cells to migrate, and proliferate (Saez et al. 2007). This has 
profound functional consequences, for example the increased rigidity of the 
tumour microenvironment promotes cell proliferation (Provenzano et al. 
2009), and increased matrix stiffness promotes myofibroblast differentiation in 
pulmonary fibrosis (X. Huang et al. 2012). However, the process of adhesion 
assembly, maturation and disassembly in response to force is dynamic, as 
opposed to a simple switch-like system (Hoffman et al. 2011). For example, 
the forces in vinculin-containing adhesions are polarised in cells, with 
increased traction forces located in adhesions undergoing assembly at the 
leading edge, and decreased forces in disassembling adhesions at the rear of 
cells, therefore allowing the cell to migrate (Grashoff et al. 2010).  
1.4.5 Integrin-dependent responses to mechanical force are 
dynamic and depend on the degree of force applied 
The processes by which adhesions interact with matrix ligands 
dynamically to control force transmission to the cytoskeleton were first 
conceptualised by the molecular clutch hypothesis (Mitchison & Kirschner 
1988; Case & Waterman 2015). In this model, actin retrograde flow due to 
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myosin-generated contraction is constant, but without engagement of adaptor 
proteins to the integrin tail, does not result in traction forces, but rather a 
stationary “lamellipodial treadmill” (Craig et al. 2012). Engagement of the 
clutch is dependent on substrate stiffness: below a threshold stiffness, 
integrins unbind and the force is released, whereas above the threshold, talin 
unfolding occurs, the adhesion matures, and mechanotransduction can take 
place (Elosegui-Artola et al. 2016). The twin processes of actomyosin 
contractility, and of actin retrograde flow result in traction on the ECM, and 
actin polymerisation at the lamellipodium pushes the leading edge forward 
(Sun et al. 2016). 
Two main types of integrin-matrix adhesive behaviour from force-
induced changes in molecular kinetics have been conceptualised. Intuitively, 
and in correlation with many biological interactions (Dembo et al. 1988; 
Merkel et al. 1999; Li, Lee, et al. 2016), slip bond behaviour describes 
weakening of integrin-ligand bonds following application of force. This 
appears to occur at low levels of tension, whereas catch bond behaviour 
describes prolongation of integrin-ligand bonds in response to force (Thomas 
et al. 2008; Kong et al. 2009), possibly due to force-induced allosteric 
changes (Lou & Zhu 2007; Li, Kong, et al. 2016). This coincides with 
adhesion maturation behaviour described above. However, elegant atomic 
force microscopy and biomembrane force probe experiments suggest that 
cells exhibit slip bond behaviour at low forces, catch bond behaviour at a 
certain range of forces, then reversion to slip bond above a certain threshold 
(Marshall et al. 2003; Wayman et al. 2010). This is reflected in other integrin-
fibronectin models that demonstrate low traction forces at low substrate 
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rigidity when the matrix is deformable by the cell. Decreasing bonding then 
occurs as rigidity increases, the matrix resists deformation and bonds break 
before new ones can be formed. Finally, a threshold stiffness is reached 
where force-induced bond strengthening occurs, i.e the clutch is engaged, 
and force transmission occurs (Elosegui-Artola et al. 2014; Elosegui-Artola et 
al. 2016) (Figure 1-7). Such dual or triphasic behaviour might help explain 
how cells regulate adhesion under conditions of varying mechanical tension, 
such as during leukocyte rolling and adhesion.  
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Figure 1-7 The molecular clutch hypothesis of integrin-matrix adhesion 
Reprinted by permission from Nature Publishing Group: Nature cell biology (Case & 
Waterman 2015), copyright (2015). Under conditions of low force, actin is not engaged with 
the ECM, and actin flows retrogradely. Under conditions of increasing force (lower panel), 
force-induced bond strengthening occurs, the clutch is engaged, and the retrograde actin flow 
changes to traction on the ECM and cellular protrusion 
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1.4.6 Responses to externally-applied mechanical force 
How cells regulate integrin-ligand adhesion in response to CMS might 
rely on these triphasic models of adhesion. Cyclic force on α5β1 integrin-
fibronectin bonds prolonged their lifetimes 100-fold (Kong et al. 2013), 
suggesting force-induced bond ‘memory’. A model for this type of ‘cyclic 
mechanical reinforcement’ suggests that each loading cycle induces changes 
in integrin conformation to a high affinity state, such that there is an 
accumulation of high-affinity bonds following repetitive, fast cycles (Li, Kong, 
et al. 2016). In correlation with this, atomic force microscopy of a single 
fibroblast bonded to a fibronectin-coated bead on a cantilever demonstrated 
that cyclic stretch rapidly promoted a decrease in bond tension, followed by 
an actomyosin-dependent gradual increase in tension over subsequent 
cycles (Watanabe-Nakayama et al. 2011).  
Indeed, the application of different types of force induces different 
effects, suggesting that cells sense and respond not only to the degree of 
force applied, but also to the nature in which it is applied. This leads to 
different downstream effects: in endothelial cells, static or tonic (continuously-
applied) stretch induces differential gene transcription to that from CMS, and 
the latter had a greater effect on vascular tube length and branch formation 
than static stretch (Zheng et al. 2008). Similarly, application of the two 
different modes of stretch in rabbit aortas induced differential tyrosine kinase 
phosphorylation (Lehoux et al. 2005). How different types of force induce 
distinct mechanotransduction is thought to be due to sensing of substrate 
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deformation at the focal adhesion-integrin-ligand interface (Hoffman et al. 
2011), but the exact mechanism, and whether this is the case in the alveolar 
epithelium, is currently unclear. 
1.5 Integrin-associated proteins 
Whereas therapeutic targeting of leukocyte integrin-ligand binding has 
been met with success in some cases, inflammatory and auto-immune 
diseases for example, (Cantor et al. 2008), this method can have serious 
adverse consequences. For example, application of stretch in alveolar 
epithelial cells in which β1-integrin activity is inhibited can induce rapid cell 
detachment, and death (Liu et al. 2011). Therefore, modulation of integrin 
signalling via associated proteins presents an attractive option. 
1.5.1 CD98hc  
Mechanical force applied to β1-integrins promoted integrin activation 
and downstream RhoA signalling (Guilluy et al. 2011). Mechanical stretch 
applied to keratinocytes also increased β1 integrin-mediated adhesion 
through induction of integrin clustering (Knies et al. 2006), and this 
mechanism may promote stretch-induced epidermal thickening in skin 
(Tokuyama et al. 2015). More specifically, CMS of renal epithelial cells 
increased β1-integrin expression and signalling, promoting downstream TGF-
β-mediated signalling (Hamzeh et al. 2015). That mechanical force can 
trigger β1-integrin-mediated signalling is evident in a variety of cell types, 
such as in cardiac myocytes where it is necessary for stretch-induced auto-
phosphorylation of FAK (Lal et al. 2007). 
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Specific integrins may have distinct roles in mechanotransduction. 
Mechanical force modulates the adhesive strength of β1-integrin-fibronectin 
bonds (Friedland et al. 2009), and changes the conformational state of β1-
integrins (Zhu et al. 2008). Increased ECM density specifically activated β1, 
but not β3, integrins in a ROCK and myosin II-dependent manner (Lin et al. 
2013), and whereas the former may regulate cell adhesion and spreading, 
the latter appears necessary for stable focal adhesion formation (Schaufler et 
al. 2016).  
CD98 (4F2, solute carrier family 3 member 2 - SLC3A2) is a 
transmembrane protein that regulates β-integrin signalling. Initially discovered 
as a marker for activated B and T lymphocytes (Haynes et al. 1981), it has 
since been discovered to have key roles in cell survival, adhesion and 
proliferation (Cantor & Ginsberg 2012). Expressed in all vertebrate cell types 
except platelets, the CD98 complex exists as a heterodimer of an 80kDa 
glycosylated heavy chain, linked by disulphide bridges to one of several 
40kDa non-glycosylated light chains (Devés & Boyd 2000) (Figure 1-8). 
Whereas the light chains regulate amino acid transport and are dispensable 
for CD98 expression (Verrey et al. 1998), the heavy chain is essential and 
interacts with β-integrin tails (Fenczik et al. 2001). CD98hc is necessary for 
normal development, and genetic deletion is lethal at the early embryonic 
stage (Tsumura et al. 2003).  
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Figure 1-8 Structure of CD98 
From (Fort et al. 2007) copyright American Society for Biochemistry and Molecular Biology – 
permissions not required. CD98 consists of a heavy chain (central – pink) linked to an N-
glycosylated ectodomain by a conserved disulphide bridge (Cys 109) with a light subunit 
consisting of a 12 trans-membrane spanning non-glycosylated protein 
 
Interaction between the CD98hc cytoplasmic tail and integrins promotes 
integrin signalling, and binding to β-integrin tails is required for adhesion-
dependent spreading of cells (Prager et al. 2007). Specifically, the 
intracellular and transmembrane domains of CD98hc are necessary and 
sufficient for integrin binding and activity (Feral et al. 2005).  
Given its capacity to modulate integrin signalling, CD98hc may play a 
key role in the regulation of the tumour microenvironment (Bajaj et al. 2016). 
As such it is up-regulated in many cancer types (Prager et al. 2009) and its 
expression correlates with aggressiveness of disease (Pöttler et al. 2011). 
This has led to the hypothesis that CD98hc expression amplifies integrin 
signalling such that cells can become anchorage independent and survive 
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and proliferate in soft matrix environments (Cantor & Ginsberg 2012), 
promoting tumourgenesis (Henderson et al. 2004). Indeed, CD98hc 
expression promotes renal epithelial cell proliferation via ERK signalling 
(Bulus et al. 2012), and suppression of CD98hc-mediated β1-integrin 
signalling has been shown recently to inhibit the progression of renal cell 
carcinoma (Poettler et al. 2013) and hepatocellular carcinoma in vivo (Wu et 
al. 2016).  
CD98hc also regulates RhoA signalling. CD98hc null fibroblasts showed 
attenuated β1-integrin-driven RhoA activity (Féral et al. 2007), and CD98hc-
mediated integrin activity regulated RhoA signalling to generate actomyosin 
contractility and traction on the ECM. Such CD98hc-regulated RhoA activity 
promotes keratinocyte proliferation and migration, and therefore skin 
homeostasis (Boulter et al. 2013). CD98hc deficiency also inhibits Ras-
induced skin tumourgenesis via decreased ROCK signalling (Estrach et al. 
2014) and, in this latter study, CD98hc-mediated ROCK signalling regulated 
epidermal stiffness and YAP/TAZ signalling, indicating CD98hc-RhoA activity 
as important for tuning mechanoresponses. 
1.6 Actin cytoskeletal mechanotransduction 
Coupled to focal adhesions via adaptor proteins, the actin cytoskeleton 
is a key component of force sensing and response (Burridge & Guilluy 2016). 
The microfilament F-actin is the major load-bearing element of the cellular 
architecture complemented by microtubules (such as tubulin) and 
intermediate filaments (such as desmin, vimentin and keratin) (Herrmann et 
al. 2007; Fletcher & Mullins 2010). Contractile actin stress fibres are bundles 
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of F-actin filaments, cross-linked by bipolar arrays of α-actinin and myosin II 
(Hu et al. 2017), and are emerging as being integral to cytoskeleton-mediated 
mechanotransduction. Ventral stress fibres, the long linear actin filaments 
that extend along the cell from one end to another, are anchored at each end 
by focal adhesions (Livne & Geiger 2016). Indeed, RhoA-mediated myosin 
driven contraction on actin filaments may be necessary for stress fibre 
assembly (Chrzanowska-Wodnicka & Burridge 1996; Even-Ram et al. 2007) 
in addition to focal adhesion maturation (Riveline et al. 2001), although recent 
evidence has suggested that myosin II-induced cross-linking of actin may be 
more important for nascent adhesion maturation than tension generation 
(Choi et al. 2008). Myosin-driven contraction of actin filaments induced α5β1 
integrin conformational change to increase ligand binding affinity (Friedland et 
al. 2009), therefore directly coupling actin contractility on stress fibres to 
tension on the ECM. 
Correspondingly, cytoskeletal remodelling and stress fibre development 
appear to be dependent on substrate rigidity in vitro. Fibroblasts cultured in 
gels contracted without stress fibre formation. However, when the gels were 
anchored to prevent deformation, stress fibre formation developed in the non-
contracted fibroblasts (Tomasek et al. 1992), suggesting that stress fibres 
hold cells in isometric tension (Burridge & Guilluy 2016). Stress fibre 
formation in response to increased rigidity of the substrata is likely to be 
mediated by the small GTPase RhoA (Chrzanowska-Wodnicka & Burridge 
1996), which shows increasing activity with increased stiffness of the matrix 
(Ridley & Hall 1992; Wozniak et al. 2003; Paszek et al. 2005). Tension on 
fibronectin-coated beads, which applied force to β1-integrins, induced RhoA 
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activation, and this was regulated through the action of two guanine 
nucleotide exchange factors (GEFs), leukaemia-associated Rho GEF (LARG) 
and GEF-H1 (Guilluy et al. 2011). The former is activated through Src 
tyrosine kinases, and the latter downstream of FAK and mitogen-activated 
protein kinase (MAPK)/ERK. Downstream ROCK-mediated activation of 
myosin II induced contractility and increased tension applied across the focal 
adhesion-ECM interface (Kimura et al. 1996). Stretch of F-actin filaments 
increased the affinity of actin for myosin II motors, thus creating a positive 
feedback loop in response to force (Uyeda et al. 2011).  
Just as focal adhesions reorient in response to CMS, the actin 
cytoskeleton, as the major load bearing element of cellular architecture, 
demonstrates stretch-induced remodelling. Cyclic strain of endothelial cell 
monolayers induced rapid formation of stress fibres, tenting in the direction of 
least strain (J. H.-C. Wang et al. 2001). Force-induced actin remodelling 
appears to be specific to the type of strain applied: whereas uniform shear 
forces induced stress fibre reorientation parallel to the direction of force in 
endothelial cells (Tzima 2006), cyclic strain of fibroblasts promoted stress 
fibres to reorient perpendicular to the direction of force (Hayakawa et al. 
2001). These responses were dependent not only on substrate rigidity (Faust 
et al. 2011), but also on the frequency and amplitude of cycles (Jungbauer et 
al. 2008). One possibility explored is that stress fibre reorientation occurs in 
response to a critical force threshold, followed by disassembly of bonds, and 
reorientation of actin to a more stable configuration (Chen et al. 2012). 
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Similarly, primary ATI subjected to CMS at high magnitude formed peri-
junctional actin rings (PJAR), associated with rapid movement of integrin-
bound arginylglycylaspartic acid (RGD) microbeads at the cell surface to 
track the displacement of anchored actin filaments (DiPaolo et al. 2010). 
These responses, the latter specific to CMS and dependent on the frequency 
of stretch applied, led to the suggestion that cells reorient actin cytoskeleton 
filaments to areas of least strain. Furthermore, rapid actin cytoskeleton 
movement and then attenuation during CMS was associated with stretch-
induced fluidisation of the cytoskeleton, followed by a stiffening or 
reinforcement process. This dual phase response correlates with the finding 
that the focal adhesion protein zyxin is recruited to stress fibres in fibroblasts 
exposed to CMS (Yoshigi et al. 2005), and whereas it is not required for 
strain-induced cytoskeletal remodelling, which is Rho-dependent, it is 
necessary for repair and thickening of stress fibres in the reinforcement 
phase which is independent of RhoA (Hoffman et al. 2012). 
However, the cytoskeleton may have a greater role in force transmission 
than passive remodelling. Human foreskin fibroblasts subjected to uniaxial 
sustained mechanical stretch showed reinforcement and reorientation of 
stress fibres along the direction of strain. Furthermore, stretch-induced 
activation of ERK localised to stress fibres and in correlation with the degree 
of strain applied, independently of myosin II-induced cell contractility (Hirata 
et al. 2015). In this way, stress fibres are a platform for force sensing and 
mechanotransductive signalling. 
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1.6.1 RhoGTPases 
That CMS may induce RhoA signalling in fibroblasts via Rho GEFs 
(Guilluy et al. 2011) correlates with data obtained from CMS of lung 
endothelial cells (Gawlak et al. 2014). In this case, 15 minutes of CMS in 
human pulmonary artery endothelial cells (HPAEC) induced cytoskeletal 
remodelling as shown by paracellular gap formation, stress fibre formation, 
RhoA activation and downstream MLC phosphorylation. Crucially, 
immunoprecipitation revealed CMS-induced, and ERK 1/2-dependent, 
association of paxillin, ERK and GEF-H1 in the focal adhesion complex, 
which promoted RhoA activation. The authors proposed that CMS induced 
Src/FAK-dependent paxillin phosphorylation, exposing binding sites for the 
GEF-H1/ERK complex. Independently, CMS-induced ERK activity is 
necessary for paxillin-GEF-H1 binding, and this complex triggers Rho-
dependent phosphorylation of MLC and actomyosin contraction.  
Overlap between stretch-induced Rho-signalling and FAK and ERK 
activity has also been demonstrated in other cell types, such as in 
cardiomyocytes (Torsoni et al. 2005), but evidence for CMS-induced RhoA 
signalling in the alveolar epithelium has been conflicting and not so 
comprehensively demonstrated. ATII isolated from rats subjected to high tidal 
volume ventilation (25ml/kg) showed an increase in activated RhoA, as did 
treatment with hyperoxia or with the two treatments combined (Desai et al. 
2007). In vitro, foetal ATII subjected to low magnitude CMS increased RhoA 
and Ras-related C3 botulinum toxin substrate 1 (Rac1) guanosine 
triphosphate (GTP) activity within 5 minutes in the former, and 15 mins for the 
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latter, and expression of dominant negative mutants of these GTPases 
inhibited CMS-induced stress fibre formation and cell realignment (Silbert et 
al. 2008).  Interestingly, expression of these mutants abrogated CMS-induced 
ERK phosphorylation, suggesting that this process is dependent on Rho 
activity, in contrast to the data from endothelial cells. Conversely, biaxial CMS 
of rat ATI showed decreases in RhoA activity and MLC phosphorylation 
(DiPaolo & Margulies 2012), and also that CMS-induced cytoskeletal 
remodelling was dependent on Rac1-mediated phosphorylation of cofilin and 
LIMK (Dipaolo et al. 2013). How these differing CMS-induced cytoskeletal 
pathways can be reconciled is not yet clear, but differences may be due to 
cell type, and the actual magnitude of stretch when applied to cells of 
different sizes. 
Murine lung epithelial cells (MLE)-12 cultured under hyperoxic 
conditions showed increased F-actin stress fibre formation, but also a 
corresponding and ROCK-dependent increase in elastic modulus, implying 
that hyperoxic-induced and RhoA-mediated cytoskeletal remodelling 
contributes to increased stiffness of cells. When these ‘stiffer’ cells were 
subjected to CMS, they detached more easily from the substrate, which 
again, was abrogated by ROCK inhibition (Wilhelm et al. 2014). This led the 
authors to believe that hyperoxia-induced ROCK activity increases cellular 
pre-stress, and therefore the susceptibility of ATII to deformation. These 
findings correlate with the previous observation that ATII decreased adhesion 
following stretch when a constitutively active RhoA mutant was used (Desai 
et al. 2007). Therefore, CMS-mediated regulation of RhoA may alter cellular 
stiffness, the deformability of cells, and subsequent mechanotransduction.  
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1.6.2 Mechanical properties of the cytoskeleton 
Cytoskeletal responses of cells to force can be described in part by the 
‘tensegrity’ model, whereby the cell is stable through a continuous balance 
between opposing tensile and compressive forces (Ingber et al. 2014). In this 
model, the compressive elements (microtubules) and tension elements (actin 
microfilaments) generate pervasive structural tension and stability (N. Wang 
et al. 2001). Force propagation along pre-stressed actin fibres is integral to 
mechanotransduction (Hu et al. 2005), but the orientation of stress fibres 
dictates the speed at which force can be transmitted throughout the cell. This 
is thought to be the mechanism by which cuboidal arterial endothelial cells 
with randomly-aligned fibres are more susceptible to the development of 
shear-stress associated atherosclerosis than elongated cells with highly 
aligned fibres (Hwang & Barakat 2012).  
These models may explain force-induced stress-fibre reorientation 
(Hayakawa et al. 2001) as an attempt to escape, or adapt to, applied force. 
Cellular pre-stress increases linearly with cell rigidity (Wang et al. 2002), and 
tunes the sensitivity of the cell to respond to external force or stretch (Cirka et 
al. 2016). The rheology of the actin cytoskeleton responds to increasing 
substrate stiffness by increasing internal cellular stiffness. Both atomic force 
microscopy creep tests and kymographs of actin intensity of fibroblasts plated 
on substrates of increasing stiffness revealed decreasing retrograde actin 
flow with increasing substrate stiffness, indicating that the cytoskeleton 
behaves as fluid-like when plated on soft substrates, but as a solid-type 
material on stiffer substrates (Gupta et al. 2015). 
 69 
Cytoskeletal remodelling in response to CMS is dynamic, possibly 
composed of an initial fluidisation or softening of the cytoskeleton, followed by 
stiffening or solidifying (Colombelli et al. 2009). This has been shown in 
airway smooth muscle cells subjected to optical magnetic twisting cytometry 
(OMTC) (Trepat et al. 2007), and in bladder smooth muscle cells (Chen et al. 
2010). In the latter case, the fluidisation response appears to occur through 
the release of existing tensile forces leading to dissociation of weak bonds or 
of actin with binding partners. The degree by which the cytoskeleton 
becomes more fluid is determined by baseline stiffness, or pre-stress. Cells 
with higher initial pre-stress, such as following treatment with TGF-β, 
decrease traction forces in response to CMS, whereas cells with low baseline 
pre-stress, such as following myosin II inhibition, increase traction forces in 
response to stretch (Cirka et al. 2016). 
1.7 Epithelial repair 
1.7.1 Integrin and RhoGTPase signalling in epithelial repair 
The lung shows significant capacity to regenerate following injury (Zeng 
et al. 2016). Recovery from lung injury requires, in part, restoration of the 
alveolar epithelium, and this process is dependent on cell spreading, 
migration and proliferation to recover the denuded basement membrane 
(Crosby & Waters 2010), Furthermore, evidence is emerging that populations 
of distal airway stem cells (DASC’s), bronchoalveolar stem cells (BASCs) and 
lineage negative epithelial progenitor cells (LNEPs) all act as progenitor cells 
that proliferate, differentiate into ATII and migrate to the site of alveolar 
damage (Kim et al. 2005; Zuo et al. 2014; Vaughan et al. 2014; Zeng et al. 
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2016). These processes of migration and repopulation required for restoration 
of the injured lung alveolar epithelium both need to occur in the setting of 
continuous CMS experienced by the lung, and are mediated by many of the 
same pathways activated in CMS-induced injury, such as cytoskeletal-
integrin-ECM interactions and RhoGTPase-driven signalling and traction 
forces (Crosby & Waters 2010).  
β1-integrin signalling mediates migration of rat ATII on fibronectin and 
collagen (Kim et al. 1997), and is also necessary for airway epithelial 
migration on laminin (White et al. 1999). Inhibitors of downstream MAPK 
signalling, such as p38 MAP kinase, JNK and ERK 1/2, inhibited airway cell 
migration (White et al. 2005). Similarly, RhoA signalling is required for wound 
repair in A549 cells, and its inhibition resulted in cytoskeletal collapse and cell 
detachment at the wound edge (T. K. Geiser et al. 2001). Therefore, targeting 
such pathways to abrogate CMS-induced injury may adversely affect 
epithelial repair. Furthermore, CMS itself has been shown to negatively 
modulate epithelial repair processes (Desai et al. 2008). 
1.7.2 The effect of CMS on epithelial repair 
CMS significantly reduced the healing or migration of airway epithelial 
cells in response to a physical wound to the cell monolayer (Savla & Waters 
1998; Crosby et al. 2011). This response may be mediated by CMS-induced 
inhibition of PI3K (Desai et al. 2010) and ameliorated by keratinocyte growth 
factor (KGF) (Waters & Savla 1999). In alveolar epithelial cells, similar CMS-
induced inhibition of migration occurred at higher magnitudes of strain and 
was associated with decreased Rac1 activity dependent on membrane 
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localisation of T-cell lymphoma invasion and metastasis-inducing protein 1 
(Tiam1) (Desai et al. 2008). Conversely, the inflammatory milieu of acute lung 
injury (ALI) or VALI may promote healing. IL-1β, a cytokine associated with 
lung injury, significantly increased rat ATII monolayer repair in vitro, via a 
MAPK-dependent mechanism (Geiser et al. 2000), and this process was also 
shown to be dependent on NF-κB signalling in airway cells (White et al. 
2008). Therefore, the effect of lung injury and VALI on repair of the alveolar 
epithelium is complex and far from being comprehensively understood. 
Mechanical strain has also been associated with decreased cell adhesion. 
ATII from rats subjected to high tidal volume ventilation with hyperoxia 
showed decreased adhesion together with reduced FAK phosphorylation and 
increased RhoA activity (Desai et al. 2007). Expression of a dominant 
negative RhoA in these cells restored adhesion. 
1.8 Hypothesis and aims 
The work in this thesis tests the hypothesis that RhoA GTPase and 
integrin signalling mediate CMS-induced injury in alveolar epithelial cells 
(Figure 1-9). 
Specifically, the aims of this project were to investigate: 
• how CMS affects cytoskeletal remodelling and RhoA GTPase 
signalling in alveolar epithelial cells (chapter 3) 
• the role of the integrin-associated protein CD98hc in CMS-
induced signalling, and in adhesion and migration in alveolar 
epithelial cells (chapter 4) 
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• to determine whether PCLS can be used as a platform in which to 
investigate CMS-induced RhoA GTPase and integrin signalling in 
alveolar epithelial cells (chapter 5) 
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Figure 1-9 Putative mechanism by which integrin and RhoA GPTase signalling may 
mediate CMS-induced injury in alveolar epithelial cells 
The work in this thesis tests the hypothesis that cyclic mechanical strain (CMS)-induced 
cytokine release is mediated through integrin and cytoskeletal Rho GTPase signalling. Panel 
A demonstrates how cellular integrins bind to ligands in the extracellular matrix (ECM), and 
are linked to the actin cytoskeleton through focal adhesion protein complexes. These are 
composed of a vast array of proteins, including focal adhesion kinase (FAK), vinculin (vinc) 
and talin. Inside out transmission of force from actomyosin contraction exerts traction on the 
ECM, allowing cells to become motile.  Panel B shows how the application of strain on the 
ECM triggers activation of β1-integrins (Guilluy et al. 2011). Force-induced integrin activation 
promotes RhoA GTPase activity via the Rho GEF GEF-H1, possibly through FAK-dependent 
formation of an ERK-paxillin complex (Gawlak et al. 2014). Downstream activation of Rho-
associated protein kinase (ROCK) activates non-muscle myosin II (NMII), promoting actin 
cytoskeletal tension and further conformational changes in mechanosensitive and focal 
adhesion proteins. This thereby affects cell matrix adhesion and downstream signalling, 
although how this may then lead to cytokine generation is currently unclear. ROCK can be 
inhibited by Y27632, and NMII by blebbistatin. 
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2 Chapter 2: Materials and methods 
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2.1 Reagents and materials 
2.1.1 General reagents 
2-mercaptoethanol Sigma-Aldrich – M6250 
2-propanolol Sigma-Aldrich - 59304 
Bovine Serum Albumin (BSA) Sigma-Aldrich – A7030 
Dimethyl sulphoxide (DMSO) Sigma-Aldrich – D5879 
Dithiothreitol (DTT) Cell Signalling – 7016 
Ethylenediaminetetraacetic acid 
(EDTA) 
Invitrogen – AM9260G 
Ethanol Sigma-Aldrich – E7023 
Glycine Sigma-Aldrich – G7126 
HEPES Life Technologies - 15630080 
Methanol Fisher Chemical – M4000/17 
Methylthiazolitetrazolium (MTT) Sigma-Aldrich - 93482 
Milk powder Marvel 
Phenylmethanesulphonyl fluoride 
(PMSF) 
Sigma-Aldrich - 93482 
Sodium Azide Sigma-Aldrich – S2002 
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Sodium Chloride Fisher Chemical – S/3161/60 
Triton X-100 Sigma-Aldrich – X100 
TRIZMA base Fisher Chemical – BP152-1 
TRIZMA hydrochloride Sigma-Aldrich – T3253 
Tween-20 Sigma-Aldrich – P2287 
 
2.1.2 Cells and culture reagents 
A549 alveolar epithelial cells ECACC - 86012804 
Dulbecco’s Modified Eagles Medium 
(DMEM) 
Life Technologies - 31885-049 
Foetal Calf Serum (FCS) Life Technologies 
Penicillin/Streptomycin Life Technologies – 15140122 
Phosphate Buffered Saline Life technologies – 10010-015 
Trypsin - EDTA Life Technologies - 25200056 
 
2.1.3 Cytoskeletal reagents 
Blebbistatin Sigma Aldrich – B0560 
Cytochalasin D Sigma Aldrich – C8273 
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Lypophosphatidic acid (LPA) Sigma Aldrich – L7260 
Y27632 ROCK inhibitor Sigma Aldrich – Y0503 
 
2.1.4 Cytokines, inhibitors and other drugs 
Human Interleukin-1β R&D Systems – 201-LB-005 
Human Tumour Necrosis Factor α 
(TNF- α) 
Thermo Scientific – 10602 HNAE5 
 
2.1.5 Molecular biology reagents 
Culture broth (LB) Sigma-Aldrich – L3022 
DH5α bacterial cells Invitrogen - 12297016 
Lipofectamine p3000 transfection kit Invitrogen – L3000001 
Maxiprep kit Invitrogen – K210016 
Optimem medium Life Technologies – 31985-062 
Qiaprep miniprep kit Qiagen – 27104 
 
2.1.5.1 RNA extraction and processing 
cDNA reverse transcription kit Applied Biosystems - 4368814 
Chloroform Sigma-Aldrich - 319988 
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DNase 1 Qiagen - 79254 
RNeasy mini kit Qiagen - 74104 
Taqman fast advanced mastermix Life technologies - 4444556 
Trizol reagent Life technologies - 15596018 
2.1.5.1.1 Taqman primers 
Species Gene Primer code 
Mouse B2m Mm00437762_m1 
Mouse HPRT Mm01545399_m1 
Mouse CXCL1 Mm04207460_m1 
Mouse CXCL2 Mm00436450_m1 
Mouse IL-6 Mm00446190_m1 
Human B2m Hs00984230_m1 
Human GAPDH Hs03929097_g1 
Human ARHGAP6 Hs00241801_m1 
Human MAPK13 Hs00234085_m1 
Human CCNA1 Hs00171105_m1 
Human CDC42EP2 Hs00198943_m1 
Human AURKC Hs00152930_m1 
Human LIMK2 Hs00948689_m1 
Human CD98hc Hs00374243_m1 
Human IL-8 Hs00174103_m1 
Table 2-1 Taqman Primers 
All Primers were purchased from Life Technologies 
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2.1.5.2 siRNA reagents 
Oligofectamine Invitrogen - 58303 
RNA/DNAse free water Life Technologies - 10977049 
siRNA buffer Dharmacon - B-002000-UB-100 
2.1.5.2.1 siRNA sequences 
Gene Code Sequence 
CD98hc 
(SLC3A2) 
D-003542-01 UAAGGCUAUGAAGAGAUAC 
Non-targeting D-001210-02 AGAAUGGUCUGGUGAAGAU 
Table 2-2 siRNA sequences used 
All siRNA sequences were purchased from siGenome, Dharmacon 
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2.1.6 Antibodies 
2.1.6.1 Primary antibodies 
 
 
Target Host Company/code Dilution 
β1-integrins  
(active 
conformations 
– HUTS4) 
Mouse Merck Millipore/MAB2079Z 1:100 (IF) 
β1-integrins   Rabbit Abcam/EP1041Y 1:100 (IF) 
1:1000 
(WB) 
CD98hc  Goat Santa Cruz/sc 7095 1:5000 
(WB) 
CD98hc D603P Rabbit Cell signalling/13180S 1:400 (IF) 
E-Cadherin Rabbit BD biosciences/610181 1:100 (IF) 
phospho-ERK 
(Thr202/Tyr204) 
Rabbit Cell signalling/4377 1:100 (IF), 
1:1000 
(WB) 
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Table 2-3 Table of primary antibodies 
IF – immunofluorescence, WB- Western Blot 
 
2.1.6.2 Secondary antibodies 
 
Target Conjugate Host Company/code Dilution 
Goat AF594 Donkey Life 
technologies/A11058 
1:500 (IF) 
Goat AF488 Donkey Life 1:500 (IF) 
total-ERK Rabbit Cell signalling/9102 1:1000 
(WB) 
phospho-FAK  
(Tyr397) D20B1 
Rabbit Cell signalling/8556 1:1000 
(WB) 
total-FAK 
D2R2E 
Rabbit Cell signalling/13009 1:1000 
(WB) 
Gapdh Rabbit Millipore/ABS16 1:20,000 
(WB) 
GRO-α Rabbit Abcam/ab86436 1:100 (IF) 
Paxillin Y113 Rabbit Abcam/ab32084 1:100 (IF) 
PH3 Rabbit Millipore/06-570 1:1000 (IF) 
PMLC2 2 Ser19 Rabbit Cell signalling/3671S 1:50 (IF) 
Pro-SPC Rabbit Millipore/AB3786 1:1000 (IF) 
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technologies/A11055 
Goat HRP Rabbit Dako/P0449 1:5000 
(WB) 
Mouse AF594 Goat Life 
technologies/A11004 
1:500 (IF) 
Mouse HRP Donkey R&D/HAF018 1:3000 (IF) 
Rabbit AF488 Goat Life 
technologies/A11008 
1:500 (IF) 
Rabbit AF594 Donkey Life 
Technologies/A21207 
1:500 (IF) 
Rabbit HRP Goat Cell signalling/7074 1:2000 
(WB) 
Table 2-4 Table of secondary antibodies 
AF – Alexa Fluor, HRP – horseradish peroxidase, IF – immunofluorescence, WB- Western 
Blot 
 
2.1.7 Precision Cut Lung Slices (PCLS) 
Agarose-type IX-A ultra-low gelling 
temperature 
Sigma-Aldrich – A9414 
Hank’s Balanced Salt Solution 
(HBSS) 
 
Life technologies – 14025-050 
2.1.7.1 Murine PCLS culture 
Dulbecco’s Modified Eagle Medium 
(low glucose, +phenol +L-glutamine) 
Life technologies - 31885-023 
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Penicillin/Streptomycin Life technologies - 15140122 
Live/dead viability kit Life Technologies – L3224 
 
2.1.7.2 Human PCLS culture 
Gentamicin 10mg/ml solution Sigma-Aldrich  - G1272 
RPMI 1640 Thermo Scientific - 11875-085 
2.1.8 Imaging reagents 
DABCO anti-fade DAPI stain Sigma Aldrich – D2552 
Mowiol Sigma Aldrich - 81381 
Paraformaldehyde Thermo Scientific - 28906 
Phalloidin stain (Alexa Fluor 488) Molecular Probes (Life Technologies) 
- A12379 
Prolong Gold anti-fade Life Technologies – P36930 
 
2.1.9 ELISA and MSD kits 
Human IL-8 ELISA DuoSet R&D - Dy208-­‐05 
Human IL-8 MSD (Vplex kit) Mesoscale discovery - K151RAD 
Murine KC/GRO MSD (Vplex kit) Mesoscale discovery - K152QTD 
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2.1.10 Western Blot reagents 
BCA assay Thermo Scientific - 23227 
Cell lysis buffer Cell Signalling – 9803S 
ECL western blot substrate Thermo Scientific -  32132 
Gel 4-12% Bis-Tris (Nupage) Life Technologies - NP0322 
Hyperfilm (Amersham) GE healthcare - 289-068–36 
LDS sample buffer (Nupage) Life Technologies - NP0007 
Protein ladder (Fermentas 
Spectra(TM)  
Thermo Scientific - 26634 
Polyvinylidene fluoride (PVDF) 
(Immobilon) Membrane 
Merck Millipore - IPVH00010 
Running Buffer (NuPAGE MES SDS)  Thermo Scientific – NP0002 
 
2.1.11 Equipment 
Appied Biosystems ViiA 7 Applied Biosystems 
Centrifuge (Mistral 2000) MSE 
iCELLigence real-time cell analysis 
software 
ACEA biosciences 
FLIM detector Becker Hickl 
FX-5000T Flexercell in vitro strain Flexcell 
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system 
Microscope (confocal - Inverted) – 
Zeiss LSM 510 
Zeiss 
Microscope (epifluorescence – 
inverted) – Zeiss Axiovert 200 
Zeiss 
Microscope (confocal – upright) – 
Leica SP5 
Leica 
Multiphoton laser - Mai Tai 690-1020 Spectra-Physics 
NanoDrop spectrophotometer Thermo Scientific 
Photospectrometer TECAN life sciences 
Tissue Slicer (VF-200) Precisionary Instruments 
Thermal Cycler (PTC-200) MJ research 
Western blot developer (XRay Film 
Processor JP-33) 
JPI Healthcare 
 
2.1.12 Software 
FIJI (Image J) Open source: 
https://imagej.net/Welcome 
Prism 6.0 Graphpad software 
Imaris Bitplane 
MSD workbench software Mesoscale Discovery 
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Tri2 Paul Barber open source (University of 
Oxford) 
https://app.assembla.com/spaces/ATD
_TRI/wiki/Download 
Volocity 6.3 PerkinElmer 
 
2.1.13 Company locations 
ACEA biosciences San Diego, CA, USA 
Addgene MA, USA 
Agilent Technologies Santa Clara, CA, USA 
Alabama Research and Development Munford, AL, USA 
Applied Biosystems California, USA 
Becker Hickl GmbH Berlin, Germany 
Bitplane (Oxford Instruments) Zurich, Switzerland 
Cambridge Bioscience Cambridge, UK 
Cell Signalling Technologies Beverley, MA, USA 
Corning New York, USA 
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Dharmacon Colorado, United States 
Eppendorf Hamburg, Germany 
Fisher Chemical Loughborough, UK 
Flexcell Burlington, NC, USA 
Graphpad software La Jolla, CA, USA 
Henkel Hertfordshire, UK 
Ibidi Martinsried, Germany 
Immune systems Devon, UK 
Invitrogen Carlsbad, CA, USA 
JPI New York, USA 
Lab tech International East Sussex, UK 
Leica Solms, Germany 
Life Technologies Paisley, UK 
Merial Animal Health Harlow, Essex 
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Merck Millipore Darmstadt, Germany 
MJ research Quebec, Canada 
Mesoscale Discovery Maryland, USA 
Molecular Probes Eugene, OR, USA 
MSE London, UK 
Nunc Roskilde, Denmark 
PerkinElmer Ohio, USA 
Precisionary Instruments Greenville, NC, USA 
Qiagen Limburg, Netherlands 
R&D Systems Abingdon, UK 
Roche Mannheim, Germany 
Santa Cruz Dallas, TX, USA 
Sigma-Aldrich Poole, UK 
Spectra-Physics Santa Clara, CA, USA 
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Tecan life sciences Männedorf, Switzerland 
VWR Leicestershire, UK 
Zeiss Jena, Germany 
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2.2 General Methods 
2.2.1 A549 cell line culture 
A549 cells (ECACC), an adherent line of human lung adenocarcinoma 
cells, were cultured in Dulbecco’s Modified Eagle Medium (DMEM). Medium 
was supplemented with foetal calf serum (FCS) (10%) and penicillin and 
streptomycin (1%), and cells cultured in T75 flasks at 37°C in a humidified 
incubator with 5% CO2.  
Passage of cells was performed by aspiration of medium and washing 
cells with phosphate buffered saline (PBS) (10mls) twice. Trypsin-EDTA (3ml 
of 0.05%) was added, and cells incubated for 3mins at 37°C. Cell detachment 
was observed by brightfield microscopy. FCS-replete DMEM (6mls) was 
added to neutralise the trypsin, and the resulting medium centrifuged (190g 
for 5 mins) to pellet the cells. Supernatant was then discarded, and cells 
resuspended in fresh culture medium (10mls). Cells were counted and cell 
suspension split accordingly, allowing for cells to be approximately 80% 
confluent after 48 hours. 
2.2.1.1 Cell counting 
Cells were counted using a haemocytometer (Immune systems 
FastRead 102, Devon, UK). Cell suspension (9µl) was added to the counting 
chamber, and cells counted under a phase-contrast microscope (Nikon, 
Surrey, UK). The counting chamber consists of ten large squares, each 
containing smaller squares in a 4x4 grid. Cells in each large square were 
counted by the total number of cells within each smaller square including cells 
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on the bottom and right borders only. The number of cells was then calculated 
using the following formula: 
Cells/ml = total number counts ⁄ number of 4x4 grids counted ×104 
2.2.1.2 MTT determination of cell viability 
Mitochondrial enzymes in metabolically active cells cleave yellow 
tetrazolium (MTT: 3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium 
bromide) into purple formazan, which can then be solubilised and quantified 
using spectrophotometry. The amount of formazan produced is directly 
proportional to the number of metabolically active cells present, when this 
technique is applied to a homogenous population of cells (Sylvester 2011).   
Following treatment, cell supernatant was removed and the cells washed 
once with warm PBS. Cells were then incubated with MTT (1mg/ml) in 
medium for 15 minutes at 37°C. MTT solution was discarded, and the plates 
allowed to dry for 30 minutes. Cells containing formazan dye were then 
solubilised by incubation in DMSO with agitation for 10 minutes, following 
which excitation was read using a photospectrometer at 550nm. 
2.2.2 Generation and culture of Precision Cut Lung Slices (PCLS) 
2.2.2.1 Murine lung slices 
Lung slices were obtained from CD1 mice euthanised by intraperitoneal 
injection of phenobarbital sodium (Euthatal; Merial) from the project licence 
‘Mechanisms of acute and chronic inflammation’ (PPL 70/7643). Following 
euthanasia, the trachea was exposed and an intra-tracheal cannula inserted. 
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The thoracic cavity was exposed, and the lungs inflated under direct vision 
with low melting point agarose (1.2ml) supplemented with HEPES (25nM). A 
subsequent bolus of air (0.3ml) was injected to ensure full inflation of the lung 
parenchyma. Tissues soaked in ice-cold HBSS were draped over the lungs to 
cool and solidify the agarose. The lungs were excised and stored in HBSS on 
ice. 
Lung lobes were embedded in agarose (2%) (which provides additional 
support during the slicing process). Lung lobes were cut in transverse section 
to a thickness of 300 µm using the tissue slicer (Precisionary Instruments 
Inc.), and individual slices were then cultured in DMEM (1ml) supplemented 
with penicillin and streptomycin (1%) in 1 well each of a 24-well plate for 1 
hour at 37°C. Medium was then changed, and slices left overnight prior to 
treatment. This method is adapted from that described previously (Henjakovic 
et al. 2008). 
2.2.2.2 Human lung slices 
PCLS were generated from disease-free resection tissue obtained from 
the Biomedical Research Unit (BRU) human respiratory biobank (ethics, 
reference number 10/H0504/9 – study number MG13). Tissue was obtained in 
RPMI 1640 supplemented with penicillin and streptomycin (1%) and 
gentamicin (10mg/ml) at 4°C. PCLS were generated using an adapted 
agarose point-injection insufflation method described in (Sturton et al. 2007). 
Lung tissue submerged in HBSS was point injected with low melting point 
agarose (3%) in HBSS supplemented with penicillin and streptomycin (1%) in 
100µl boluses stepwise throughout the tissue using a fine gauge needle, such 
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that the tissue inflated evenly. Approximately 1-2ml of agarose was required 
per gram of tissue. Inflated tissue was then submerged in HBSS, and allowed 
to cool at -20 °C for 10 minutes. The tissue was cored into 8mm diameter 
cylinders using a weighted coring tool (Alabama Research & Development). 
Cores were embedded in low melting point agarose, and sliced as for murine 
lung slices (2.1.7.1) but to thicknesses of 400µm (Figure 2-1). 
Individual slices were placed into RPMI 1640 (1ml) supplemented with 
peniciilin, streptomycin and gentamicin as above, and incubated for 1 hour at 
37°C. The medium was then changed 6 times at 30-minute intervals, and 
slices left overnight prior to treatment.  
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Figure 2-1 Generation and culture of Precision Cut Lung Slices (PCLS) 
Human PCLS were point injected with agarose (panel A) and cored (panel B). Cores of 
human tissue, or whole murine lobes were loaded into the tissue slicer (Panel C) and PCLS 
generated. These were then adhered onto Bioflex plates (Panel D) using ethyl-cyanoacrylate 
(panel E) for Cyclic Mechanical Strain (CMS) studies. Photograph in Panel B courtesy of 
John-Poul Ng-Blichfeldt and Panel C courtesy of Joana Alçada. 
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2.2.2.3 PCLS viability studies 
Fluorescent staining of live and dead cells provides an opportunity to 
explore the viability of excised and ex vivo tissues, not amenable to traditional 
cell-based viability assays (Johnson & Rabinovitch 2012). Treated PCLS were 
cut from silicone membranes, placed into 24-well plates with coverslip bottom 
(Ibidi µ-plate) and incubated with ethidium/calcein (4µM) in warmed PBS (Life 
Technologies) for 45 minutes at 37°C. They were then imaged immediately in 
an inverted confocal microscope using a 488nm laser for calcein, and 543nm 
laser for ethidium in HBSS. Cells treated with methanol (70% for 30 minutes) 
were used as a control: staining positive for ethidium nuclei (dead) staining 
but negative for calcein cytoplasm (live) staining (Figure 2-2). 
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Figure 2-2 Optimisation of Calcein and Ethidium staining in murine Precision Cut Lung 
Slices (PCLS) 
Murine PCLS were treated with methanol (70%) for 30 minutes, then stained with increasing 
concentrations of calcein and ethidium homodimer (top panel). The concentration that 
demonstrated clear ethidium homodimer (dead) nuclear staining without calcein (live) 
cytoplasm staining was selected as 4µM. This concentration was then applied to live PCLS 
(bottom panel). Scale bars represent 100µm. 
 
2.2.3 Molecular Biology 
2.2.3.1 Ribose nucleic acid (RNA) extraction 
RNA was extracted from isolated cells by the addition of Trizol reagent 
(300µl, Life Technologies) to each well of a 6-well plate, and cells immediately 
scraped and the resultant solution placed into microcentrifuge tubes and 
 98 
stored at -80°C for future use. Chloroform (300µl, Sigma-Aldrich) was added, 
samples agitated for 15 seconds, and then centrifuged (12,000g for 15 mins) 
at 4°C to separate organic and aqueous phases. 250µl of the top aqueous 
phase, in which total RNA is located, was removed and placed in a new 
microcentrifuge tube. An equal volume of ethanol (70%) was added to this 
solution to precipitate nucleic acids.  
The RNeasy mini kit (Qiagen) was used to isolate RNA. The solution 
was transferred to an RNeasy mini column and centrifuged (8,000g for 15 
seconds), and the effluent discarded. RW1 wash buffer (350µl) was then 
added to remove excess ethanol, and the column centrifuged for a further 15 
seconds at 8,000g. DNase1 (80µl, Qiagen) was added to minimise genomic 
DNA contamination, and the solution incubated for 15 mins at room 
temperature (RT). A subsequent wash step by adding RW1 buffer (350µl) and 
centrifugation (8,000g for 15 seconds) followed, and the effluent was 
discarded. The column was then washed twice with RPE (500µl) and 
centrifuged (8,000g for 15 seconds in the first instance, and 2 minutes in the 
second). The effluent was discarded, and the columns transferred to a new 
collection tube. A further centrifugation step at full speed for 1 minute was 
used to remove excess ethanol, and then total RNA was eluted into a new 
microcentrifuge tube by adding RNAase-free water (50µl) and centrifugation 
(8,000g for 15 seconds). Concentration and purity of RNA was determined by 
using a NanoDrop spectrophotometer (Thermo Scientific). 
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2.2.3.2 Reverse transcription (RT) protocol  
A high capacity cDNA reverse transcription kit (Life Technologies) was 
used to convert total RNA to cDNA. Eluted RNA (1µg) was made up to 10µl in 
RNase-free dH2O, and then mixed with reverse transcription components 
containing (10µl): 10x RT buffer (2µl), 25x dNTPs (0.8µl), 10x random primers 
(2µl), reverse transcriptase enzyme (1µl) and RNAase-free dH2O (4.2µl). A 
PTC-200 Peltier thermal cycler (MJ Research) was used to synthesise cDNA. 
First, random primers bind to the RNA during a heating step of 25 °C for 10 
minutes, then cDNA conversion occurs during a subsequent heating step of 
37°C for 120 minutes, followed by denaturing of the reverse transcriptase by 
heating the samples to 85°C for 5 minutes. cDNA obtained from the reaction 
was then diluted 1:5 by adding DNAase-free water (80µl). For all experiments, 
a reverse transcriptase control was used, where a reaction is performed 
without reverse transcriptase, therefore allowing for contamination of genomic 
DNA to be seen in downstream reactions. 
2.2.3.3 Polymerase chain reaction (PCR) 
2.2.3.3.1 Working principle 
PCR amplifies sequences of DNA through recurrent cycles of DNA 
polymerase-catalysed reactions, and cDNA generated from RNA via the 
reverse transcriptase process as described above (2.2.3.2) can be subjected 
to PCR for the amplification of specific sequences derived from a gene of 
interest (Gibbs 1990). Primers, synthetic oligonucleotides complementary to 
each strand of DNA sequences surrounding the gene of interest, are selected 
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or designed, and bind to the DNA template. This allows Taq polymerase, a 
heat-stable DNA polymerase, to start catalysing the synthesis of a replicate 
DNA strand. Through repeated cycles, the newly synthesised DNA strands 
then become a template for subsequent synthesis, and the initial target DNA 
sequence can be amplified exponentially (Figure 2-3). 
The three stages of PCR include: 
1. Denaturation, where the two strands of DNA are broken apart 
by heating the reaction mixture to 94°C, which disrupts the 
hydrogen bonds between the strands. 
2. Annealing, where hydrogen bonds from between the primer and 
single-stranded complementary DNA template by cooling of the 
reaction mixture to 55-65°C. 
3. Extension, where Taq polymerase attaches to the cDNA at the 
3’ end of the primer, and extends it by adding complementary 
deoxyribonucleotide triphosphates (dNTPs) in a 5’ to 3’ 
direction, therefore doubling the amount of target DNA.  
4. After all rounds of PCR are completed, a final elongation step 
extends any remaining single DNA strands 
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Figure 2-3 Principle of the Polymerase Chain Reaction 
 
2.2.3.3.2 Quantitative real time PCR (qPCR) 
By using oligonucleotide primers consisting of probes, which emit a 
fluorescent signal upon cleavage or hybridisation, PCR products can be 
quantified at each cycle (Kubista et al. 2006). The threshold cycle (CT) 
describes the cycle at which the fluorescent signal exceeds a threshold level, 
is arbitrarily set during exponential amplification, and is inversely related to the 
amount of amplicon in the reaction. Therefore, the lower the CT, the greater 
the amplicon (Pinhu et al. 2008). Data are presented either as absolute, 
where a standard curve allows for quantification of exact copy number, or 
relative to a reference gene, which does not change between conditions. The 
work in this thesis was conducted using real time qPCR, with two reference 
genes previously determined to show stability in A549 cells with CMS, 
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GAPDH and B2M (Pinhu et al. 2008). One form of RT-PCR probe, SYBR 
green, was used for gene array analyses, and another, Taqman, used for 
individual gene analyses. Both methods are described below. 
2.2.3.3.3 SYBR Green 1 
This process involves DNA binding dyes that fluoresce at 520nm when 
hybridised to double stranded DNA, but have undetectable fluorescence when 
in the un-bound state. Although simple and inexpensive, this technique is non-
specific, in that SYBR green 1 will not only bind to amplified target DNA, but to 
all available dsDNA including genomic, non-specific PCR products and primer 
dimers. 
The Cytoskeletal Regulators RT2 PCR array (Qiagen #330231) used in 
this thesis (Section 1.1.1) is based on SYBR green qPCR. RNA from three 
independent experiments was isolated from cells as described above, and 
synthesised to cDNA using the RT2  First Strand cDNA synthesis kit. Briefly, 
RNA (500ng) was made up to 10µl and genomic DNA eliminated by dilution in 
a 1:5 ratio with Buffer GE1. Samples were incubated for 5 mins in a 
thermocycler at 42 °C and subsequently kept on ice. Reverse transcriptase 
mixture (10µl) containing: 5x Buffer BC3 (4µl), Control P2 (1µl), RE3 Reverse 
Transcriptase Mix (2µl) and RNase-free water (3µl) was added to each 
sample, and reaction mixtures for each sample incubated at 42°C for 15 
minutes for reverse transcription to occur. The reaction was stopped by a 
heating step of 95°C for 5 minutes. cDNA samples were then diluted by the 
addition of RNase-free water (91µl). 
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qPCR was performed using RT2 SYBR Green Mastermix (Qiagen) 
supplied with the kit. Briefly, cDNA prepared as described (102µl) was added 
to a mixture of 2x RT2 SYBR Green Mastermix (650µl) and RNase-free water 
(548µl), and 10µl of this mixture added to each well of the RT2 Profiler PCR 
Array plate, which already contains primers for detection of specific genes of 
interest. qPCR was performed using an Applied Biosystems ViiA 7 machine 
with the following steps: 
1. 95 °C for 10 minutes for activation of DNA Taq Polymerase 
2. 95 °C for 15 seconds over 40 cycles for denaturation 
3. 60 °C for 1 minute over 40 cycles for annealing and extension. 
Relative gene product levels were quantified using SYBR green 
fluorescence at the end of each PCR cycle. 
2.2.3.3.4 Taqman 
This system uses oligonucleotide probes containing forward and reverse 
primers, and a Taqman probe dual-labelled with a fluorophore and quencher 
binding to a region between the primers. The probe and primer anneal to 
complementary sequences, and during extension, Taq polymerase cleaves 
the probe by exonuclease activity, dissociating the fluorophore from its 
quencher, allowing for its excitation and subsequent emission at 517nm (for 6-
carboxyfluorescein (FAM)-labelled fluorophores). 
For the work presented in this thesis, individual genes were assessed 
using Taqman probes. cDNA (2.4µl), synthesised as described (2.2.3.2), was 
added to each well of a 384-well block. Master mix (3.6µl), composed of 
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Taqman Fast Advanced Master Mix (3µl), Taqman primers (0.3µl) (2.1.5.1.1) 
and RNase-free dH2O (0.3µl), was added to each well, and PCR performed 
using an Applied Biosystems ViiA 7 machine with the following steps: 
1. 50 °C for 2 minutes for uracil N-glycosylase (UNG) incubation 
2. 95 °C for 20 seconds for activation of Taq Polymerase 
3. 95 °C for 1 second over 40 cycles for denaturation 
4. 60 °C for 20 seconds over 40 cycles for annealing and extension. 
2.2.3.3.5 Taqman primers 
Primers were purchased from Life Technologies unless otherwise 
specified (Table 2-1). Primers were chosen that did not detect gene products 
with similar or off-target sequences. Furthermore, all primers that were 
selected were designed across exon-exon junctions, and therefore 
amplification of genomic DNA was minimised, and primers did not target 5’ 
untranslated regions (UTR) (which have variable sequences between 
transcripts). 
2.2.3.4 Quantification of gene expression 
Gene expression was quantified using the comparative CT method 
(Schmittgen & Livak 2008), where the CT value of the gene of interest is 
normalised to the CT value of the housekeeping gene as described in the 
following equation (Livak & Schmittgen 2001). 
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2!!!!"   = [ CT  target  gene− CT  reference  gene     sample  A   
-­‐  [(CT  target  gene  -­‐  CT  reference  gene)  sample  B 
Equation 1 Comparative CT method  
 
For the work presented in this thesis, sample A was the experimental 
condition, and sample B, untreated or controls. Therefore, quantitative PCR 
data are presented as the fold change from untreated controls, and averaged 
over two housekeeping genes. Although this technique makes the assumption 
that the PCR efficiency of the gene of interest and housekeeping genes are 
the same, it is a widely used and validated method (Schmittgen & Livak 
2008). 
2.2.3.5 RNA interference 
2.2.3.5.1 Working principle 
Double stranded RNA of less than 30 nucleotides can induce gene-
specific silencing in mammalian cells as part of anti-viral defences (Elbashir et 
al. 2001). Small interfering RNA (siRNA) of these lengths are recruited into a 
multi-protein complex, the RNA-induced silencing complex (RISC) which 
guides these short strands of RNA to bind to complementary single stranded 
RNA. There, they mediate degradation of these RNA transcripts via catalytic 
cleavage, causing gene silencing. siRNA technology avoids the non-specific 
anti-viral responses induced by long double stranded DNA. 
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2.2.3.5.2 Transfection of siRNA into cells 
Cells at approximately 30-50% confluence were transfected with siRNA 
targeting CD98hc or non-targeting controls (Dharmacon) (Table 2-2). For 
each well of a 6-well Bioflex plate, siRNA (10µM) was complexed with 
oligofectamine (Invitrogen) as described below (Table 2-5). Cells were left to 
transfect for 48 hours, and treated as necessary. 
For each well of a 6-well plate, prepare - 
A: 10µl siRNA with 190µl media and B: 4µl oligofectamine with 196µl media 
 Allow complexes to incubate for 5 minutes at room temperature (RT) 
Mix A and B by gentle pipetting, and allow to incubate for 20 minutes at RT 
Aspirate media from wells, and wash twice with warm PBS. 
Add 1600µl media to wells 
Add 400µl complexes to wells 
Change media at 5 hours to serum and antibiotic replete media. 
Table 2-5 siRNA transfection protocol 
Serum and antibiotic-free DMEM medium was used, as oligofectamine can introduce these 
components into cells. 
 
2.2.4 in vitro cellular assays 
2.2.4.1 Application of Cyclic Mechanical Strain (CMS) 
2.2.4.1.1 Flexercell system and working principle 
The FX-5000T system was used to apply CMS to monolayers of A549 
cells or to PCLS adhered to flexible silicone membranes. The system is 
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composed of a Flexcell central computer system, baseplate and gaskets, 
Bioflex plates and corresponding loading stations. The system is calibrated to 
apply strain amplitudes of 0-30% elongation to cells, 0-20% when a central 
loading post is used, and 30% without a loading post. For our work, strain 
amplitudes of 0, 5, 20 and 30% elongation were applied.  
Cells are cultured on 6-well Bioflex plates, the culture surface of which is 
a flexible and transparent silicone elastomer membrane. For the experiments 
described below plates pre-coated with collagen I were used. CMS is applied 
by the creation of a vacuum in the gasket in which the Bioflex plates are 
seated, which therefore deforms the flexible membrane on which cells are 
cultured (Schaffer et al. 1994; Gilbert et al. 1994). When loading stations are 
used, uniform radial and circumferential strain is applied across the 
membrane, with stretch of cells of up to 20% elongation possible. When 
loading stations are removed, stretch of cells up to 30% is possible, but the 
stretch applied is not equibiaxial across the strain field (Figure 2-4). 
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Figure 2-4 The Flexcell FX-5000™ system 
Panel A shows the components of the Flexcell FX-5000™ system (courtesy of Flexcell 
product information), which is computer driven, and a vacuum exerted by the vacuum pump 
pulls cells plated on the Bioflex™ culture plates downwards, creating equibiaxial stretch. 
Panels B and C demonstrate the effect of a vacuum on plated cells, both without and with a 
loading post respectively. 
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2.2.4.1.2 Application of CMS to cells using the Flexercell system 
Our group has previously determined that stretch of 30% elongation for 
up to 2 hours induced optimal IL-8 cytokine mRNA expression and protein 
generation (Pinhu 2008). Furthermore, a stretch/relaxation ratio of 1:1 and a 
frequency of 20 cycles per minute (0.33Hz) was applied, as these parameters 
were equivalent to those used during mechanical ventilation of patients. 
Unless otherwise stated, these parameters were used during the work in this 
thesis when applying mechanical strain to cells.  
Alveolar epithelial cells during normal, tidal volume breathing are thought 
to experience magnitudes of strain between 1 and 5%, whereas during high 
tidal volume mechanical ventilation, cells might experience up to 30% strain 
(Vlahakis et al. 1999). Although these are approximations, inflation of the lung 
to total lung capacity (TLC) is estimated to increase strain to the range of 15-
40% and potentially higher, and the heterogeneous nature of the state of 
inflation of injured lung results in some alveolar units experiencing 
deformation many times greater than neighbouring collapsed lung units (Roan 
& Waters 2011).  
Although lung volume more than doubles when lungs are inflated to 
100% TLC (Tschumperlin & Margulies 1999) some of this change in alveolar 
surface area derives from unfolding of alveolar septal pleats (Gil et al. 1979). 
Consequently, the epithelial basement membrane might only increase by as 
much as 50% or a strain of 22%. The elongation magnitudes used when 
applying mechanical strain in vitro are therefore approximations of normal and 
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injurious strain rates applied to healthy and injured lung by mechanical 
ventilation.  
2.2.4.1.3 Preparation of A549 cells for application of cyclic mechanical strain 
Seeding of A549 cells was optimised to enable the cells to be 30% 
confluent at the time of siRNA transfection, 50-70% confluent at the time of 
DNA transfection, and 80-100% confluent at the time of application of CMS. 
Cell seeding densities of 150 x 105 cells/well produced a confluent monolayer 
of cells at the time of CMS, and when compared to other seeding densities in 
preliminary experiments, although CMS-induced IL-8 release was not 
statistically significant at any seeding density, the mean increase at 150 x 105 
cells/well was greatest (1.76 times baseline IL-8 release). The absence of 
statistical significance was attributed to high baseline IL-8 release in these 
experiments (Figure 2-5). 
 
Figure 2-5 Optimising cell seeding density for CMS-induced IL-8 release 
A549 cells were seeded at the above densities, and CMS applied equibiaxially at 30% 
elongation for 2 hours. Panel shows IL-8 generation as sampled from cell supernatant at 24 
hours following either static conditions or CMS. Data are for three individual experiments, and 
are presented as mean ± SEM. Data analysis by Kruskal-Wallis test. 
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2.2.4.2 ‘Scratch assay’ epithelial migration model 
Following treatment, monolayers of A549 cells plated and transfected in 
6-well plates (Corning) were scratched with a P1000 pipette tip down the 
centre of each well to create a wound. Wells were washed with PBS to 
remove damaged or dead cells, and fresh culture medium replaced. Images 
were taken using a Zeiss Axiovert 200 (Zeiss: time 0 hours) inverted 
microscope with incubator, and the stage parameters noted to ensure the 
same field was imaged at later time points. Cells were cultured for a further 
16-24 hours to allow for cell migration into the scratched area (Figure 2-6).  
Wound area was calculated at each time point using Volocity software 
(PerkinElmer), and the difference in wound area between 0 and 16 hours 
calculated. Repair was expressed as a percentage of original wound area 
covered by cells.  
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Figure 2-6 Outline of ‘scratch assay’ epithelial migration model 
A confluent monolayer of cells was scratched with a pipette tip, imaged at time=0 hours, then 
again at time = 16-24 hours to observe cell migration into the scratched area. 
 
As an indicator of cell spreading, inter-nuclear distance was calculated 
by fixation of cells in 4% PFA at 24 hours, and staining with DAPI (500mM). 
Cells were covered with Prolong Gold antifade mountant (Life Technology) 
and imaged using the DAPI filter on the Zeiss Axiovert 200 inverted 
microscope. Inter-nuclear distance was calculated using FIJI software using 
mean grey pixel intensity and centroid measurements, and the nearest 
neighbor distance (NND) calculated using the NND macro for Image J 
developed by Yuxiong Mao (Davis et al. 2016). 
2.2.4.3 Electrical impedance assay 
Epithelial barrier integrity was measured using the real-time cell analysis 
(RTCA) iCELLigence system (ACEA Biosciences). This model relies on the 
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passage of a current along electrodes at the bottom of a cell culture well. 
Cells plated in the well impede the passage of current, such that increasing 
density of cells with intact tight junctions increase resistance, termed the cell 
index (Figure 2-7).  
To prime the system, cell culture medium (150µl) was added to 
iCELLigence 8 well E-Plates (ACEA Biosciences) and incubated for 30 min at 
37°C. A measurement of impedance without cells was designated as the 
baseline. A549 cells seeded at a density of 12,000 cells/well in cell culture 
medium (150µl) were placed into the culture medium present in the wells, to 
give a total volume of cell culture medium of 300µl/well. Cell impedance 
measurements were recorded every 10 minutes and transfection and 
treatment steps performed over the next 160 hours. Cell index was 
normalised at specific points, such as prior to transfection or prior to 
wounding. The change in normalised cell index over time was calculated 
using RTCA iCELLigence software (ACEA Biosciences). 
 
Figure 2-7 Electrical impedance assay 
Cells are plated into wells containing impedance electrodes (yellow). At baseline conditions 
and prior to cell adherence and proliferation, electrical current flows un-impeded through the 
culture medium (orange). With cell adherence and proliferation, resistance to the flow of 
current is increased. 
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2.2.4.4 Cell adhesion assay 
A549 cells seeded in 6-well plates (Corning) were grown to confluence, 
treated as required and then washed twice in PBS. Cells were fixed for 10 
minutes in PFA (4%), then stained with crystal violet solution (0.1%) for 10 
minutes. Stained cells were washed with running water until the run-off 
became clear, and left overnight to dry. Stained cells were then solubilised in 
methanol with agitation, and the solubilised crystal violet read in a plate 
reader at 570nm wavelength.  
2.2.5 Imaging techniques 
2.2.5.1 Confocal laser scanning microscopy 
2.2.5.1.1 Working Principle 
Confocal laser scanning microscopy scans specimens with focused 
beams of light, and uses a pinhole to reduce out of focus information at the 
point of detection (Poobalasingam et al. 2017). This allows for sharper images 
enabling greater detail, and optical sectioning of specimens in three 
dimensions (Pawley & Masters 2008). Using either antibody-based or direct 
fluorescence technology, laser-emitted light at particular wavelengths excites 
the fluorescent label, leading to emission at a higher wavelength, which is 
then collected through the objective lens, focussed through the pinhole, and 
recorded by a light-sensitive detector to generate an output signal transmitted 
to a computer for image acquisition (Figure 2-8). 
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Figure 2-8 Line diagram representation of confocal microscopy process 
Light from the excitation source passes through a pinhole aperture and is reflected by a 
dichromatic mirror. The light is then scanned across the specimen in a defined focal plane 
and emitted light from the excited fluorophore passes through the dichromatic filter and is 
focussed by the detection pinhole aperture. Imaging at focal planes occurs because out of 
focus light (above and below the focal plane being imaged) does not pass through the 
detection pinhole. 
2.2.5.1.2 Fluorescence 
Absorption of energy by a molecule can cause it to transition from a 
ground state (S0) to an excited-state (S1-S2). The molecule rapidly reverts its 
energy state back to S1 through internal conversion (vibrational relaxation) 
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and then from S1-S0. This latter transition produces fluorescence emission 
due to the energy release in the form of a photon (Figure 2-9). 
 
Figure 2-9 Jablonski diagram 
Based on (Jablonski 1933). S0, S1 and S2 represent the ground, first and second electronic 
states respectively. Horizontal lines represent vibrational energy levels at each state. Vertical 
lines with arrows represent transition between states. Once a molecule absorbs energy in the 
form of electromagnetic radiation, the fluorophore transitions from S0 to S1 or S2. 
Fluorescence occurs when the fluorophore transitions from the lowest vibrational energy state 
of S1 to S0. 
 
2.2.5.1.3 Preparation of cell samples for confocal immunofluorescence  
For fixation, permeabilisation and labelling of cells for 
immunofluorescence, the following protocol was used unless otherwise 
specified. 
Cells on coverslips or in Corning 24-well coverslip-grade plastic wells 
were fixed in PFA (4%) for 10 minutes at RT, and washed for 3 x 5 mins with 
gentle agitation. Cells were permeabilised by addition of Triton-X (0.2% in 
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PBS) for a further 5 minutes. At this stage, cells cultured in 6-well Bioflex 
plates were processed by cutting the membrane from the plate whilst 
immersed in PBS, and cutting into small 1cm square sections which were 
then placed into Corning 24-well plates. Blocking of non-specific antigens was 
facilitated by incubating fixed cells in BSA (1%) - Triton (0.1%) in PBS for 1 
hour. Cells were then incubated in relevant primary antibody (Table 2-3) in 
blocking solution either overnight at 4°C or for 1 hour at RT. Cells were then 
washed as above, and secondary antibody (Table 2-4) together with 
phalloidin and DAPI stain added for 1 hour at RT, followed by a further wash 
step. At this stage, sections of membrane were removed from the 24-well 
plates, placed into slides in which artificial gaskets were made, covered with 
Mowiol solution and then covered with an imaging-grade coverslip. Cells on 
coverslips were simply covered with Mowiol and inverted to cure on slides. All 
samples were left to cure in the dark for 48 hours at room temperature. 
Unless otherwise specified, samples were imaged using Leica SP5 
upright confocal microscope, with 40x 1.25 or 63x 1.4 HCX PL APO oil 
objectives.  
2.2.5.1.4 Preparation of tissue samples for confocal immunofluorescence  
For fixation, permeabilisation and labelling of precision cut lung slices 
(PCLS) for immunofluorescence, the following protocol was used unless 
otherwise specified. 
PCLS were fixed in PFA (4%) for 30 minutes at RT, and washed for 3 x 
5 mins with gentle agitation. Cells were permeabilised and non-specific 
antigen binding blocked by Triton-X (0.3%) and BSA (1%) in PBS for either 2 
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hours at RT or overnight at 4°C. PCLS were then incubated in relevant 
primary antibody (Table 2-3) in blocking solution for 48 hours at 4°C. PCLS 
were then washed as above, and secondary antibody together with phalloidin 
and DAPI stain added for 2 hours at RT, followed by a further wash step. At 
this stage, PCLS were inverted, placed into Corning 24-well µ-plates, 
immersed in Prolong Gold solution, and then covered with a coverslip to 
compress the PCLS. All samples were left to cure in the dark for 24 hours at 
room temperature. 
Unless otherwise specified, PCLS were imaged using a Zeiss LSM-510 
inverted confocal microscope, using 20 X 0.8 EC Plan-Neofluar objective lens. 
For immunofluorescence experiments using cell and tissue preparations, 
gain and offset were set such that no signal was obtained from secondary-
antibody only conditions. These settings were then used for imaging 
experimental samples. 
2.2.5.2 Fluorescence Lifetime Imaging 
2.2.5.2.1 Förster Resonance Energy Transfer (FRET) 
In lieu of transfer of energy to the external environment in the form of 
fluorescence, this process describes the situation in which energy released in 
the transition from the excited state to the ground state is transferred from a 
donor (D) to an acceptor fluorophore (A). This process, in which the donor is 
initially excited, occurs if the acceptor molecule is in close proximity to the 
donor, and energy is transferred via dipole-dipole interactions.  
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For FRET to occur, several conditions need to be met. First, both donor 
and acceptor need to be within nanometre range, and FRET is generally only 
observed at DA distances of less than 10nm (Pietraszewska-Bogiel & Gadella 
2011). Consequently, FRET microscopy is ideal for measuring interactions in 
cellular biology. Second, there must be sufficient overlap between donor 
emission and acceptor absorption. Third, the acceptor transition dipole 
moment must not be perpendicular to the electric field of the dipole field of the 
donor (Pietraszewska-Bogiel & Gadella 2011). The efficiency of the energy 
transfer in FRET (E) is directly dependent on the distance between the donor 
and acceptor (Förster 1948), and is expressed in the following equation: 
 
  𝐸 = 1/(1+ 𝑅𝑅! ! 
Equation 2 FRET efficiency 
Where E = fraction of photons absorbed by donors whose energy is transferred to acceptors, 
R = distance between donor and acceptor, R0 = Forster radius (distance at which energy 
transfer is at 50%). 
 
The Förster radius (R0) is dependent on the orientation of transition 
dipoles, spectral overlap between donor and acceptor, and other 
environmental factors as described by the following equation: 
𝑅! = [𝑘!  ×  𝐽 𝜆 ×  𝑛!!  ×  𝑄]!!  ×9.7  ×10! 
Equation 3 Förster radius 
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Where k2 = relative orientation of the transition dipoles between D and A, 𝐽 𝜆  is the spectral 
overlap between donor emission and acceptor absorption (overlap integral, cm6mol-1), n = 
refractive index of intervening medium, 𝑄 = fluorescence quantum yield of the donor. 
 
2.2.5.2.2 Fluorescence Lifetime Imaging Microscopy (FLIM) 
FRET measurements can be confounded by several limitations, 
including direct excitation of acceptor fluorophores at donor excitation 
wavelengths and cross talk between donor and acceptor emissions. Many of 
these issues can be avoided by the use of FLIM, where the fluorescence 
lifetime (τ) of the donor is determined, reflecting the time taken for the 
population of excited donor fluorophores to decay to 1/e of the original value. 
The greater the efficiency of FRET between the donor and acceptor, the 
shorter the fluorescence lifetime of the donor (Koushik & Vogel 2008).  
The two most common current methods for FLIM are time-domain and 
frequency domain lifetime imaging. The former method, used in this work, 
relies on donor excitation with pulses of light shorter than the donor lifetime, in 
the order of picoseconds. Donor fluorescence emission decay is then 
measured on the nanosecond scale, and donor fluorescence lifetime (τD) 
calculated by measuring the exponential decay in intensity. This is derived by 
counting the number of photons, either in time bins using gated detection, or 
from time-correlated single photon counting (TCSPC), where repetitive pulsed 
excitation of the sample leads to the emission of a single photon per pulse, 
which is timed at detection, and a histogram of decays can be produced. 
Excitation by multiphoton microscopy uses excitation pulses of near infra-red 
light. This causes non-linear absorption in fluorophores, which has the 
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advantage of reducing excitation to a small area of the focal plane, reducing 
photobleaching.  
2.2.5.2.3 Vinculin tension sensor (VinTS) FRET probes 
Vinculin tension sensor and control probes were purchased from 
Addgene (plasmid 26019). The VinTS probe comprises a tension sensor 
module (TSMod) consisting of a 40-amino acid-long elastic domain linking a 
donor fluorophore (mTFP1) and an acceptor (venus) that FRET when in close 
proximity. The linker protein is formed from the spider silk protein flagelliform, 
the structure of which is composed of repetitive amino-acid motifs. These 
effectively act as ‘nanosprings’, making the structure suitable for measuring 
forces on the piconewton scale (Grashoff et al. 2010) (Figure 2-10). 
The Vinculin construct was created by introducing TSMod cDNA into a 
chicken vinculin cassette, and the construct inserted into a pcDNA3.1 
expression vector. The construct is such that the mTFP1 donor is associated 
with the vinculin head domain (Vh), followed by the flexible linker, and the 
venus acceptor associated with the tail domain (Vt). Therefore, tension across 
the vinculin protein would be expected to distend the linker, decreasing FRET 
efficiency between the two fluorophores. Controls included a construct devoid 
of a vinculin tail domain (tail-less/ VinTL – plasmid 26020), and one where the 
vinculin protein is intact, but associated to a venus fluorophore only (vinculin 
venus/VinV – plasmid 27300). The tension sensor module alone was also 
transfected into cells by the authors, and observed to localise throughout the 
cytoplasm (TSMod – plasmid 26021). 
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Figure 2-10 Vinculin tension sensor (VinTS) constructs and plasmid map 
Panel A reprinted by permission from Nature Publishing Group: Nature (Grashoff et al. 2010), 
copyright (2010), shows the constructs: mTFP1 donor and venus acceptor are separated by a 
40 amino acid-long flexible linker. Increasing force across the constructs separates the donor 
from the acceptor, decreasing FRET. Panel B shows the plasmid map containing the 708 
base pair (bp) mTFP1 and 717 mVenus cassettes. 
 
The authors found that in transfected cells, VinTS recruited to focal 
adhesions, and did not affect focal adhesion shape, size or f-actin association 
when compared with cells transfected with the venus-only construct, and that 
expression of vinculin in these cells was comparable to endogenous levels. 
Furthermore, expression of the construct did not affect vinculin activation 
status, and intermolecular FRET was negligible. Single-molecule fluorescence 
force spectroscopy was used to calibrate the sensor, and demonstrated that 
the sensor was sensitive with forces between 1-6pN, and that the average 
force in stationary focal adhesions was approximately 2.5pN. 
2.2.5.2.4 Raichu RhoA GFP probes 
Raichu RhoA probes were a gift from Professor Tony Ng, King’s College 
London, and are a variant of the CFP-YFP RhoA probe reported previously 
(Makrogianneli et al. 2009), modified to express GFP-RFP FRET pairs 
(Heasman et al. 2010; Makrogianneli et al. 2009). The probe consists of a 
donor GFP domain associated with truncated RhoA, followed by RhoA-
binding domain (RBD) of protein kinase-N (PKN). Intramolecular binding of 
GTP (active)-RhoA to the PKN effector changes the conformation of the 
probe, bringing the FRET pairs into closer proximity, and increasing FRET. In 
contrast, GDP-bound (inactive) RhoA holds the construct in an open position, 
diminishing FRET.  
 124 
Raichu RhoA is anchored to the plasma membrane via the carboxy 
terminus region of k-Ras, and also cannot bind to RhoGDI (Guanine 
Nucleotide Dissociation Inhibitors), which maintain the GDP-bound form of 
RhoA in the cytosol. Raichu RhoA probes therefore monitor the activity of 
endogenous, and RhoGDI-unbound, RhoA at the plasma membrane, which 
has the advantage of reducing background signal from the cytosol. The 
probes consist of the Raichu RhoA probe itself (Figure 2-11), an inactive 
construct (T19N) where Asn was substituted for Thr19 of RhoA, therefore 
decreasing its affinity to guanine nucleotides, and a GFP-only construct. 
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Figure 2-11 pRaichu RhoA probe 
Panel A shows the construct consisting of a donor GFP domain associated with truncated 
RhoA, followed by RhoA-binding domain (RBD) of PKN. Binding of GTP (active)-RhoA to the 
PKN effector changes the conformation of the probe to bring the FRET pairs into closer 
proximity, increasing FRET. GDP-bound (inactive) RhoA holds the construct in an open 
position, diminishing FRET. Panel B shows the plasmid map, with modified mRFP and eGFP 
domains. 
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2.2.5.2.5 Transfection of A549 cells with plasmid DNA 
Cells at approximately 70% confluence were transfected with either the 
VinTS or Raichu FRET probes using lipofectamine reagent (Invitrogen). For 
each well of a 6-well Bioflex plate, 2.5µg DNA was complexed with opti-MEM 
medium (Life Technologies) and P3000/lipofectamine as described (Table 
2-6). Cells were left to transfect for 48 hours then treated as described. Fixed 
cells were imaged on excised Bioflex membranes.  
Component Volume 
Cells 0.25-1 x 106 
Opti-MEM medium 125µl 
Lipofectamine 3000 Reagent 3.75µl 
DNA complex 
Opti-MEM medium 125µl 
DNA 2.5ng 
P3000 Reagent 5µl 
Diluted DNA with P3000 reagent (125µl) added to lipofectamine reagent 
(125µl) and incubated for 10-15 minutes at room temperature 
250 µl added to well, and cells incubated for 28 hours at 37 °C 
Table 2-6 Protocol for lipofectamine-induced transfection of plasmid DNA into A549 
cells 
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2.2.5.2.6 FLIM setup for Raichu and VinTS probes 
Following transfection and treatment, cells were fixed in PFA (4%) for 10 
minutes, membranes washed and cut as described for confocal imaging 
(2.2.5.1.3), immersed in Mowiol with DABCO (Sigma Aldrich) and placed onto 
slides with coverslip applied. 
A Leica SP5 upright confocal microscope with a tunable infrared laser 
(Spectraphysics Mai Tai 690-1020) and Becker Hickl FLIM detector was used 
for the work in this thesis. A 63x 1.4 HCX PL APO oil objective was used. 
Measurements on fixed samples were performed at room temperature.  
The two photon Mai Tai laser delivers under 100 femtosecond pulses at 
80 ±1 MHz. Excitation for both probes was set at 890nm and data were 
collected at 500 ± 40nm for the VinTS probes, and 480 ± 20 nm for the 
Raichu probes, through a band-pass filter. Laser power, gain and offset were 
adjusted to give average photon counting rates of 104-105 photons/second. 
Acquisition times of 240s for VinTS probes, and 300s for Raichu probes, 
achieved photon statistics sufficient for fitting without observable 
photobleaching.  
Instrument response was measured by imaging reflection scattering 
from urea crystals mounted on a coverslip, and used in data analysis by 
iterative re-convolution. 
2.2.5.2.7 FLIM analysis 
 FLIM data acquired using Becker Hickl software were saved and 
processed using Time Resolved Analysis software (TRI2) (developed by Paul 
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Barber, University of Oxford, (Barber et al. 2009). Data for both probes were 
fitted to a Marquardt mono-exponential decay as described by the following 
equation: 
𝑓 𝑡 =   𝑍 + 𝐴  exp  (− 𝑡𝜏) 
Equation 4 Marquardt mono-exponential decay model 
Fit function (f), t = time variable, Z = background, A = peak strength of the exponential and τ = 
lifetime. 
 
Pseudocolour images are generated showing the lifetime (tau) for each 
pixel of the original image, and histograms generated indicating the number of 
pixels with each lifetime. For VinTS probes, areas of focal adhesions were 
masked, and pre-processing applied such that 103 signal counts were 
obtained in all areas within the mask. For Raichu probes, masks were applied 
to the whole cell. 
FRET efficiency was derived from lifetimes using the following equation 
𝐸 = 1− 𝜏!"#$  𝜏!  
Equation 5 FRET efficiency 
(FRET efficiency) is determined by the lifetime of the donor τD and the donor lifetime in the 
presence of the acceptor τFRET. 
 
 For the VinTS probe, I could not calculate FRET efficiency given that we 
did not have available an uncomplexed mTFP probe to measure donor 
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lifetimes. Although the average fluorescence lifetime of mTFP1 has previously 
been demonstrated to be 2.98s (Grashoff et al. 2010), this could not work for 
our system where all other parameters are likely to be different. For the 
Raichu probes, donor GFP lifetimes were calculated as 2.11ns and FRET 
efficiency calculated correspondingly. 
2.2.6 Other antibody-based assays 
2.2.6.1 Enzyme-linked Immunosorbent Assay (ELISA) 
2.2.6.1.1 Working Principle 
Enzyme-linked immunosorbent assay (ELISA) is a technique whereby 
antibodies are used to detect and quantify solid-phase bound proteins or 
proteins in solution. Two different types of ELISA are used commonly, 
including sandwich ELISAs, which detect proteins in solution by the use of an 
immobilised capture antibody, or a technique where the target protein is 
immobilised and captured by the antibody in solution (Figure 2-12). 
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Figure 2-12 Enzyme-linked immunosorbent assay (ELISA) working principle 
Panel A shows the basis for a sandwich ELISA and B shows target protein immobilisation and 
capture in solution. Panel C shows the basic steps of a sandwich ELISA. 
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2.2.6.1.2 Duoset ELISA 
Sandwich ELISAs for the detection of human IL-8 on A549 cells were 
performed using a standard protocol provided by the manufacturer (R&D 
Systems, UK).  
Wash buffer Block buffer Reagent 
diluent 
Substrate 
solution 
Stop solution 
0.05% Tween 
20 in PBS 
1% BSA in 
PBS (0.2µm 
filtered and 
pH 7.2-7.4) 
Tris-buffered 
saline (20mM 
Trizma base, 
150mM 
NaCl), 0.1% 
BSA, 0.05% 
Tween-20 
Reagents A 
and B 
2N H2SO4 
Table 2-7 Duoset ELISA reagents 
 
Wells were coated with 4µg/ml capture antibody (100µl) diluted in sterile, 
filtered PBS, and the plate was sealed and incubated at room temperature 
overnight. The following day, wells were aspirated and washed 3 times with 
wash buffer (Table 2-7), and plates were dried on a paper towel. Wells were 
blocked with block buffer (300µl) for 2 hours. A subsequent wash step was 
performed, and 100µl of either standard or sample (diluted in reagent buffer) 
was added to appropriate wells, and the plate sealed and incubated for a 
further 2 hours. Following a further wash step, 20ng/ml biotinylated detection 
antibody (100µl) was added to wells, and the plate sealed and incubated at 
room temperature for a further 2 hours. Following a subsequent wash step, 
streptavidin horseradish peroxidase (HRP) (100µl) was added to each well, 
and the plate sealed and incubated for 20 minutes. A final wash step was 
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performed, substrate solution (100µl) was added, and the plate incubated for 
20 minutes at room temperature. Stop solution (50µl) was added to each well 
to end the reaction, and the plate absorbance was read using a plate reader 
(TECAN) at 450nm with a correction of 570nm. 
2.2.6.2 Electrochemiluminescence (MSD) 
2.2.6.2.1 Working Principle 
Mesoscale Discovery multiplex plate technology allows for the detection 
of multiple proteins from the same biological sample, and at concentrations far 
below those seen with standard ELISA techniques. The microplate consists of 
wells, each with micro-spots containing capture antibody for specific proteins 
of interest. Sample is added to the wells, and the technique follows that of a 
standard ELISA. In this case, the detection antibody is conjugated to a Sulfo-
TagTM group, and following addition of READ buffer, the plate reader pulses a 
small electric current across each micro-spot. By electrochemiluminescence, 
voltage applied to the plate electrodes causes the captured labels to emit light 
in proportion to the quantity of Sulfo-tagged antibody bound to the protein of 
interest in each well. The luminous intensity is then measured by the plate 
reader instrument (Figure 2-13). 
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Figure 2-13 Mesoscale Discovery (MSD) electrochemiluminescence 
Samples are incubated in the multi-spot plate, each spot containing a capture antibody for a 
specific cytokine. Quantity of cytokine is measured using cytokine-specific detection antibody 
labelled with Sulfo-tag™ reagent. 
 
2.2.6.2.2 MSD protocol 
Supernatant following treatment of either murine or human PCLS were 
analysed for KC/GRO-α or IL-8 respectively using the designated V-PLEX 
MSD kit. Reagents were prepared as per manufacturers’ instructions, and 
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calibrators (standards) diluted as required. 50µl of the sample (diluted 2-fold 
in diluent 2) or calibrator standard was added to respective wells, and the 
plate sealed and incubated at room temperature for 2 hours with shaking. 
Wells were then washed 3 times with wash buffer (PBS + 0.05% Tween 20), 
and detection antibody (25µl) added to each well. The plate was sealed and 
incubated for a further 2 hours with shaking. Following a final wash step, 2x 
Read buffer-T (150µl) was added to each well, and the plate read on the 
SECTOR TM reader. Standard curves were fitted using the MSD Workbench 
software (version 4.0) and samples fitted to the curve. 
2.2.6.3 Western Blotting 
2.2.6.3.1 Working Principle 
Western or immunoblotting allows for the identification and quantification 
of proteins from cell or tissue lysates. The technique relies on fractionation of 
the protein mixture by gel electrophoresis, giving a breakdown of protein 
components by molecular weight. These fractionated proteins are transferred 
to either a nitrocellulose or PVDF membrane, which is incubated with a 
blocking protein to shield non-specific binding sites. The membrane is then 
incubated in a primary antibody, which captures the target protein. Wash 
steps remove unbound antibody, after which the membrane is incubated with 
HRP-conjugated secondary antibody to bind the primary antibody-immobilised 
protein complex. Following a subsequent wash step, addition of a specific 
chemiluminescent substrate generates a light signal, the intensity of which is 
dependent on the quantity of HRP-primary antibody-target protein complex 
(Figure 2-14). 
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Figure 2-14 Western Blot general principle 
Courtesy of L.Pinhu (Pinhu 2008) and A. Proudfoot (Proudfoot 2014) 
 
2.2.6.3.2 Western Blot protocol 
Following treatment, A549 cells were washed once in ice-cold PBS, then 
lysed in cell lysis buffer (Cell Signalling) supplemented with complete EDTA-
free protease inhibitors (Roche), PhosSTOP phosphatase inhibitors (Roche), 
and PMSF (1µ, Sigma-Aldrich) to inhibit degradation and dephosphorylation 
of proteins, and scraped from wells. Lysed cells were collected into 
microcentrifuge tubes, and kept on ice for 30 minutes, with agitation every 10 
minutes. Samples were then centrifuged (14,000g for 10 min) at 4°C. Pellets 
were discarded, and the supernatant (containing protein) was placed in 
microcentrifuge tubes, and stored on ice or at -80 °C.  
+
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Protein concentration was determined using the Pierce bicinchoninic 
acid (BCA) assay (Thermo Scientific). This method relies on the reduction of 
Cu+2 to Cu+1 by protein in an alkaline medium. The purple product formed by 
chelation of bicinchoninic acid by Cu+1 is then measured by calometry. Diluted 
sample (25µl) or BSA standard (ranging in concentration from 2000 to 0 
µg/ml) were added to individual wells of a 96-well plate (Costar). Supplied 
BCA working reagent (200µl) was then added to each well, and the plate 
agitated for 30 seconds, followed by incubation at 37°C for 30 minutes. The 
plate was then cooled, and read using a spectrophotometer at 562nm. Protein 
concentration was calculated by comparing absorbance of samples to a linear 
standard curve of the absorbance of known BSA standards. 
10-20 µg of sample protein were diluted in ddH2O and NuPage 4x LDS 
Sample Buffer (4µl) (with 2.5% β-mercaptoethanol for reducing samples, 
Sigma-Aldrich) to a total volume of 16µl. For denaturing conditions, samples 
were heated at 95 °C for 5 minutes on a heat block. Protein samples were 
loaded into wells of a pre-cast Bis-Tris gel (4-12 %, Invitrogen) and a 
molecular weight marker added to one well to monitor progress of 
electrophoresis. The samples were then resolved by gel electrophoresis in 
running buffer (125V), separating proteins by molecular weight. Protein was 
transferred to a PVDF membrane using wet electro-transfer in transfer buffer 
(30 minutes at 100V). To block non-specific protein binding on the PVDF 
membrane, blots were incubated with either BSA (5 %, Sigma-Aldrich) or non-
fat dried milk powder (Marvel) in Tris-buffered saline (Table 2-8) containing 
Tween 20 (0.1%) for 1 hour at room temperature.  
 137 
Membranes were incubated with primary antibody overnight at 4°C in 
blocking solution with gentle agitation at the appropriate concentration (Table 
2-3). Blots were washed three times for 15 minutes each, to remove unbound 
antibody, using TBS-T with agitation. Blots were then incubated with an 
appropriate HRP conjugated secondary antibody (Table 2-4) diluted in 
blocking solution for 1 hour at room temperature, followed by a final wash 
step. 
Bound antibodies were visualised by incubation with ECL western blot 
substrate (1ml, Thermo Scientific) for 5 min in the dark. This reaction relies on 
the catalysis by HRP of the oxidation of luminol into a light-emitting 
compound. Blots were exposed to Amersham Hyperfilm ECL (GE Healthcare) 
in the dark to visualise protein bands, and densitometry calculated using Fiji 
software. 
Transfer buffer Tris-buffered saline 
25mM Trizma base, 192mM glycine,  20% 
methanol in ddH2O 
20 mM Trizma base, 137 mM 
NaCl (pH7.4) 
Table 2-8 Western blot reagents 
 
2.2.7 Statistical analysis 
2.2.7.1 Data processing 
Data were collated in excel spreadsheets and analysed using Prism 
software v6.0 (GraphPad software, CA, USA). 
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2.2.7.2 Data presentation and analysis 
Unless otherwise stated, data assumed to be non-parametric were 
presented as the median and interquartile range (IQR). Non-parametric 
analysis was used (Kruskal Wallis, Mann Whitney, Wilcoxon-paired) as 
normal distribution of data could not be assessed due to smaller sample 
sizes. Normally distributed (parametric) data were presented as the mean and 
standard error of the mean (SEM). P-values were adjusted for multiple 
comparisons and a p-value of <0.05 was considered significant.  
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3 Chapter 3: Cyclic Mechanical Strain (CMS)-
induced cytoskeletal remodelling, 
RhoGTPase signalling and force transduction 
in alveolar epithelial cells 
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3.1 Introduction 
The cellular actin cytoskeleton, as the major load-bearing apparatus of 
the cell, is a key regulator of mechanotrandsduction (Burridge & Guilluy 
2016). Application of external force induced remodelling of the actin 
architecture, with re-orientation of stress fibres and focal adhesions in both 
endothelial cells (J. H.-C. Wang et al. 2001; Tzima 2006) and fibroblasts 
(Wang et al. 2004).  In epithelial cells, CMS promoted rapid actin remodelling 
(DiPaolo et al. 2010) dependent on the frequency of applied strain. However, 
the actin cytoskeleton does not passively remodel in response to force. 
Stretching of individual actin fibres promoted downstream signalling 
(Hayakawa et al. 2008), In fibroblasts, CMS-induced ERK activation was 
localised to actin stress fibres in a strain-dependent manner (Hirata et al. 
2015), suggesting that the cytoskeleton acts as a platform for CMS-induced 
signalling. 
CMS-induced actin remodelling is highly dependent on Rho-GTPases, 
and RhoA signalling in particular. RhoA activation, which is a critical mediator 
of mechanotransduction in spreading cells (Plotnikov et al. 2012), was 
increased in rats subjected to high tidal volume ventilation (Desai et al. 2007) 
and regulated stretch-induced downstream signalling in cardiomyocytes 
(Torsoni et al. 2005). Furthermore, CMS-induced β1-integrin activation may 
directly promote activation of a Rho-GEF, GEF-H1 (Guilluy et al. 2011), which 
formed a stretch-induced complex with paxillin and ERK 1/2 to promote 
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activation of RhoA  and trigger downstream myosin II-mediated actomyosin 
contraction (Gawlak et al. 2014).  
These cytoskeletal and Rho-GTPase responses to CMS affect the 
mechanical properties of cells. RhoA activity is associated with increases in 
the stiffness of alveolar epithelial cells (Wilhelm et al. 2014). Baseline stiffness 
tuned the sensitivity of cells to externally-applied force (Cirka et al. 2016), 
suggesting that RhoA-mediated alterations in cytoskeletal dynamics may 
affect the susceptibility of cells to stretch-induced injury. Indeed, cellular 
responses to CMS are comprised of both softening (Trepat et al. 2007) and 
reinforcement (Krishnan et al. 2009; Colombelli et al. 2009) of the 
cytoskeleton, with the former being independent of RhoA signalling (Chen et 
al. 2010). 
However, there are few consistent data to demonstrate CMS-induced 
cytoskeletal remodelling and RhoA signalling in alveolar epithelial cells 
(DiPaolo & Margulies 2012), and particularly in response to pathological 
stretch. The work in this chapter is based on the hypothesis that CMS-induced 
cytokine release in alveolar epithelial cells is dependent on cytoskeletal 
remodelling and RhoA signalling. Specifically, the aims of the work in this 
chapter are: 
a. To determine whether CMS-induced cytokine release in alveolar 
epithelial cells is associated with cytoskeletal and focal adhesion 
remodelling 
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b. To investigate the association between CMS-induced 
cytoskeletal remodelling and changes in traction forces across 
focal adhesions in these cells 
c. To investigate the role of RhoA-ROCK signalling in CMS-
induced mechanotransduction in these cells. 
 
 
Cellular integrins bind to ligands in the extracellular matrix (ECM), and are linked to the actin 
cytoskeleton through focal adhesion protein complexes. These are composed of a vast array 
of proteins, including focal adhesion kinase (FAK), vinculin (vinc) and talin. Inside out 
transmission of force from actomyosin contraction exerts traction on the ECM, allowing cells 
to become motile (Figure A).  The application of strain on the ECM triggers β1-integrin-
mediated activation of RhoGEFs, leading to activation of RhoA and Rho-associated protein 
kinase (ROCK). ROCK activates non-muscle myosin II (NMII), affecting actin cytoskeletal 
tension, and promoting further conformational changes in mechanosensitive and focal 
adhesion proteins, thereby affecting cell matrix adhesion and downstream signalling leading 
to cytokine generation. ROCK can be inhibited by Y27632, and NMII by blebbistatin (Figure 
B). 
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3.2 Specific methods 
3.2.1 Cytoskeletal gene regulation following CMS 
A549 cells seeded on collagen I-coated BioFlex™ 6-well plates were 
exposed to CMS for 2 hours at 0.33Hz, and cells immediately lysed and 
processed for RT-PCR by the cytoskeleton array PCR assay as described 
(2.2.3.3.3). 
3.2.2 ROCK and myosin II inhibition, and analysis of CMS-induced 
cytokine generation 
A549 cells seeded on collagen I-coated BioFlex™ 6-well plates were 
treated with relevant inhibitors, exposed to CMS for 2 hours at 0.33Hz, and 
supernatant collected at 24 hours for assessment of cytokine release as 
described (2.2.6.1.2). For inhibition of ROCK, myosin II and actin 
polymerisation, cells were incubated with either: Y27632 (10µM, 1 hour); 
Blebbistatin (20µM, 30 minutes); or cytochalasin D (0.5µM, 30 minutes) 
respectively prior to CMS. For LPA–induced RhoA agonism, cells were 
incubated for 30 minutes prior to CMS with lypophosphatidic acid (LPA) 
(10µM). For assessment of chemical-induced cytokine release, cells were 
treated with TNF-α (10ng/ml) for 24 hours prior to sampling of supernatant. 
Cell viability was determined as described (2.2.1.2). 
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3.2.3 Immunofluorescence for cytoskeletal and focal adhesion 
remodelling after CMS 
Cells were subjected to CMS for 0, 10, 30 or 60 minutes, fixed, stained 
and imaged by confocal microscopy as described (2.2.5.1.3). Antibodies for 
paxillin (rabbit 1:100) and PMLC2 (rabbit 1:50) (Table 2-3) and stains for f-
actin (phalloidin 1:50) and nuclei (DAPI 500mM) (2.2.5.1.3) were used. Fixed 
and stained cells were mounted in Mowiol plus DABCO anti-fade. Areas of 
cells and cell-free area calculations were performed using Image J software, 
and the latter with a macro developed in-house. Corrected total cell 
fluorescent measurements were performed using Image J software by taking 
the integrated density of selected cells and subtracting the area of a 
background selection multiplied by its mean fluorescence as described 
previously (McCloy et al. 2014).  
3.2.4 Analysis of CMS-induced FAK phosphorylation 
Cells subjected to CMS as above were lysed at their respective time 
points and protein levels calculated by BCA protein assay as described 
(2.2.6.3.2). Western Blot under reducing and denaturing conditions was 
performed using rabbit anti-pFAK Y397 (1:1000), total FAK (1:1000) or 
GAPDH (1:20,000) (Table 2-3).  
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3.2.5  Measurement of CMS-induced cell traction forces and RhoA 
activity 
Cells were transfected with the VinTS FRET tension sensor DNA 
(Grashoff et al. 2010) or the Raichu RhoA activity probe (Heasman et al. 
2010) using lipofectamine reagent (Table 2-6), fixed following either 0 or 1 
minute CMS, and mounted as described (2.2.5.1.3). FLIM microscopy was 
performed using a multiphoton upright microscope (Leica SP5) with a two 
photon Mai Tai laser (690-1040nm) (Newport spectra-physics), and Becker 
Hickl FLIM photon detector as described in (2.2.5.2.6). 
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3.3 Results 
3.3.1 CMS-induced cytoskeletal remodelling 
To examine the effect of CMS on F-actin cytoskeletal remodelling, cells 
were subjected to CMS for 0 (static), 10, 30 or 60 minutes, fixed, stained with 
phalloidin and imaged by confocal immunofluorescence microscopy. At 
baseline, cells demonstrated rhomboid-type morphology, with random 
orientation of stress fibres. By 10 minutes CMS, cell-cell attachment 
diminished as measured by an increase in cell-free area by approximately 
12%. By 60 minutes CMS, cell-free area had significantly increased to 32% of 
the total area. The size of individual cells also decreased significantly with 
increasing duration of CMS. Stress fibres adopted more co-ordinated 
alignment after 10 and 30 minutes CMS. By 60 minutes CMS, phalloidin 
staining was only visible at the periphery of cells (Figure 3-1).  
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Figure 3-1 Effect of Cyclic Mechanical Strain (CMS) on cytoskeletal architecture 
A549 cells were subjected to 30% equibiaxial CMS for 0 to 60 minutes, fixed and the actin 
cytoskeleton stained with phalloidin for confocal immunofluorescence microscopy. Panel A 
shows phalloidin-actin staining over a time course of CMS. Panel B shows the cell-free area 
at each respective time point and C shows the area in µm2 of individual cells. Scale bar 
represents 50µm. Arrows indicate actomyosin stress fibres. Data are for two fields per time 
point from three individual experiments, and images representative of those from all 
experiments. Area of individual cells calculated from maximum intensity projection images of 
5 cells per field of view. Data are presented as the median ± IQR analysed by Kruskall-Wallis 
test, **p<0.01, ***p<0.001 
 
3.3.2 CMS-induced focal adhesion remodelling  
At baseline, paxillin-stained focal adhesions could be seen at the ends of 
stress fibres, at the periphery of cells. Following 10 and 30 minutes CMS, 
numerous focal adhesions could be seen capping small stress fibres at the 
periphery and throughout the interior of cells. By 60 minutes CMS, stress 
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fibres could not be seen within the cell, and focal adhesions were less 
elongated and predominantly at the cell periphery (Figure 3-2). 
	  
Figure 3-2 Cyclic Mechanical Strain (CMS)-induced focal adhesion remodelling 
A549 cells were subjected to 30% equibiaxial CMS for 0 to 60 minutes and fixed. The actin 
cytoskeleton was stained with phalloidin (green), and focal adhesions with paxillin (red) for 
confocal immunofluorescence microscopy. Arrows show focal adhesions capping small stress 
fibres present throughout the cell. Arrowhead shows small focal adhesions at the peripheries 
of the cell following 60 minutes CMS. Scale bar represents 10µm. Images representative of 
three individual experiments. 
 
3.3.3 The effect of ROCK inhibition on CMS-induced cytoskeletal 
and focal adhesion remodelling 
Whereas application of CMS to A549 cells induced both cytoskeletal 
remodelling and focal adhesion redistribution, cells treated with Y27632 did 
not demonstrate similar CMS-induced reorganisation. Under baseline 
conditions, cells were larger than their untreated controls and did not 
decrease in size with CMS as demonstrated in untreated cells. There were no 
visible stress fibres either at baseline or during CMS, and no correlation 
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between small paxillin-stained focal adhesions, and phalloidin-stained F-actin 
(Figure 3-3). 
 
Figure 3-3 Effect of Rho-associated protein kinase (ROCK) inhibition on CMS-
induced cytoskeletal and focal adhesion remodelling 
A549 cells were treated with Y27632 (10µM) for 1 hour, subjected to 30% equibiaxial CMS 
for 0 to 60 minutes, then fixed. The actin cytoskeleton was stained with phalloidin (green), 
and focal adhesions with paxillin (red) for confocal immunofluorescence microscopy. 
Arrows show small focal adhesions dissociated from any organised actin structure. Scale 
bar represents 50 and 10µm as indicated.  
 
	  
3.3.4 The effect of ROCK inhibition on CMS-induced IL-8 release 
Inhibition of ROCK by Y27632 (10uM for 1 hr) led to a significant 
reduction in CMS-induced IL-8 release in A549 cells, and to a level 
comparable with un-stretched cells, when compared to the untreated group 
(Figure 3-4 – a). Application of Y27632 did not affect cell viability as assessed 
by MTT assay at 24 hours following CMS (Figure 3-4 – b). In order to test 
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whether Y27632-induced abrogation of IL-8 release was specific to 
mechanical stimulation, untreated or Y27632-treated cells were exposed to 
TNF-α (10ng/ml). These experiments demonstrated that IL-8 generation was 
at a level comparable with untreated cells (Figure 3-4 - c).  
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Figure 3-4 The effect of ROCK inhibition on CMS-induced cytokine release 
A549 cells were either untreated or Y27632 (10µM) was applied for one hour. CMS was 
applied equibiaxially at 30% elongation for 2 hours. Panel A shows IL-8 generation as 
sampled from cell supernatant at 24 hours following CMS. Panel B shows cell viability at 24 
hours following CMS as assessed by MTT assay. Panel C shows IL-8 release in respective 
treatments at 24 hours following TNF-α treatment Data are for n=3 from three individual 
experiments for panel A, and n=4 from two experiments for panels B and C, and are 
presented as median ± IQR. Data analysis by Mann Whitney test, *p<0.05. 
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3.3.5 The effect of LPA and cytochalasin D on CMS-induced IL-8 
release 
Treatment with the RhoA agonist lypophosphatidic acid (LPA) (10µM), or 
the inhibitor of actin polymerisation, cytochalasin D, (0.5µM), for 30 minutes 
had expected morphological effects on actin cytoskeletal architecture as 
demonstrated by phalloidin F-actin staining. Increased density of actin-fibres 
was observed with LPA treatment, whereas cytochalasin-D reduced cellular 
F-actin content, leaving no visible stress fibre architecture (Figure 3-5 - a). 
Treatment with LPA did not lead to statistically significant increases in CMS-
induced IL-8 release. Similarly, cytochalasin D did not abrogate nor lead to a 
statistically significant increase in CMS-induced IL-8 release (Figure 3-5 - b).  
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Figure 3-5 LPA treatment does not increase CMS-induced IL-8 release 
A549 cells were either untreated, lypophosphatidic acid (10µM) or cytochalasin D (0.5µM) 
applied for 30 minutes. CMS was applied equibiaxially at 30% elongation for 2 hours. Panel A 
shows phalloidin staining of the f-actin cytoskeleton in respective treatments at baseline 
(static) conditions. Panel B shows IL-8 generation as sampled from cell supernatant at 24 
hours following CMS. Data are for three individual experiments, and are presented as median 
± IQR. Data analysis by Mann Whitney test, *p<0.05  
 
3.3.6 The effect of CMS and ROCK inhibition on FAK 
phosphorylation 
To determine the effect of CMS (0 to 60 minutes) and ROCK inhibition 
on FAK activation (autophosphorylation at tyrosine 397) western blots were 
performed. FAK phosphorylation was minimal at baseline (static) in untreated 
cells. Following application of 30% CMS, FAK phosphorylation was 
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approximately 3 times that of baseline at 30 minutes and 60 minutes, although 
these results were not statistically significant. ROCK inhibition (Y27632) was 
associated with FAK phosphorylation at baseline and at 10 minutes, but with a 
decrease at 30 and 60 minutes CMS (Figure 3-6). 
 
 
Figure 3-6 The effect of CMS and ROCK inhibition on FAK phosphorylation 
A549 cells were either untreated, or subjected to y27632 (10µM) for 1 hour. CMS was applied 
equibiaxially at 30% elongation for 0-60 minutes. Panel A shows western blot images of both 
phosphorylated and total FAK over the time course of CMS. Panel B shows calculated image 
densities for respective blots. Data are presented as the median and IQR for 4 independent 
experiments. Statistical analysis by Kruskal-Wallis test. 
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3.3.7 The effect of myosin II inhibition on CMS-induced cytokine 
release 
To test the effect of inhibition of downstream ROCK signalling on CMS-
induced mechanotransduction, myosin II activity was blocked with blebbistatin 
(20µM). Whereas CMS-induced IL-8 generation was intact in vehicle-treated 
controls, this effect was abrogated in blebbistatin-treated cells (Figure 3-7 – 
a). Blebbistatin treatment did not affect cell viability as assessed by MTT 
assay (Figure 3-7 – b), and the ability of blebbistatin-treated cells to generate 
IL-8 in response to chemical stimulation (10ng/ml TNF-α) was preserved 
(Figure 3-7 - c). 
 156 
 
Figure 3-7 The effect of myosin II inhibition on CMS-induced cytokine release 
A549 cells were either untreated or blebbistatin (20µM) was applied for 30 minutes. CMS was 
applied equibiaxially at 30% elongation for 2 hours. Panel A shows IL-8 generation as 
sampled from cell supernatant at 24 hours following CMS. Panel B shows cell viability at 24 
hours following CMS as assessed by MTT assay. Panel C shows IL-8 release in respective 
treatments at 24 hours following TNF-α treatment Data are for n=6 from three individual 
experiments for panel A, and n=3 from three individual experiments for panels b and c, and 
are presented as median ± IQR. Data analysis by Mann Whitney test, **p<0.01 
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3.3.8 The effect of myosin II inhibition on CMS-induced 
cytoskeletal and focal adhesion remodelling 
To assess the effect of blebbistatin treatment on CMS-induced 
cytoskeletal remodelling, cells were stained for actin and paxillin after CMS (0-
60 mins). At baseline, blebbistatin-treated cells exhibited similar baseline 
morphology to Y27632-treated cells, with few visible stress fibres and small 
focal adhesions associated with disorganised actin architecture. Following 60 
minutes CMS, cell-cell detachment and cellular contraction seen in vehicle-
treated controls was not evident in blebbistatin-treated cells (Figure 3-8). 
 
 
Figure 3-8 The effect of myosin II inhibition on CMS-induced cytoskeletal and focal 
adhesion remodelling 
A549 cells were treated with blebbistatin (20µM) for 30 minutes, subjected to 30% 
equibiaxial CMS for 0 to 60 minutes, then fixed. The actin cytoskeleton was stained with 
phalloidin (green), and focal adhesions with paxillin (red) for confocal immunofluorescence 
microscopy. Scale bars represent 50 or 10µm. 
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3.3.9 The effect of CMS on cellular traction force 
To assess the effect of CMS on tension forces experienced by cells, 
cells were transfected with the vinculin TS tension sensor FRET probe. FLIM 
microscopy was performed to ascertain fluorescence lifetimes for either 
unstretched (static) cells, or cells exposed to CMS for 1 minute. Venus-only 
probes had lifetimes of approximately 2.3, tail-less controls and static cells of 
1.8. When CMS was applied for 1 minute, mean fluorescent lifetime 
decreased to 1.6, indicating a reduction in tension across vinculin. However, 
given the absence of an uncomplexed mTFP1 probe, we could not calculate 
FRET efficiency, and these results can only be indicative of CMS-induced 
changes in cellular tension (Figure 3-9). 
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Figure 3-9 The effect of CMS on cellular traction force 
Cells were transfected with the Vinculin TS tension FRET probe, and cells either unstretched 
(static), or subjected to CMS for 1 minute. At each time point, cells were fixed, and FLIM 
microscopy used to ascertain respective fluorescent lifetimes. Panel A shows ‘heat map’ 
colouring of lifetimes for venus-only, and tailless controls, and for static cells or those 
subjected to CMS. Lower lifetimes are on the blue end of the spectrum as detailed below 
each heat map.. Panel B shows collated histograms of fluorescent lifetimes for all conditions. 
Panel C shows collated histograms of fluorescent lifetimes for cells under static and CMS 
conditions. Data are from n=6 cells, and images representative. 
 
3.3.10 The effect of CMS on RhoA activity 
Experiments were designed to test the effect of CMS on RhoA activity in 
alveolar epithelial cells using the Raichu FRET probe. Cells were transfected 
and CMS applied for either 0 (static) or 1 minute. FLIM was performed to 
ascertain fluorescence lifetimes for cells under respective conditions. Rho-
GFP-only probes had mean lifetimes of 2.1, inactive Rho (T19) probe of 2.1 
and static cells of 1.9. When CMS was applied for 1 minute, mean fluorescent 
lifetime decreased to 1.86. 1 minute CMS significantly increased FRET 
efficiency in these cells, implying a CMS-induced increase in RhoA activity 
(Figure 3-10). 
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Figure 3-10 The effect of CMS on RhoA activity 
Cells were transfected with the Raichu RhoA FRET probe, and either unstretched (static), or 
subjected to CMS for 1 minute. At each time point, cells were fixed, and FLIM microscopy 
used to ascertain respective fluorescent lifetimes. Panel A shows heat maps of lifetimes for 
Rho-GFP, Rho-inactive controls (T19N) and for static cells or those subjected to CMS. Lower 
lifetimes are on the blue end of the spectrum. Panel B shows collated histograms of 
fluorescent lifetimes for all conditions. Panel C shows collated histograms of fluorescent 
lifetimes for cells under static and CMS conditions. Panel D shows calculated FRET 
efficiencies for cells subjected to static or CMS conditions. Data are presented as median ± 
interquartile range for 7 cells per condition, and analysed by Wilcoxon paired test, *p<0.05. 
Images shown are representative of respective conditions. 
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3.4 Discussion 
3.4.1 Summary of important findings 
CMS applied to cells induced cytoskeletal remodelling, including stress 
fibre re-orientation in one direction, a reduction in the area of individual cells 
and increases in cell-free area. CMS also induced focal adhesion 
redistribution to the ends of stress fibres seen throughout cells. Inhibition of 
ROCK with Y27632 abrogated CMS-induced IL-8 generation, but without 
affecting cell viability, or the ability of cells to generate IL-8 in response to 
chemical stimuli (TNF-α). This correlated with a decrease in CMS-induced 
FAK phosphorylation. Downstream inhibition of myosin II with blebbistatin also 
abrogated CMS-induced IL-8 generation in a manner similar to that seen with 
Y27632, and was associated with similar morphological features. Finally, 
preliminary experiments using FRET sensors demonstrated that CMS for 1 
minute was associated with decreased cell traction forces, and significantly 
increased RhoA activity.  
3.4.2 CMS-induced cytoskeletal and focal adhesion remodelling 
CMS induced cytoskeletal reorganisation, with loss of random 
orientation of stress fibres, decreased cellular area and increased cell-free 
area. Stress fibre reassembly and realignment is a well-documented response 
of endothelial cells (J. H.-C. Wang et al. 2001) and fibroblasts (Greiner et al. 
2013) subjected to mechanical stresses or increased ECM rigidity. In these 
cells, mechanical force-induced cytoskeletal remodelling occurred via integrin-
mediated Rho signalling (Guilluy et al. 2011; Tzima et al. 2001). CMS-induced 
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Rho signalling in particular promoted reorientation of stress fibres and focal 
adhesions perpendicular to the direction of uniaxial force (Goldyn et al. 2009; 
Abiko et al. 2015; Kaunas et al. 2005). This mechanism has been proposed 
as an adaptation to reduce injury from external forces (Faust et al. 2011; 
Hwang & Barakat 2012).  
Evidence of similar CMS-induced actin remodelling in epithelial cells is 
less extensive. In equibiaxial CMS of foetal ATII, stress fibre reorientation was 
induced along the long axis of the cell, and was dependent on RhoA signalling 
(Silbert et al. 2008). Another study of biaxial CMS of rat ATI found 
perijunctional actin ring (PJAR) formation within 10 minutes in a manner 
dependent on magnitude of stretch and frequency, and associated with 
spontaneous movement of actin-focal adhesion-bound microbeads (DiPaolo 
et al. 2010). In the latter study, the authors concluded that this effect was 
specific to the cell type used, as PJAR were evident in A549 at baseline, and 
not altered by CMS. Our results may be different due to differences in the 
degree of CMS applied, the method used to apply CMS and the fact that the 
authors serum-starved cells prior to application of CMS, which is known to 
impede Rho-dependent stress fibre formation (Machesky & Hall 1997).  
Furthermore, our observations indicated that CMS promotes a decrease 
in cellular area, perhaps indicating an increase in cellular contraction. This 
was associated with an increase in denuded, or cell-free, area. These 
observations correlate with those of CMS-induced gaps in monolayers of rat 
ATII (Crosby et al. 2011), and with those demonstrating that VALI is 
associated with denudation of the lung epithelial basement membrane or 
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epithelial ‘leak’ (Frank et al. 2002; Matthay et al. 2012; Hamlington et al. 
2016). While CMS-induced injury to the lung epithelium is generally 
associated with cell apoptosis and death (Crosby et al. 2011), our work 
demonstrates that A549 viability is not reduced following CMS. We were not 
able to ascertain whether the increase in cell-free area and decrease in cell 
size were secondary to primary cellular contraction in response to CMS, or 
due to broken cell-matrix and cell-cell adhesions and unopposed cell 
contraction. However, work in endothelial cell monolayers lends weight to the 
latter, suggesting that whereas cytokine-induced injury contributes to vascular 
permeability, a separate Rho and focal-adhesion-dependent contractile 
process also induces endothelial gap formation (Birukova et al. 2016). 
ROCK and myosin II inhibition abrogated CMS-induced cytoskeletal 
remodelling. That this pathway mediates CMS-induced cytoskeletal 
remodelling has been demonstrated previously in ATII (Silbert et al. 2008), 
where dominant negative expression of RhoA abrogated CMS-induced stress 
fibre assembly or realignment. In fibroblasts subjected to uniaxial CMS 
(Hoffman et al. 2012), Y27632 (3µM for 2 hours) both abrogated stress fibre 
production at basal states, and reduced formation and perpendicular 
realignment following CMS. Our observations of inhibited stress fibre 
assembly and CMS-induced reorientation in cells following ROCK and myosin 
II inhibition correlate with those of fibroblasts (Greiner et al. 2013), endothelial 
cells (Lee et al. 2010; Kaunas et al. 2005) and ATI (DiPaolo & Margulies 
2012) but in the latter case no differences in CMS-induced cytoskeletal 
remodelling were seen when compared to untreated controls. Again, these 
differences may be secondary to the degree of CMS applied. Indeed, in 
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endothelial cells, Rho-mediated CMS-induced stress fibre construction and 
reorganisation was dependent on strain rate (Lee et al. 2010). 
Our experiments also indicated that CMS induced the appearances of 
‘breaks’ in stress fibres within cells, with reorganisation of focal adhesions to 
the free ends of the actomyosin fibre. The application of mechanical force 
promotes focal adhesion maturation (Riveline et al. 2001; Gawlak et al. 2014), 
but also myosin-dependent realignment (Greiner et al. 2013). However, focal 
adhesions also transiently assemble and disassemble in response to 
externally-applied force, such as with primary ATII subjected to tonic stretch 
(Liu et al. 2011), and this behaviour may be protective. In this case, cells 
transiently contracted, disassembled adhesions and partially detached, but 
without cell death. Reducing integrin-ECM binding increased this transient 
stretch-induced cell contraction but abrogated cell death. Conversely, 
increasing integrin activity reduced transient disassembly contraction, but 
increased cell death, suggesting that transient focal adhesion disassembly 
allows cells to escape stretch-induced injury.  
In our case, focal adhesions associated with stress fibres within the cell 
during CMS. A similar phenotype occurs when stress fibres are mechanically 
broken, and in that case, the adaptor protein zyxin relocated from focal 
adhesions to newly maturing adhesions at the severed ends as the filament 
retracts (Colombelli et al. 2009). Crucially, zyxin redistributed to areas of high 
strain (Smith et al. 2010). This phenomenon occurred in response to CMS 
where it contributed to stress fibre cytoskeletal re-enforcement (Yoshigi et al. 
2005) by recruiting actin-binding proteins α-actinin and Drosophila enabled 
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(Ena) / vasodilator-stimulated phosphoprotein (VASP) (Hoffman et al. 2012). 
In this case, zyxin was not required for CMS-induced cytoskeletal re-
orientation, but for subsequent re-enforcement of stress fibres. Therefore, the 
focal adhesion reorientation seen in our model may represent CMS-induced 
relocation of zyxin to repair damaged stress fibres.  
3.4.3 Rho-ROCK-myosin II signalling is required for CMS-induced 
cytokine generation 
My data (3.3.4, 3.3.7) indicate that ROCK and myosin II are required for 
CMS-induced cytokine generation in alveolar epithelial cells. Inhibition of both 
elements, with 10µM Y27632 in the former and 20µM blebbistatin in the latter, 
significantly abrogated CMS-induced IL-8 release in these cells. Furthermore, 
the doses used were comparable with previous studies in vitro (Torsoni et al. 
2005) and did not reduce cell viability in comparison to untreated cells. Finally, 
cells were still able to generate IL-8 in response to chemical stimulation from 
TNF-α, suggesting that ROCK and myosin II regulate pathways specific to 
strain-induced cytokine generation.  
Neutrophil chemokines like IL-8 play an important role in the 
pathogenesis of ARDS, which is sensitive to high tidal volume stretch of the 
alveolar epithelium (Ranieri et al. 1999). This corresponds with data 
suggesting that CMS of alveolar epithelial cells in vitro induced IL-8 
generation (Vlahakis et al. 1999). My data correlate with work in bronchial 
epithelial cells (Thomas et al. 2006), where CMS-induced IL-8 release was 
abrogated by inhibition of ROCK. Similarly, the application of 18% CMS to 
endothelial cells over 48-72 hours resulted in an increase in IL-8 release, 
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abrogated by siRNA knockdown of the Rho GEF GEFH1 (Tian et al. 2016). 
This also abrogated CMS-induced actin remodelling, indicating the role of 
RhoA signalling in stretch-induced mechanotransduction.  
How might CMS-induced cytokine generation progress via ROCK 
signalling? Rho-ROCK-myosin II-driven contractility increases cellular pre-
stress (Cirka et al. 2016) and elastic modulus (Wilhelm et al. 2014). Both of 
these effects could increase the susceptibility of the cell to externally-applied 
strain. However, how this process links with previously determined 
ERK/oxidative stress pathways is not clear. CMS promoted expression of the 
Rho activating protein GEF-H1 downstream of FAK activation (Guilluy et al. 
2011), which forms a complex with ERK and paxillin to stimulate Rho activity 
(Gawlak et al. 2014). GEF-H1 is required for CMS-induced cytokine 
generation in endothelial cells (Tian et al. 2016). Rho-GEF-H1 and RhoA are 
upstream of ROCK, indicating either the possibility of a positive feedback loop 
driven by myosin-induced contractility, or of independent effects of 
ROCK/myosin II and GEF-H1/RhoA.  
Given the strong possibility of RhoA-mediated mechanotransduction 
indicated by these results, I attempted to ascertain if treatment with LPA 
would agonise CMS-induced cytokine release. Phalloidin staining suggested 
that treatment with LPA (10µM for 30 mins) promoted increased stress fibre 
formation (3.3.5), as previously described in Swiss 3T3 cells (Ridley & Hall 
1992). However, there was no increase in CMS-induced IL-8 generation 
following this treatment. There are numerous potential reasons for this. First, I 
could not confirm that LPA treatment did increase RhoA activity: results from 
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rhotekin-bead pull-down and the raichu RhoA probe were inconclusive. 
Another possibility is that RhoA activity is already maximal in untreated cells, 
and therefore cannot be potentiated further. 
I also aimed to determine whether inhibition of actin polymerisation by 
cytochalasin D would have a similar effect to ROCK inhibition on CMS-
induced cytokine release. However, despite phalloidin-stained morphology 
consistent with cytochalasin-D-mediated inhibition of actin polymerisation, the 
cytokine response to CMS was preserved, and not abrogated as I expected. 
Although there are few data examining the effect of cytochalasin-D on CMS-
induced mechanotransduction, previous work by our group suggests that the 
same dose inhibited CMS-induced ERK phosphorylation and oxidative stress 
in A549 cells (Pinhu 2008). Cytochalasin D has also been shown to decrease 
the elastic modulus of cells subjected to hyperoxia (Roan et al. 2012). Taking 
all this into account, it would be expected to reduce stretch-induced cytokine 
generation.  
I cannot preclude the possibility that this indicates a role for RhoA and 
myosin II signalling in CMS-induced IL-8 release, but independent of 
cytoskeletal integrity. One possibility may be that mechanical force promotes 
IL-8 gene transcription or protein translation, possibly via direct force 
transduction to the nucleus (Guilluy et al. 2014). Another potential explanation 
is that actin polymerisation has a minor role in stress fibre and focal adhesion 
assembly (Chrzanowska-Wodnicka & Burridge 1996), when compared to 
Rho-driven myosin contractility. However, given that contrasting data implies 
that polymerisation is critical for the development of stress fibre and focal 
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adhesion mechanosensitive elements (Hotulainen & Lappalainen 2006; 
Oakes et al. 2012), I cannot fully explain these results. Finally, CMS may 
contribute to actin polymerisation itself, counteracting the effect of 
cytochalasin-D, and restoring the ability of cells to sense and respond to 
external force (Riveline et al. 2001). In conclusion, these data suggest that the 
role of the cytoskeleton in CMS-induced IL-8 release may be more complex, 
and the possibility for direct nuclear mechanotransduction, potentially with a 
role for RhoA-ROCK-myosin II activity, cannot be ignored. 
Mechanical force (Friedland et al. 2009), and specifically CMS is 
associated with increased β1-integrin activity (Wernig et al. 2003) (Hamzeh et 
al. 2015) (Sanchez-Esteban et al. 2006). Force-induced β1-integrin activity 
activated RhoA via FAK and GEF-H1 activation (Guilluy et al. 2011). FAK is 
critical for integrin-mediated adhesion and response to substrate rigidity 
(Provenzano et al. 2009), and is activated by autophosphorylation at Y397 in 
response to CMS as demonstrated in lung endothelial cells. This then 
phosphorylates paxillin, enabling GEF-H1-paxillin-ERK complex formation 
(Gawlak et al. 2014). Indeed, inhibition of FAK abrogated force-induced GEF-
H1 activation (Guilluy et al. 2011).  
In our system, FAK phosphorylation at Y397, as a read-out of 
mechanoresponse to CMS, increased following 30 minutes of stretch. 
However, baseline phosphorylation was observed in cells following ROCK 
inhibition which contrasts with observations from mouse lung epithelial cells 
(Wilhelm et al. 2014) and cardiomyocytes (Torsoni et al. 2005).  A CMS-
dependent increase in phosphorylation was not observed in these cells, such 
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as at 30 minutes. Considering the above schema of CMS-induced RhoA 
activation, ROCK activation can be considered downstream of FAK, and its 
inhibition would not be expected to affect FAK phosphorylation in response to 
mechanical force. Therefore, these effects of CMS on FAK phosphorylation 
may be considered to be secondary to Rho-ROCK-mediated reinforcement 
following repeated loading cycles, i.e an indication of the ability of the cell to 
tune traction forces in response to force. Indeed, FAK may not regulate CMS-
induced stress fibre remodelling or ERK activation as these occur even in the 
absence of FAK in aortic endothelial cells subjected to CMS (Hsu et al. 2010), 
and CMS-induced cell reorientation is myosin II-dependent (Greiner et al. 
2013). Therefore, we can consider CMS-induced FAK signalling in this case 
as occurring both upstream of RhoA-ROCK activation, and as a dynamic 
response to mechanosensation. However, as seen following cytochalasin D 
treatment, the possibility of mechanotransduction directly affecting IL-8 
transcription, translation or trafficking cannot be ignored. 
3.4.4 Cellular tension during CMS-induced mechanotransduction 
From preliminary experiments of cellular tension measurements using 
FRET constructs, we cautiously conclude that CMS of 1 minute induced a 
decrease in tension across vinculin focal adhesions. If these results prove to 
be consistent, they would suggest that force transmission is decreased very 
rapidly following the onset of externally applied force. These observations are 
in agreement with previous descriptions of mechanical responses to CMS. 
Cell traction forces of human airway smooth muscle cells demonstrated acute 
decreases following transient stretch, implying rapid cytoskeletal ‘softening’ or 
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fluidisation (Trepat et al. 2007; Krishnan et al. 2009). Similarly, transient 
stretch of human bladder smooth muscle cells promoted the same rapid 
fluidisation response, followed by a slow increase in traction force and cell 
stiffness as measured by elastic modulus (Chen et al. 2010). Indeed, 
macroscopically, the lung shows evidence of strain-induced hardening with an 
exponential increase in stress with applied strain to isolated lung parenchymal 
strips (Navajas et al. 1995). 
This dual response also correlates with actin dynamics seen in various 
systems. For example, a rapid increase in movement of actin filaments was 
observed within 1 minute CMS in rat ATI, which then slows down, suggesting 
acute malleability of the actin cytoskeleton followed by recovery or 
reinforcement (DiPaolo et al. 2010). Fibroblasts subjected to uniaxial stretch 
demonstrated a two-phase response composed of initial stress fibre 
reorientation followed by zyxin-mediated reinforcement (Hoffman et al. 2012). 
Mechanisms that could account for initial cytoskeletal fluidisation are not 
entirely clear. Possibilities include purely physical properties of the cell, force-
induced dissociation of actin from binding partners such as α-catenin or 
VASP, or activation of cofilin (Chen et al. 2010). Whether rapid dissociation of 
zyxin from focal adhesions to stress fibres can account for fluidisation also 
remains to be seen, although initial actin reorganisation is zyxin-independent 
(Hoffman et al. 2012).  
Initial fluidisation as a physical response of the cell to acute strain in our 
model may be related to CMS-induced changes in stress fibre and focal 
adhesion dynamics. Acute strain on individual stress fibres decreases their 
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ability to transmit force through their corresponding focal adhesion, followed 
by a zyxin-dependent restoration phase corresponding to stress fibre repair 
(Smith et al. 2010). Accordingly, severing of individual stress fibres with 
femtosecond laser nanoscissor techniques revealed an immediate retraction 
of the fibre associated with a dissipation of force to the ECM. Crucially, in this 
case the degree of recoil corresponded with tensile pre-stress: when this was 
reduced by inhibition of ROCK-myosin II-driven contractility, elastic recoil of 
stress fibres also decreased (Kumar et al. 2006; Colombelli et al. 2009). We 
therefore suggest that CMS-induced damage to stress fibres corresponds with 
prompt relaxation of tension throughout the cell, and that this elastic recoil 
may be inhibited by decreasing myosin II driven cellular pre-stress.  
Our aim to measure cellular tension in cells following ROCK inhibition 
was impeded by the small focal adhesions in those cells as seen in previous 
studies (Rápalo et al. 2015), which made it difficult to establish fluorescent 
lifetimes. However, Grashoff et al. overcame this issue, and ascertained that 
tension following ROCK and myosin II inhibition is decreased (Grashoff et al. 
2010). This reinforces our belief that these cells are less susceptible to CMS-
induced injury because their baseline pre-stress is reduced. Similar 
observations were seen when ROCK inhibition protected alveolar epithelial 
cells from susceptibility to hyperoxia and CMS, possibly by preventing 
hyperoxia-induced increases in cellular pre-stress (Wilhelm et al. 2014). In 
this context, we would expect to see no fluidisation of ROCK-inhibited cells 
following onset of CMS, but rather an increase in tension such as that 
observed in valvular interstitial cells with reduced pre-stress following myosin 
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II inhibition (Cirka et al. 2016). In this context, cells tune traction forces to 
maintain an optimum equilibrium in response to external forces.  
That inhibition of Rho alters baseline cytoskeletal properties to tune 
susceptibility to CMS is in agreement with observations by Yalcin et al. Where 
actin was depolymerised with latrunculin A, alveolar epithelial cells subjected 
to CMS exhibited both increased cell adhesion and cell viability. Using optical 
tweezer techniques, the authors demonstrated that the rheology of the 
latrunculin-treated cells was ‘softer’ and more visco-elastic and fluid-like than 
that of untreated cells. It was proposed that this softer rheology predisposed 
the latrunculin-treated cells to deform more slowly and ‘dampen’ out the 
applied force. This effect could be replicated by heating the cells to 37°C 
(Yalcin et al. 2009).  
However, my results must be interpreted with caution. First, the 
complexity of the experimental technique limited the data gathered to that 
from 6 cells at present. Second, I note that the fluorescent lifetimes from 1 
minute CMS are lower than those of the tail-less probe, suggesting lower 
tension. Given that no tension can be applied across this control probe, my 
hypothesis is that either the control probe does not function correctly in my 
set-up, or that CMS at the magnitude applied in my case led to breakage of 
the filamentous linker between FRET donor and acceptor, allowing for greater 
proximity between the two, and therefore increased FRET. This may be 
possible, given that the TSMod is sensitive to forces in the range of 1-6 pN 
(Grashoff et al. 2010), and the force required to stretch actin stress fibres from 
relaxed length to original length is thought to be in the region of 10nN 
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(Kassianidou & Kumar 2015). The force required to break individual stress 
fibres may be even greater, given that stress fibres appear to undergo local 
increases in tension in zones liable to break (Smith et al. 2010). 
3.4.5 CMS-induced regulation of RhoA activity 
In this context, I sought to establish the relationship between early 
changes in cellular traction forces and RhoA activity. Using a previously 
described raichu RhoA FRET probe (Heasman et al. 2010), preliminary 
results demonstrated that 1 minute CMS increased RhoA activity. These 
observations contrast with other attempts to characterise RhoA-ROCK activity 
during CMS of alveolar epithelial cells.  
MLC2 phosphorylation and RhoA activity decreased in rat ATI subjected 
to CMS of 37% elongation for 10 and 60 minutes (DiPaolo & Margulies 2012). 
When Silbert et al. subjected foetal ATII to low magnitude (5%) CMS, RhoA 
activity initially decreased at 1 minute, followed by an increase at 5 minutes 
(Silbert et al. 2008). My results correlate more closely with those observed in 
cardiomyocytes, where CMS induced RhoA activity by 1 minute, which 
persisted until 10 minutes (Kawamura et al. 2003). Differences again may be 
accounted for by cell type, but also the method used to ascertain RhoA 
activity. I used a FRET sensor on the basis that it would provide greater 
spatio-temporal information that a standard pull-down assay (Pertz et al. 
2006).  
That RhoA expression may be up-regulated within 1 minute CMS 
corresponds with stretch-induced β1 integrin activation and FAK-regulated 
 175 
GEF-H1 expression (Guilluy et al. 2011). Downstream of RhoA, ROCK 
activation promotes myosin II activity through MLC2 phosphorylation 
(Totsukawa et al. 2000). Myosin-driven contractility increases cellular pre-
stress, and possibly the cell stiffening response to externally-applied force 
(Guilluy et al. 2011) (Watanabe-Nakayama et al. 2011). Although increased 
pre-stress and stiffening are thought to be a cellular adaptation to maintain 
cellular integrity in the face of externally applied force (Watanabe-Nakayama 
et al. 2011) (Guilluy et al. 2011), such a response may mediate cytokine 
generation following increased susceptibility to transmitted force across a 
tense cytoskeleton.  
The effect of RhoA-mediated cytokine release in alveolar distension may 
have implications for the pathogenesis of lung injury. Pre-treatment of rats 
with Y27632 in a caecal ligation model of sepsis reduced lung injury 
parameters including interstitial oedema, lung architectural damage and 
inflammatory cell infiltration (Cinel et al. 2012). Although the animals in this 
case were not ventilated, and the authors did not discuss the effect of 
modulation of alveolar distension-induced cytokine release in the progression 
of lung injury, this ties with other observations of Rho-mediated and CMS-
induced ‘second-hit’ lung injury. Y27632 attenuated Rho and CMS-mediated 
augmentation of IL-6 induced endothelial cell permeability in vitro, and lung 
injury in vivo (Birukova et al. 2012), and knockdown of GEF-H1 abrogated 
CMS-induced endothelial disruption in an LPS two-hit model of lung injury 
(Tian et al. 2016). These data add to a growing body of evidence from 
endothelial cells that VALI follows this two-hit model, composed of a Rho-
independent IL-6 mediated disruption of endothelial integrity, such as from 
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sepsis, augmented by a focal adhesion and Rho-dependent stretch-induced 
injury (Birukova et al. 2016). 
Finally, that RhoA signalling may mediate stretch-induced lung injury 
correlates with previously observed signalling pathways in lung 
mechanobiology. Mitochondrial ROS, the generation of which has been linked 
to CMS-induced mechanotransduction pathways in the lung (Pinhu 2008; 
Nurit Davidovich et al. 2013; Rápalo et al. 2015) were shown to activate 
ROCK and MLC-mediated cytoskeletal remodelling in a drosophila model of 
wound healing (Muliyil & Narasimha 2014), and may also be responsible for 
increasing the pre-stress of cells via this pathway (Wilhelm et al. 2014).  
3.4.6 Limitations 
Application of CMS to cells using the Flexcell system, particularly when 
applying stretch magnitudes of over 30%, is associated with heterogeneity of 
the strain field. In a system such as mine, where sections of the flexible 
silicone membrane are cut for immunofluorescence microscopy or FLIM, 
these heterogeneities will lead to inconsistencies in observations or 
measurements. One possible solution to this is to use stretch magnitudes of 
20%, and only section the membrane lying over the loading post (Ursekar et 
al. 2014).  Furthermore, when considering the effect of CMS on cells, it must 
be appreciated that there may be shear forces applied as the cells are 
stretched within the media (Pinhu 2008).  
When measuring the effect of CMS on cellular size and on cell-free area, 
an actin dye was used. However, results may have been confounded by the 
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effects of CMS on actin composition at the lamellipodium. The use of a 
membrane dye may provide more accurate information on the precise 
boundaries of cells.  
Finally, investigating the effects of CMS at fixed times may only offer 
‘snapshots’ of what may be a dynamic and constantly-adapting picture. 
Therefore, the effects of CMS on cytoskeletal and focal adhesion remodelling, 
cellular traction forces and RhoA activity may only be relevant at the time 
points measured, and may not reflect complex, rapid and evolving signalling 
over time. The combination of high-speed FRET imaging (Poland et al. 2015), 
with recent development of platforms for real-time imaging (Rápalo et al. 
2015) may provide more insight into CMS-induced signalling in future.  
3.4.7 Conclusions 
I have shown that CMS promoted cytoskeletal remodelling and focal 
adhesion re-distribution in alveolar epithelial cells, and that remodelling and 
cytokine generation are dependent on RhoA-ROCK-myosin II signalling. 
Furthermore, preliminary results suggest that CMS induced rapid (1 minute) 
decreases in cellular tension at focal adhesions, and increased RhoA activity.  
I believe that RhoA-ROCK signalling may mediate CMS-induced 
mechanotransduction and cytokine generation by altering baseline 
cytoskeletal tension (pre-stress), which alters the susceptibility of cells to 
transmission of force from CMS. However, the fact that cytochalasin D did not 
affect CMS-induced IL-8 release, if consistent, reveals a potential greater 
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level of complexity than the pathway hypothesised, possibly including direct 
nuclear mechanotransduction. 
3.4.8 Future directions 
Although I have ascertained preliminary results for the effects of CMS on 
a short time-scale (1 minute) on cellular traction and RhoA activity, evidence 
suggests that cells exhibit biphasic responses to CMS, with an initial reduction 
in traction forces followed by a slow reinforcement. Therefore, I aim to 
measure these effects over longer time periods of CMS, from 1 minute to 10 
minutes, with the aim of developing a more robust picture of cellular 
responses over time. Furthermore, I aim to use frequency domain FLIM to 
accelerate data acquisition. 
Another future aim is to use staining for zyxin to determine whether focal 
adhesion redistribution and remodelling correlates with zyxin mobilisation from 
focal adhesions to sites of stress fibre repair, and if this is associated with 
CMS-induced remodelling and stiffening.  
In order to ascertain how the role of cellular pre-stress correlates with 
the results seen following application of cytochalasin D, it would be prudent to 
apply the cellular tension measurements to cells in this condition. 
Finally, these investigations have focussed on the role of signalling 
within single cells during CMS. However, a sub-confluent monolayer of cells 
does not respond to CMS with a significant cytokine response (2.2.4.1.3). 
Therefore, cell-cell interactions are likely to play a major role in CMS-induced 
injurious mechanotransduction. Assessment of the roles of α and β catenin, in 
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addition to other cell-cell adhesion markers, will be critical for understanding 
the interplay between cell-cell and cell-matrix adhesions in CMS-induced 
mechanotransduction signalling.  
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4 Chapter 4: The role of CD98hc in responses 
of the lung alveolar epithelium to Cyclic 
Mechanical Strain (CMS) 
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4.1 Introduction 
Results from the previous chapter indicated that CMS induced RhoA 
activation in alveolar epithelial cells. Previous studies demonstrated that 
mechanical force-induced β1-integrin activation promoted RhoA signalling 
(Guilluy et al. 2011), and that β1-integrin activation in response to increased 
ECM rigidity required ROCK-myosin II signalling (Lin et al. 2013).  
The transmembrane protein, CD98hc, interacts with β-integrin tails 
(Fenczik et al. 2001), mediates β-integrin-dependent adhesive signalling, and 
regulates adhesion-dependent spreading of cells (Prager et al. 2007). In 
embryonic stem cells, CD98hc, and specifically the intracellular and 
transmembrane domains that interact with β1-integrins, was required for 
adhesion-induced and integrin-dependent activation of Akt and Rac GTPase 
(Feral et al. 2005). These integrin-mediating properties of CD98hc may 
underlie its capacity to promote anchorage-independence and tumourgenesis 
(Cantor & Ginsberg 2012) (Henderson et al. 2004). Furthermore, CD98hc 
regulated β1-integrin-mediated RhoA activity (Féral et al. 2007), and ROCK 
signalling (Estrach et al. 2014) in fibroblasts. 
Although depletion of β-integrin induced cell detachment and death in 
ATII exposed to tonic stretch (Liu et al. 2011), the targeting of integrin-
mediating proteins, such as CD98hc, to affect downstream integrin signalling 
is an attractive prospect (Cantor et al. 2008). CD98hc may therefore represent 
a potential target for CMS-induced injurious mechanotransduction occurring 
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via β-integrin and RhoA signalling processes. However, recovery of the lung 
from injury is dependent, in part, on adhesion, migration and proliferative 
restoration of the alveolar epithelium (Crosby & Waters 2010). Given that β1-
integrin signalling (Kim et al. 1997), and RhoA signalling (Reffay et al. 2014) 
regulate epithelial cell migration, the effect of CD98hc depletion on adhesion, 
migration and epithelial barrier integrity must be carefully evaluated before 
credence is given to its potential as a therapeutic target in VALI. 
Therefore the work in this chapter is based on the hypothesis that CMS-
induced cytokine release in alveolar epithelial cells is mediated via CD98hc-
induced baseline RhoA activity and cellular tension. Specifically, the aims of 
the work in this chapter are: 
a. To investigate the effect of CD98hc knockdown on CMS-induced 
mehcanotransduction, integrin activity and downstream FAK 
signalling 
b. To establish whether knockdown of CD98hc mediates baseline 
RhoA activity and cellular tension 
c. To determine whether knockdown of CD98hc decreases the 
migratory and adhesive capacity of alveolar epithelial cells, which is 
essential for repair of the injured alveolar epithelium.  
To achieve these aims, I will use siRNA to knockdown CD98hc, and will 
apply biaxial CMS to A549 cells in vitro, using FRET techniques already 
described to ascertain RhoA signalling and traction forces. 
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4.2 Specific methods 
4.2.1 Effect of CD98hc knockdown (kd) on CMS-induced IL-8 
protein, gene expression and cell viability  
A549 cells seeded on collagen I-coated BioFlex™ 6 well plates were 
transfected with either non-targeting or CD98hc siRNA at 24 hours when 30-
50% confluent as described (2.2.3.5.2). Efficiency of knockdown was 
assessed by immunoblotting of protein (2.2.6.3) for CD98hc (1:10,000) 
referenced to β-actin expression (1:1000) (2.1.6.1). 
At 48 hours following transfection, cells were exposed to 30% CMS for 2 
hours at 0.33Hz, and supernatant collected at 24 hours for assessment of 
cytokine release by ELISA as described (2.2.6.1). For gene expression 
analyses, cells were lysed in Trizol reagent immediately following CMS, and 
reverse transcription and RT PCR steps followed as described (2.2.3.3).  
For assessment of cell viability following CMS, cells with respective 
treatments were treated with MTT reagent 24 hours after CMS, and 
processed as described (2.2.1.2). Finally, for assessment of the ability of 
CD98hc kd cells to generate IL-8 in response to chemical stimulation, cells 
were treated with IL-1β (500 pg/ml). Supernatant was collected at 24 hours 
following CMS and analysed by ELISA as described (2.2.6.1). 
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4.2.2 β1-integrin-mediated signalling and mechanotransduction in 
CMS  
Cells, either untreated or transfected with non-targeting or CD98hc kd 
siRNA, were subjected to CMS for 0-120 minutes, and cells immediately lysed 
and protein extracted for immunoblotting as described (2.2.6.3). Protein was 
incubated with antibodies against activated β1-integrin (Wu et al. 2015). 
(Luque et al. 1996) (HUTS4, non-reducing and non-denaturing, 1:1000), total 
β1-integrin (1:1000), pFAK Y397 D20B1 (1:1000), total FAK (1:1000), 
CD98hc (1:10,000), p-ERK p42/44 (1:1000), total ERK p42/44 (1:1000) or 
GAPDH (1:20,000) (2.1.6.1, Table 2-3).  
Immunofluorescence of activated β1-integrin in cells transfected with 
non-targeting or CD98hc kd siRNA was performed by concurrent fixation and 
permeabilisation of cells with 4% PFA in the presence of 0.1% triton, followed 
by blocking in 1% BSA for 1 hour and incubation in HUTS4 antibody (1:100) 
for 1 hour at room temperature. Subsequent wash, incubation in secondary 
antibody and imaging steps were followed as described (2.2.5.1.3). 
To assess the effect of exposure of cells to ambient conditions on β1-
integrin activity in cells, A549 cells were plated in separate petri-dishes. 
Medium change was conducted in all cells, and cells lysed for protein analysis 
either immediately (0 minutes) or at 5, 30 or 60 minutes. Immunoblotting for 
activated β1-integrin activity was then performed as described previously 
(2.2.6.3). 
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4.2.3 Assessment of the effect of CD98hc kd on cellular tension 
and RhoA activity  
Cells were transfected with either non-targeting or CD98hc kd siRNA at 
24 hours after seeding as described (2.2.3.5), then subsequently transfected 
with either the vinculin FRET tension sensor DNA (Grashoff et al. 2010) or the 
Raichu RhoA activity probe (Heasman et al. 2010) (2.2.5.2.3, 2.2.5.2.4, 
2.2.5.2.5) 48 hours after seeding at approximately 60-75% confluence. Cells 
were fixed after either 0 or 1 minute CMS, mounted, and FLIM microscopy 
performed as described (2.2.5.2). 
4.2.4 Assessment of epithelial cell migration in CD98hc kd cells 
Monolayers of A549 were seeded in 6-well plates and transfected with 
either non-targeting or CD98hc kd siRNA at 24 hours as described (2.2.3.5). 
Monolayers were scratched at 72 hours following seeding, and epithelial 
migration assessed immediately (t=0 hours) or at 16 hours as described 
(2.2.4.2). For inter-nuclear distance measurements, cells were fixed at 24 
hours and images taken at equal points along the wound. Inter-nuclear 
distances were calculated using the ‘nearest neighbour’ plugin for Image J 
imaging software (Fiji, http://fiji.sc/Fiji).  
4.2.5 Assessment of epithelial monolayer integrity in CD98hc kd 
cells 
A549 cells were seeded at 0.01 x106 cells/well in 8-well RTCA 
iCELLigence electrical impedance plates as described (2.2.4.3). siRNA 
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transfection was performed at 24 hours (2.2.3.5) and the wells scratched with 
a P200 pipette tip when cell index reached a plateau (indicating monolayer 
integrity) at approximately 106 hours. For monolayer growth following 
transfection, indices were normalised at a point following transfection, and the 
slope (change in normalized cell index/hr) was calculated from the point prior 
to scratch to the normalization point. For recovery of monolayer integrity after 
scratch, indices were normalised at the plateau point, and the slope 
calculated for the difference between this point and at 24 hours following 
scratch.  
4.2.6  The effect of CD98hc kd on cell-matrix adhesion after CMS  
To ascertain sensitivity of the assay to differences in cell density, cells 
were seeded at either 150, 75, 37.5, 18.75, 9.375 x 103 cells per well, and 
incubated for 72 hours. At 72 hours, 5 mM EDTA in calcium and magnesium 
deplete PBS was added to another well seeded at 150 x 103  cells for 2 hours 
as a negative control. Cells were washed, fixed and stained with 0.1% crystal 
violet solution as described (2.2.4.4). Stained cells were solubilised in 
methanol, and the solubilised crystal violet read in a plate reader at 570nm 
wavelength.  
To assess the effect of CD98hc knockdown on cell-matrix adhesion 
following CMS, plated cells were transfected 24 hours following seeding 
(2.2.3.5) then exposed to either static conditions, or 30% CMS for 2 hours. 
Cells were then immediately washed, fixed and stained with crystal violet 
solution, and the optical density of solubilised solution measured as described 
above.  
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4.3 Results 
4.3.1 The effect of CD98hc knockdown on CMS-induced IL-8 
protein and gene expression 
To examine the role of CD98hc in CMS-induced mechanotransduction, 
CD98hc was knocked down by siRNA gene silencing, achieving efficient and 
consistent knockdown at 48 hours following transfection (Figure 4-1 - a). 
CD98hc knockdown cells demonstrated significantly reduced CMS-induced 
IL-8 release when compared to siRNA control or untreated cells (Figure 4-1 - 
b). Furthermore, cell viability as assessed by MTT assay was not significantly 
different between conditions (Figure 4-1 - c) and there was no difference in 
the ability of CD98hc knockdown cells to generate IL-8 in response to IL-1β 
treatment than controls. Finally, CD98hc kd demonstrated a significant ability 
to reduce CD98hc mRNA expression in addition to protein, but there was a 
limited decrease in IL-8 mRNA expression following application of CMS 
(Figure 4-1 – e-f). 
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Figure 4-1 The effect of CD98hc knockdown on CMS-induced IL-8 protein and gene 
expression 
Panel A shows densitometry from western blot for CD98hc following either no treatment 
(untreated), vehicle + scrambled siRNA sequence (siRNA control) or CD98 knockdown 
(CD98hc kd) relative to β–actin. Panel B shows IL-8 cytokine released from cells following 
exposure to either static (0% CMS) or 30% CMS conditions. Panel C shows cell viability as 
assessed by MTT assay of cells with respective treatments under either static or CMS 
conditions. Panel D shows IL-8 cytokine release for cells from respective conditions treated 
with either control or IL-1 β. Panel E shows CD98hc mRNA expression relative to untreated 
cells for cells treated with either siRNA control or CD98hc kd. Panel F shows IL-8 mRNA 
expression for cells with respective treatments exposed to either static or CMS conditions. For 
panels E—F, data are presented as fold change in expression (ΔΔCT) for the average of two 
housekeeping genes (GAPDH and B2M), and normalized for untreated control conditions. All 
data are presented as the median ± IQR of three independent experiments. Statistical 
analysis was by Friedman’s test with Dunn’s post-test correction for Panel B and by Wilcoxon 
test for Panel E, * p<0.05. 
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4.3.2 The effect of CD98hc knockdown on CMS-induced β1-
integrin and MAPK p42/44 (ERK 1/2) activity 
CMS induced RhoA activity via activation of β1-integrin in fibroblasts 
(Guilluy et al. 2011), and CD98hc interacts with β1-integrins to modulate 
downstream signalling (Feral et al. 2005). To determine whether CMS 
promoted β1-integrin activation in alveolar epithelial cells, the HUTS4 
antibody for β1 integrin in an extended (activated) conformation was used. At 
5 and 10 minutes CMS, activated β1 integrin blots were more dense than for 
static conditions, although the differences in calculated optical density did not 
reach significance. At 30-120 minutes CMS, there was minimal difference 
seen in blot activity between conditions. To determine whether the application 
of CMS correlated with known pathways of CMS, blots were also probed for 
MAPK p42/44 at these time points, demonstrating an increase in blot density 
at 10 minutes CMS as expected (Figure 4-2 – a-b).  
When this was repeated with untreated, siRNA control and CD98hc 
knockdown conditions, this trend did not occur and there was no observable 
gross difference between β1 integrin activity in all conditions, from 10-60 
minutes CMS (Figure 4-2 – c-d). Immunofluorescence for β1 integrin 
demonstrated staining at focal adhesions, indicating that β1 integrin activity is 
not affected by CD98hc knockdown (Figure 4-2 – e). 
In order to determine whether the difference in activated β1-integrin 
activity with CMS from untreated cells alone (Figure 4-2 – a-b) and control 
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cells following transfection (Figure 4-2 – c-d) was due to experimental setup, 
cells were plated in individual petri dishes, and integrin activity assessed at 
varying times following medium change. β1-integrin activation was greatest 5 
minutes after medium change, suggesting that the results obtained in (Figure 
4-2 – a-b) may be due to exposure of cells to ambient conditions, as this was 
not the case in (Figure 4-2 – c-d) due to experimental setup.  
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Figure 4-2 The effect of CD98hc knockdown on CMS-induced β1-integrin activity 
Panel A shows a time course of CMS whereby A549 cells were either static (CMS -) or 
stretched to 30% CMS (CMS +) from 0 to 120 minutes, and cells lysed and immunoblotted for 
activated β1-integrin (HUTS4). Panel B shows densitometry for blots at respective time 
points, normalised for 0 minute baseline. Panel C shows time course of blots for cells either 
untreated, treated with non-targeting siRNA (si-control) or with CD98hc knockdown siRNA. 
Panel D shows respective densitometry, normalised for 0 (static) time point for each 
condition. Panel E shows immunofluorescence staining for activated β1-integrin in si-control 
or CD98hc knockdown cells. Panel F shows immunoblots for activated β1-integrin in cells 
following medium change. Panels A-D: data for 3 individual experiments, shown as median ± 
IQR. Panel E-F: data for one experiment, scale bar = 10µm, arrowheads show positive 
staining at focal adhesions. 
 
4.3.3 The effect of CD98hc knockdown on CMS-induced FAK and 
ERK activity, and on actin cytoskeletal integrity 
Previous studies have shown CD98hc- β1-integrin interactions to induce 
FAK activation. Therefore, a time course of CMS was assessed for FAK 
phosphorylation with CD98hc knockdown. FAK phosphorylation at Y397 was 
increased by 60 mins in non-targeting control conditions as per previous 
results. CD98hc knockdown showed baseline phosphorylation with minimal 
changes over time, similar to that observed when cells were treated with 
Y27632. Phosphorylation of ERK 1/2 by 10 minutes CMS was preserved with 
CD98hc knockdown (Figure 4-3 – a). Furthermore, phalloidin staining of 
CD98hc knockdown cells demonstrated intact actin stress fibre formation, in 
comparison with cells treated with the ROCK inhibitor Y27632 (Figure 4-2– b). 
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Figure 4-3 The effect of CD98hc knockdown on CMS-induced FAK and ERK activation, 
and on actin cytoskeletal integrity 
Panel A shows immunoblots for FAK and ERK activation following treatment with either non-
targeting siRNA (si-control) or with CD98hc knockdown siRNA (CD98hckd). Cells were lysed 
over a time course of 30% CMS from 0 mins (static) to 60 mins. The top panel shows 
expression of CD98hc in si-control or knockdown conditions. The middle panel shows 
phosphorylation of FAK (y397) in comparison with total FAK, and the bottom panel shows 
phosphorylation of ERK 1/2 in comparison with total ERK. Data are representative of three 
experiments performed per condition. Panel B shows immunofluorescence of phalloidin-
stained cells treated with either non-targeting siRNA (si-control) or with CD98hc knockdown 
siRNA (cd98hc kd). Cells treated with the ROCK inhibitor Y27632 are shown for comparison. 
Scale bar – 50 µm. 
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4.3.4 The effect of CD98hc knockdown on baseline and CMS-
induced cellular tension 
CD98hc-null cells have demonstrated both reduced RhoA activity and 
tissue tension (Estrach et al. 2014). In order to assess the effect of CD98hc 
knockdown on baseline cellular tension and RhoA activity, dual transfection of 
cells with each FRET sensor combined with siRNA knockdown was 
attempted. An initial aim was to obtain FLIM data for respective sensors and 
to also image for CD98hc in order to determine whether cells in which FLIM 
data was acquired were expressing CD98hc. Both dual transfection and 
imaging was successful, and immunofluorescence for CD98hc demonstrated 
knockdown in cells expressing FRET sensors (Figure 4-4). However, FLIM 
acquisition of cells in these conditions was poor, and this was attributed to 
leaching of the FRET probe from cells due to the methanol fixation required 
for CD98hc immunofluorescence. When the experiment was repeated with 
PFA fixation, FLIM activity was similar to that seen in untreated cells.  
Several observations were made from FLIM analysis of cells transfected 
with the VinTS probe. First, although a degree of heterogeneity was seen in 
the lifetimes of probes in all conditions, the mean lifetimes of both non-
targeting siRNA control cells (1.77 ns) and of CD98hc cells (1.71ns) 
overlapped in the static state, with a trend towards decreased lifetimes 
(indicating decreased tension) with CD98hc kd. Following 1 minute of CMS, 
the mean lifetime of si-control cells was decreased to 1.75, and that for 
CD98hc kd cells increased to 1.93, indicating decreased and increased 
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tension respectively, following onset of CMS Figure 4-5. FRET efficiencies 
could not be calculated as described previously given the lack of an mTFP 
probe with which to derive uncomplexed donor lifetimes. 
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Figure 4-4 Dual transfection of A549 cells with CD98hc knockdown siRNA and RhoGFP 
FRET probe 
Dual transfection of A549 cells with both CD98hc knockdown siRNA and Rho-GFP FRET 
probe, and immunofluorescence staining for CD98hc (red) and Rho-GFP (green). The top 
panel shows untreated cells, the middle panel shows cells treated with non-targeting control 
siRNA (si-control) and the bottom panel, cells treated with CD98hc knockdown siRNA. 
Images representative of 3-5 cells per condition. Scale bar - 10µm. 
 197 
 
Figure 4-5 The effect of CD98hc knockdown on cellular traction forces 
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A549 cells were transfected with both CD98hc knockdown siRNA or non-targeting control 
(si-control), and the VinTs tension sensor, and subjected to either static conditions or 30% 
CMS for one minute. Panel A shows FLIM heat maps of cells from respective conditions. 
The blue end of the spectrum indicates short fluorescent lifetimes, whereas the red end 
suggests long lifetimes. Panel B shows combined histograms of lifetimes for cells treated 
with non-targeting controls for both static and 1 min CMS conditions on the left, and for 
CD98hc kd on the right. Panel C shows how histograms compare for both non-targeting 
controls and CD98hc kd under static conditions (left) and following 1 min CMS (right). Data 
shows histograms from 6 cells per condition. 
 
 
4.3.5 The effect of CD98hc knockdown on RhoA activity 
In order to ascertain the effect of CD98hc knockdown on RhoA activity, 
cells were transfected with both CD98hc kd siRNA and the Raichu RhoA 
probe. Results indicated that with both non-targeting controls and CD98hc 
knockdown treatment, 1 min of CMS induced the cellular protrusions seen 
with untreated cells. From these preliminary results, CD98hc knockdown 
significantly reduced baseline FRET efficiency (and therefore RhoA activity) in 
CD98hc kd cells when compared to controls. Following 1 minute CMS, there 
was no significant difference between both groups, although FRET efficiency 
(indicating RhoA activity) was noted to trend towards a decrease in si-control 
cells, and an increase in CD98hc cells, with CMS (Figure 4-6).  
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Figure 4-6 The effect of CD98hc knockdown on RhoA activity 
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A549 cells were transfected with both CD98hc knockdown siRNA or non-targeting control (si-
control), and the Raichu RhoA FRET sensor, and subjected to either static conditions or 30% 
CMS for one minute. Panel A shows FLIM heat maps of cells from respective conditions. The 
blue end of the spectrum indicates short fluorescent lifetimes, whereas the red end suggests 
long lifetimes. Arrows indicate cellular protrusions noted following application of CMS. Panel 
B shows combined histograms of lifetimes for cells treated with non-targeting controls or 
CD98hc kd under static conditions on the left, and following 1 minute CMS on the right. Panel 
C shows FRET efficiencies for both treatments under static conditions on the left, and 
following 1 minute CMS on the right. Panel D shows combined histograms for non-targeting 
controls (left) and CD98hc knockdown (right) following both static and 1 min CMS conditions. 
Panel E shows FRET efficiencies for non-targeting controls (left) and CD98hc knockdown 
(right) following both static and 1 minute CMS conditions. Data are presented as the median ± 
IQR for 5 cells (si-control: static), 6 cells (CD98hc kd:static and si-control: 1 min CMS) and 4 
cells (CD98hc kd: 1 min CMS). Data were analysed by Mann-Whitney test, *p<0.05. 
4.3.6 The effect of CD98hc knockdown on epithelial cell migration 
in a wound healing model 
Decreased expression of CD98hc reduced migration and survival in 
various cell types (Feral et al. 2005; Poettler et al. 2013). However, intact cell 
migration is critical for restoration of the injured alveolar epithelium (Atabai et 
al. 2002). Any potential therapeutic modality for VALI that disrupts alveolar 
epithelial cell migration may therefore be counterproductive.  
To determine the effect of CD98hc kd on epithelial migration in response 
to a wound, a scratch wound was applied to confluent monolayers of 
transfected cells and controls that were either untreated, or treated with 
serum-free medium or IL-1β  (20ng/ml). Although there was no difference in 
the percentage area healed at 16 hours between non-targeting control and 
CD98hc knockdown cells, there was also no difference found between 
untreated and IL-1β controls. Conversely, application of serum-free medium 
significantly reduced epithelial migration as expected (Figure 4-7 – a-b). To 
further elucidate the effect of different treatments on the migration of cells, the 
distance between DAPI-stained nuclei at the wound edge was assessed. In 
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this case, there were significant differences in internuclear distance between 
untreated and positive (IL-1β) or negative (serum-free) controls, but CD98hc 
did not significantly alter cell spreading (Figure 4-7 – c-d). 
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Figure 4-7 The effect of CD98hc knockdown on epithelial cell migration in a wound 
healing model 
A549 cells seeded on 6-well plates were either untreated or transfected with non-targeting (si-
control) or CD98hc siRNA (cd98hc kd), and grown to confluence. A scratch wound was 
applied across the well, controls treated with either serum-free medium or IL-1β  (20ng/ml), 
and the percentage area healed calculated. Panel A shows representative images of wounds 
at 0 and 16 hours following scratching. Panel B shows calculated percentage of the area 
healed, and panel C the internuclear distance as a measure of cell spreading at the wound 
edge. Panel D shows representative images of DAPI-stained nuclei at the wound edge. Data 
are presented as the median ± IQR for three independent experiments for A and B, and 
analysed by paired Friedman test with Dunn’s multiple comparison correction, and nuclei from 
one experiment for C and D, analysed by Kruskal-Wallis test with Dunn’s multiple comparison 
correction, **p<0.01, ***p<0.001. Scale bars represent 100µm. 
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4.3.7 The effect of CD98hc knockdown on epithelial monolayer 
integrity 
To measure epithelial monolayer integrity following CD98hc 
knockdown, trans-epithelial resistance to an electric current was used. 
Following transfection, there was an increase in the rate of increase of 
monolayer integrity with CD98hc kd cells compared to non-targeting siRNA-
treated cells, but no differences between untreated controls and CD98hc 
knockdown cells (Figure 4-8 – a-b). Following the application of a wound to 
the monolayer, CD98hc had a slower rate of recovery of the wound when 
compared to non-targeting controls. IL-1β treated cells had a significantly 
increased recovery when compared to untreated controls Figure 4-8 – c-d). 
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Figure 4-8 The effect of CD98hc knockdown on epithelial monolayer permeability as 
measured by trans-epithelial resistance 
A549 cells seeded on collagen-coated ICELLigence 8-well electrode array plates were either 
untreated or transfected with non-targeting or CD98hc siRNA, and trans-epithelial resistance 
measured and presented as normalised cell index to represent resistance of the epithelial 
monolayer to an electric current. Panel A shows representative normalised cell index for the 
respective treatments following transfection for a period of approximately 60 hours until 
confluence was achieved. Panel B shows slope as a measure of change in normalised cell 
index over the measured time for respective treatments. Panel C shows representative 
normalised cell index for respective treatments over 24 hours following wounding of the 
monolayer. At this point, one well was treated with IL-1β (20 ng/ml). Panel D shows slope for 
respective treatments. Cell index measurements were collected every 10 minutes. Indices 
were normalised at the lines shown. Data are presented as the mean ± SEM and analysed by 
paired one-way ANOVA for the interactions shown, with Holm-Sidak’s multiple comparison 
correction for n =12 from 4 independent experiments. *p<0.05, ***p<0.001.  
 
4.3.8 The effect of CD98hc knockdown on cell-matrix adhesion 
Inhibition of β1-integrin function can induce cell detachment from the 
ECM (Liu et al. 2011). A crystal violet assay was used to establish the effect 
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of CD98hc knockdown on cell-matrix adhesion and cell detachment following 
CMS. Firstly, optical densities of solubilised crystal violet decreased stepwise 
with decreasing cell seeding density, indicating that the assay was sensitive to 
decreases in cell number (Figure 4-9 – a-b). Secondly, CD98hc knockdown 
cells did not significantly affect cell adhesion following CMS when compared 
to static conditions, or untreated and non-targeting siRNA controls (Figure 4-9 
– c-d). 
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Figure 4-9 The effect of CD98hc kd on cell-matrix adhesion following CMS 
Panel A shows photographs of wells containing crystal violet-stained cells seeded at 
different densities, with 5mM EDTA control (on cells seeded at 150 x 103). Panel B shows 
optical densities of solubilised crystal violet at the different seeding densities, read at 
570nm wavelength. Panel C shows photographs of wells containing crystal violet-stained 
cells either untreated, or treated with non-targeting control siRNA (si-control) or with 
CD98hc knockdown siRNA (cd98 kd) and exposed to either static conditions, or 30% CMS 
for 2 hours. Insets show bright field microscopy at 5x magnification. Scale bars – 500µm. 
Panel D shows solubilised crystal violet from the different conditions, read at 570nm 
wavelength.  Data shown as median ± IQR for 3 independent experiments for panels A-B, 
and n=6 from 3 independent experiments for C-D. 
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4.4 Discussion 
4.4.1 Summary of results 
The work in this chapter first aimed to establish the effect of CD98hc 
knockdown on mechanotransduction, integrin activity, and FAK activation in 
response to CMS. I demonstrated that CD98hc siRNA reduced expression of 
CD98hc on a protein and mRNA transcript level. CD98hc kd reduced CMS-
induced IL-8 generation, without decreasing cell viability or the ability of cells 
to generate IL-8 in response to chemical stimulation. CD98hc knockdown did 
not reduce β1-integrin activity. However, knockdown did abrogate CMS-
induced FAK autophosphorylation in a manner similar to that observed with 
inhibition of ROCK, but without the morphological changes seen with inhibition 
of that pathway. Phosphorylation of ERK 1/2 at 10 minutes CMS was 
preserved in knockdown cells. 
I also aimed to determine whether CD98hc inhibition affected Rho-
ROCK signalling by altering RhoA activity. I found that, from preliminary FLIM 
data using a RhoA FRET biosensor, CD98hc significantly reduced RhoA 
activity in comparison to non-targeting siRNA controls. Furthermore, there 
was a trend towards decreased cell-matrix tension in the knockdown cells 
when compared with controls, and whereas untreated cells demonstrated a 
decrease in tension following onset of CMS, the opposite was observed in 
CD98hc knockdown cells.  
Finally, I also aimed to investigate the effect of CD98hc knockdown on 
the migratory and adhesive capacity of alveolar epithelial cells, and found 
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that, although CD98hc kd did not affect cell migration in an in vitro wound 
healing model, it did decrease the rate of healing in an impedance-based 
assay. However, CD98hc kd did not affect cell-matrix adhesion, and did not 
induce cell detachment following 2 hours CMS. 
4.4.2 Mechanotransduction, integrin and focal adhesion signalling 
My results demonstrated that CD98hc knockdown significantly reduced 
CMS-induced IL-8 generation without affecting cell viability or the ability of 
cells to release IL-8 in response to chemical stimulation. Interestingly, the 
effect of CD98hc kd on CMS-induced IL-8 mRNA transcription was minimal, 
which might suggest a post-translational effect of CD98hc on CMS-induced 
IL-8 release. However, the IL-8 response to chemical stimulation, in this case 
IL-1β, was intact following knockdown. This indicates that CD98hc kd does 
not affect IL-8 protein trafficking to such an extent as to inhibit this response. 
However, although these data might reflect the relative abundance of IL-8 
mRNA transcript available for translation, the potential effect of CD98hc on 
post-translational modification in the context of these data must be taken into 
account. IL-8 undergoes significant post-translational NH2-terminal proteolytic 
processing (Mortier et al. 2008), and CD98hc kd may have an effect on this 
process. 
Integrin β1 activity was preserved in CD98hc kd cells, indicating that 
CD98hc does not affect the activation of integrins in response to matrix rigidity 
(inside-out signalling) but may affect signalling downstream of integrin 
activation (outside-in signalling). Furthermore, CD98hc kd cells abrogated 
CMS-induced FAK activity in a manner similar to that observed with inhibition 
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of ROCK, without affecting CMS-induced ERK activation. However, although I 
initially observed a non-significant increase in β1- integrin activity with CMS in 
untreated cells, these observations were not repeated when the experimental 
setup was changed. 
Mechanical force has been shown to promote β1-integrin function and 
downstream focal adhesion kinase signalling (Friedland et al. 2009), and 
tension applied directly to β1-integrins induced downstream RhoA activity 
(Guilluy et al. 2011). In the former study, α5β1-integrin bonds with fibronectin 
changed from a ‘relaxed’ state to tensed, cross-linkable bonds following the 
application of external force (centripetal force from a centrifuge), suggesting 
that mechanical force on integrins can increase bond or adhesion strength. 
Furthermore, inhibition of cytoskeletal tension by pharmacological inhibition of 
myosin II activity decreased the number of initial tensed bonds, but these 
could be induced with force, indicating that external force is sufficient to 
promote integrin-fibronectin bonding under tension as a model of outside-in 
signalling. Other studies corroborate such mechanical force-induced integrin 
activity. Cyclic stretch of renal epithelial cells increased β1-integrin mRNA 
expression (Hamzeh et al. 2015) to regulate downstream fibrotic signalling, 
and mechanical stretch of keratinocytes increased β1-integrin-mediated 
adhesion to substrate and ERK 1/2 activation, and promoted clustering of β1-
integrins on the basal cell membrane (Knies et al. 2006).  β3-integrins were 
also shown to activate in response to shear stresses (Tzima et al. 2001).  
These phenomena may represent force-induced strengthening of 
integrin-ligand bonds. Experiments using atomic force microscopy of both 
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isolated integrin α5β1-fibronectin bonds and in K562 cells exposed to 
repetitive cyclic forces demonstrated an increase in bond strength in a 
manner described as cyclic mechanical reinforcement (Kong et al. 2013). 
Moreover, this reinforcement was positively correlated with increased strain 
rate, it required a flexible integrin hybrid domain, and was also specific to 
cyclic strain as opposed to tonic or linear strain. 
CD98hc constitutively binds to the c-terminal domain of β1 and β3 
integrin cytoplasmic tails (Zent et al. 2000; Rintoul et al. 2002; Prager et al. 
2007) and regulates downstream β1-integrin signalling. Cross-linking CD98hc 
increased β1-integrin-mediated adhesion of small cell lung cancer cells 
(Fenczik et al. 1997), and stimulated downstream integrin signalling in an 
FAK-dependent manner (Rintoul et al. 2002). Moreover, it is the β1-integrin-
binding cytoplasmic domain of CD98hc which promotes downstream integrin 
FAK and ERK activation, and tumour growth. Accordingly, transfection of 
dominant active FAK into CD98hc-null cells rescued CD98hc and integrin-
dependent cell spreading behaviour (Poettler et al. 2013). These data suggest 
that CD98hc co-operates with β1-integrins to regulate integrin signalling via 
FAK. 
To assess integrin activation status, I used the HUTS-4 antibody which 
detects β1-integrin in a high affinity conformation (Luque et al. 1996), 
specifically the hybrid domain (Byron et al. 2009) (Figure 4-10). This becomes 
exposed following the increase in hinge angle between the βA and hybrid 
domains when the integrin has high affinity for ligand (Luo et al. 2003). 
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Therefore, HUTS-4 has been used to detect activated β1-integrins by 
immunoblotting (Yao et al. 2013).  
My results correspond with previous observations that β-integrin activity 
is not affected by CD98hc regulation as detected by a monoclonal antibody to 
an active conformation of β3 integrins, WOW -1 (Poettler et al. 2013), and 
CD98hc-null cells did not affect β1-integrin expression or β1-integrin-
dependent fibronectin binding (Feral et al. 2005). Taken together, these 
observations suggest that CD98hc does not regulate inside-out integrin 
activity, but rather affects downstream integrin signalling.  
Conversely, others have observed that CD98 knockdown in 
hepatocellular carcinoma cells significantly decreased β1- integrin activity, as 
demonstrated by the HUTS4 probe and downstream FAK activity. 
Overexpression of CD98hc had the opposite effect (Wu et al. 2015). These 
different observations may be accounted for by differences in experimental 
setup. First, hepatocellular carcinoma cells were used, which have a distinct 
ECM profile (Giannelli et al. 2001). Second, stable hairpin (shRNA) 
knockdown was used. Finally, membrane fractions were measured by flow 
cytometry.  
I initially observed an (non-significant) increase in β1-integrin activity 
with 5-10 minutes CMS, which was not repeated when a different 
experimental technique was used. This led me to question whether repeated 
removal of cells from the incubator might increase β1-integrin activity. When 
individual petri dishes of cells were removed from the incubator and subjected 
to medium change, increased β1-integrin activity was observed 5 minutes 
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later, suggesting that changes in the ambient conditions of cells might affect 
integrin activity. Indeed, cells exposed to acidic environments demonstrated 
increased β3-integrin activity (Paradise et al. 2011). Furthermore, changes in 
oxygen concentration affects ECM composition (Vogel et al. 2017) and cell-
matrix adhesion (Roan et al. 2012).  
 
Figure 4-10 The HUTS4 antibody detects β1-integrin activation at the exposed hybrid 
domain in the high-affinity state 
Based on (Byron et al. 2009). TM – transmembrane, EGF – epidermal growth factor. 
 
I have investigated the activation status of β1-integrins only, and β1-
integrins clearly play a critical role in mechanotransduction, particularly as β1, 
and not β3-integrins mediated traction forces in a Rho kinase and myosin-
dependent manner in fibroblasts plated onto micropost arrays (Lin et al. 
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2013). However, it is becoming clear that the interplay between different 
integrin subtypes mediates different elements of cell adhesion and motility. 
Inhibition of integrin αvβ3 activation may not affect initial adhesion and 
spreading, which is mediated by α5β1 as shown in human osteosarcoma 
cells, but it is essential for the formation of stable focal adhesions (Schaufler 
et al. 2016). Furthermore, both α5β1 and αvβ6 integrins regulated rigidity 
sensing and the integrin-ECM bond dynamics in response to matrix stiffness 
(Elosegui-Artola et al. 2014) Other studies have shown that αvβ3 can fully 
compensate for loss of α5β1 integrins, and that both subtypes can support 
traction forces albeit at different magnitudes and with different cellular 
functional responses (Balcioglu et al. 2015). Therefore, it would be prudent to 
assess the activation states on an array of different integrin subtypes during 
CMS.  
Finally, attempts were made to establish the efficacy of the probe by 
using positive controls of Mn2+ and Mg2+ to induce integrin activation, and this, 
together with the use of integrin-inhibiting antibodies, is part of ongoing work. 
Therefore, these results must be interpreted with caution until the sensitivity of 
the probe can be validated by robust controls such as these.  
4.4.3 CD98hc–regulated tension at focal adhesions and RhoA 
activity  
My previous results suggested a potential decrease in cell-matrix 
tension, as expressed across vinculin following 1 minute CMS (3.3.9). These 
changes correlated with an increase in RhoA expression following 1 minute 
CMS. Results from this chapter indicate that CD98hc may have an effect on 
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decreasing baseline cellular tension, but this cannot be concluded from these 
results. I can cautiously conclude from these data that CD98hc reduces 
baseline RhoA activity in A549 cells, but I aim to increase the rate of data 
collection from these FRET probes by using frequency domain FLIM before 
further conclusions can be made. 
An initial decrease in cellular tension with onset of mechanical stretch 
may represent part of a dual response to CMS, reflecting an initial actin-
mediated fluidisation of the cytoskeleton followed by cyclic force-induced 
strengthening, as previously discussed (1.6.2, 3.4.4). It may also represent a 
rupture in stress fibres, integrin-ECM bonds, or even of the FRET probe itself. 
CD98hc expression is associated with anchorage-independence and tumour 
progression in a manner thought to derive from its ability to amplify β1-
integrin-mediated downstream signalling, therefore allowing cells to survive 
and proliferate in softer matrix environments (Cantor & Ginsberg 2012). In a 
Ras-driven model of squamous cell carcinoma, CD98hc-deficiency reduced 
epidermal thickness as demonstrated by AFM measurements, and this 
correlated with tumour regression (Estrach et al. 2014). The authors 
demonstrated that CD98hc-mediated β1-integrin signalling increased the 
stiffness of the tumour environment through increased RhoA activity and 
YAP/TAZ signalling. Similarly, CD98hc-mediated RhoA contractility has also 
been shown to regulate fibronectin matrix assembly (Féral et al. 2007), 
therefore further affecting integrin-ECM binding and also cellular traction 
forces. 
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In my model, CD98hc kd cells demonstrated a small reduction in 
baseline tension when compared to controls, but without affecting the 
morphological appearance of the actin cytoskeleton. That decreased baseline 
tension can reduce CMS-induced injurious signalling has been shown in 
alveolar epithelial cells subjected to hyperoxia, where an increased elastic 
modulus augmented CMS-induced cellular detachment (Roan et al. 2012), 
and this effect was prevented by inhibition of ROCK (Wilhelm et al. 2014).  
I also witnessed a subsequent increase in tension when CD98hc kd cells 
were subjected to 1 min CMS when compared to controls. This could either 
be attributed to the fact that these cells have fewer broken stress fibres or 
adhesions, or that this follows universal mechanical properties governing cell 
pre-stress and response to strain. For example, when valvular interstitial cells 
were treated with inhibitors of myosin II to decrease their pre-stress, they 
increased traction forces in response to CMS, whereas cells with higher 
baseline pre-stress following TGF-β treatment dropped their traction forces 
with CMS (Cirka et al. 2016). This response was attributed to homeostatic 
maintenance of constant tension levels. My results give a preliminary 
indication that CD98hc knockdown cells may have behaved in this way, and 
that their reduced baseline pre-stress protected them from CMS-induced 
injury, as occurs following ROCK inhibition. 
I therefore tried to ascertain RhoA activity in CD98kd before and during 
CMS, and from preliminary observations using FRET constructs, found that 
CD98hc knockdown reduced RhoA activity when compared with controls. 
These results correlate with previous observations in different cell types. 
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CD98hc-null fibroblasts failed to increase RhoA activity in response to 
interaction with a 3D matrix, but did in response to LPA (Féral et al. 2007). 
This led the authors to conclude that CD98hc is required for RhoA activation 
in response to cell-matrix adhesion. Subsequent studies demonstrated that 
RhoA activation was reduced in the CD98hc-deficient epidermis of mice 
(Boulter et al. 2013), and that downstream ROCK-mediated phosphorylation 
of the regulatory subunit of myosin phosphatase was also decreased (Estrach 
et al. 2014). These results suggest that CD98hc regulates cell stiffness via 
RhoA-ROCK and downstream myosin II and YAP/TAZ activity. This may 
influence stiffness-dependent injury in alveolar epithelial cells by increasing 
the elastic modulus (Wilhelm et al. 2014). Therefore, CD98hc may regulate 
RhoA-ROCK activity in alveolar epithelial cells to tune cellular stiffness and 
susceptibility to injury. 
However, these results must be interpreted in the context of several 
limitations to my approach. First, cells were fixed at either static conditions or 
at 1 minute following CMS. Therefore, measurements of both cellular tension 
and RhoA activity can only be interpreted as a ‘snapshot’ at that time and may 
even be affected by the process of transfer from the flexcell bioreactor and of 
fixation. I attempted to develop a live stretch model using the Flexcell 
apparatus, but unfortunately to date have been unsuccessful due to difficulties 
with maintaining a focal plane during CMS. Newer methods of live-cell 
imaging with CMS should help overcome this (Rápalo et al. 2015).  
Second, although I attempted to stain transfected cells for CD98hc to 
assess RhoA activity or cellular tension in cells positive or negative for 
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CD98hc, the methanol fixation required for CD98hc imaging precluded this 
due to effects on the image quality of the respective FRET probes. Therefore, 
I cannot be certain that each of the cells assessed as CD98hc kd are actually 
deplete of CD98. Finally, as encountered in other aspects of this work, it 
appears that the non-targeting siRNA used as a control has effects that 
differentiate it from untreated controls. This is not uncommon, is largely due to 
effects on complementary sequences, and may be overcome in future by the 
use of smart pool siRNA (Hannus et al. 2014). 
Third, although I attempted to use inhibitors of RhoA and ROCK to 
validate the FRET probes, these proved problematic in reducing the size of 
focal adhesions which therefore precluded measurement of cellular tension. 
However, both the RhoA inhibitor, C3 transferase, and the RhoA activator, 
calpeptin or LPA, will be used for ongoing investigation of RhoA activation in 
CMS and the role of CD98hc. These positive and negative controls will 
increase the robustness of the results obtained using the probes. 
Therefore, I cannot be absolutely certain that CD98hc kd reduces 
baseline RhoA activity to reduce myosin II-mediated cellular stiffness and 
therefore susceptibility to CMS-induced injury without addressing these 
issues. The FRET-based approach was selected as it provides greater spatial 
information on RhoA activity on a cell-by-cell basis (Heasman et al. 2010) 
(Pertz et al. 2006). However, I also attempted to use rhotekin-bound pulldown 
techniques to assess active, GTP-bound RhoA with CD98hc knockdown but 
internal controls demonstrated that the technique did not work consistently. 
An alternative approach is an ELISA-based assay, previously used to 
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ascertain the role of CD98hc on RhoA activity (Féral et al. 2007). A 
combination of all three methods would be expected to provide better clarity. 
Finally, a ‘rescue’ of RhoA activity in CD98hc kd cells, possibly using 
calpeptin or LPA, would also provide more evidence in favour of a RhoA-
mediated effect of CD98hc on cell stiffness and mechanotransduction. 
4.4.4 Migration and adhesion 
Alveolar epithelial cell migration is critical for restoration of the denuded 
basement membrane following injury (Crosby & Waters 2010), and β1-integrin 
and RhoA signalling are instrumental for this process (Shen et al. 2015). 
Therefore, I expected any interference in these signalling pathways to have a 
prohibitive effect on alveolar cell migration in response to a wound, and on 
cell adhesion during CMS. CD98hc depletion inhibited β1-integrin-dependent 
spreading and migration in renal epithelial cells (Poettler et al. 2013), in 
embryonic stem cells via the RhoGTPase Rac (Feral et al. 2005), and in 
epidermal cells via impaired RhoA signalling in response to a wound (Boulter 
et al. 2013).  
A scratch assay is a well-documented experiment allowing assessment 
of epithelial migration in response to a ‘wound’ in a monolayer of cells (Liang 
et al. 2007) and has previously been used in alveolar epithelial cells (Geiser et 
al. 2000; T. Geiser et al. 2001). 16 hours was selected as the optimal time 
point to detect closure rates, as longer durations led to complete closure of 
wounds, with the risk of contact inhibition confounding results (Puliafito et al. 
2012). Other studies with alveolar epithelial or A549 cells used an 18 hour 
time point (Ng-Blichfeldt et al. 2017; T. Geiser et al. 2001). 
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There were no differences detected in the percentage area of the wound 
healed between CD98hc kd cells and untreated or non-targeting controls, or 
in inter-nuclear distance between cells at the wound edge. The fact that IL-1β 
treatment did not elicit a significant increase in healing in comparison to 
untreated controls, in contrast to previous observations (Geiser et al. 2000), 
suggests an impairment in the sensitivity of this assay in my hands. This was 
improved when inter-nuclear distance was measured, and significant 
differences between untreated, IL-1β –treated and serum-free controls were 
observed as expected from previous studies (Galiacy et al. 2003). 
To improve sensitivity of the assay further, a method of continuous 
electrical impedance of the monolayer was assessed as a measure of 
monolayer permeability. Cell index is an arbitrary value derived from the real-
time electrical impedance to electric current from the monolayer, and is 
proportional to the area of the well covered by cells (Rahim & Üren 2011). 
This method has previously been used to characterise cell adhesion in airway 
epithelial cells (Heijink et al. 2010). The rate of increase in electrical 
impedance following application of a wound to the monolayer was assessed, 
and in this case, CD98hc kd was observed to decrease the rate of wound 
healing when compared to siRNA controls in accordance with our hypothesis. 
One explanation for this discrepancy between techniques may be that, 
as the use of 10% FCS increases wound healing significantly from serum-free 
conditions (Galiacy et al. 2003), the use of 10% serum throughout the 
conditions amplifies wound healing to such an extent that this overrides other 
factors, and differences between conditions cannot be easily detected. Serum 
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contains additional factors such as LPA that can promote wound healing and 
cell migration (Mills & Moolenaar 2003), and the use of a lower concentration 
of serum (such as 2%, 1% or serum starvation) may increase the sensitivity of 
the assay  (Ng-Blichfeldt et al. 2017). 
Another factor is that wound healing in this model may not be due to 
epithelial cell migration alone, as proliferation along the wound edge cannot 
be excluded. To overcome this issue, hydroxyurea has previously been used 
to inhibit proliferation (Grochot-Przeczek et al. 2009), and this will be 
considered in future experiments. However, previous assays of wound healing 
with ATII have demonstrated that proliferation does not mediate wound 
closure in these cells (Galiacy et al. 2003), although staining for proliferative 
markers such as ki67 or phospho-histone H3 (PH3) at the wound edge would 
confirm or refute this. 
It was noted that the non-targeting siRNA control reduced cell 
impedance following transfection, whereas there were no observed 
differences between CD98hc kd cells and untreated controls. This again 
would suggest either off-target effects of the siRNA control, or cytotoxicity that 
is prevented by CD98hc kd. I previously observed no differences in cell 
viability between the different conditions as measured by MTT assay, 
suggesting that the defect is not due to cell death, but perhaps due to 
impairments in cell-matrix or cell-cell adhesion. 
β1-integrin signalling can mediate cell adhesion to collagen fibrils 
(Jokinen et al. 2004), and therefore we aimed to determine whether targeting 
CD98hc would affect cell adhesion in the context of CMS in our system. 
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CD98hc mediates β1-integrin-mediated adhesion in renal epithelial cells (Cai 
et al. 2005), and lung (Fenczik et al. 1997) and breast (Chandrasekaran et al. 
1999) cancer cells. Furthermore, high tidal volume ventilation (under 
hyperoxic conditions) decreased alveolar epithelial cell adhesion (Desai et al. 
2007), and whereas transient disassembly of cell-matrix adhesions has been 
shown to be protect cells from stretch-induced injury, complete disassembly 
or inhibition of β1-integrin signalling does not, and actually promotes cell 
detachment and death (Liu et al. 2011). 
My results suggest that CD98hc kd does not reduce adhesion in cells 
following CMS, using crystal violet staining and solubilisation immediately 
following CMS as previously described (Cai et al. 2005). However, whereas 
crosslinking or increased expression of CD98hc has been shown repeatedly 
to augment adhesion, other studies have found that decreased CD98hc 
expression does not necessarily decrease cell-matrix adhesion. For example, 
CD98hc null ES cells did not have impeded adhesion to fibronectin (Feral et 
al. 2005), and depletion of CD98hc did not affect keratinocyte adhesion to 
type I collagen (Boulter et al. 2013). This latter study also noted that CD98hc 
absence in vivo in the epidermis did not resemble adhesion defects resulting 
from β1-integrin loss. Taken together these data confirm results 
demonstrating that CD98hc does not affect β1-integrin activity per se, and 
therefore does not modulate the ability of cells to adhere or not. Its role may 
be to modulate strength of adhesions resulting from rigidity sensing and 
mechanotransduction via β1-integrin-mediated downstream signalling. 
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Whereas the adhesion protocol used correlated optical density of 
solubilised crystal violet staining with cell seeding density in a linear fashion 
(4.3.8), this does not confirm that it is sensitive to small reductions in cell 
number resulting from adhesion defects. More sensitive approaches may 
include staining fixed and adherent cells following CMS with live/dead 
markers, such as the calcein/ethidium homodimers, and counting cells per 
field, or reading the luminescence on a plate reader. This would have the 
additional advantage of identifying dead cells following CMS (Pipparelli et al. 
2013). However, for the purposes of this study, this straightforward assay 
revealed no reduction in adhesion following CMS in CD98 knockdown cells 
when compared with controls. 
4.4.5 Summary and limitations 
In summary, I have shown that, although CD98hc knockdown did not 
affect β1-integrin activity, it did reduce CMS-induced cytokine generation and 
baseline RhoA activity in A549 cells compared to non-targeting controls. 
CD98hc kd also appeared to reduce baseline tension across focal adhesions, 
and this increased in response to 1 minute CMS unlike that observed in 
untreated and siRNA control cells. However, there was a reduction in the rate 
of epithelial migration to recover a wound in the epithelial monolayer (as 
measured by the electrical impedance assay). Therefore, my putative model 
for CD98hc-mediated mechanotransduction involves CD98hc regulating 
downstream RhoA and myosin II activation in the quiescent state, reducing 
cellular pre-stress and therefore the force propagated throughout the cell. 
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Figure 4-11 Putative mechanism for the effect of CD98hc kd on reducing CMS-induced 
injurious signalling 
This putative mechanism involves CD98hc kd-mediated reduction of RhoA activity, reducing 
baseline ‘pre-stress’ or cellular tension via ROCK and non-muscle myosin II-mediated cellular 
contractility (upper panel). Therefore, when CMS is applied, there is decreased transmission 
of force throughout the cell, and a reduction in CMS-induced IL-8 generation (lower panel). 
The role of CD98hc on cell-cell adhesion/interactions has not been explored, and the effect of 
CD98hc kd on α- and β-catenin and E-cadherin, and subsequent effects of tension of the 
epithelial monolayer, would be an interesting avenue for further research (upper panel). 
 
However, beyond the limitations of in vitro mechanotransduction 
experimentation using the Flexcell system discussed previously (3.4.6), the 
model of transfection could be optimised. Single-target siRNA to induce gene 
silencing are efficient, practical and cost effective, but limited by off-target 
 225 
effects. We have seen that the non-targeting control siRNA induced 
differences in epithelial layer integrity, cellular tension and RhoA activity from 
untreated controls. One possible way to avoid such off-target effects in future 
is to use siRNA pools containing up to 60 low concentration siRNA sequences 
(Hannus et al. 2014).  
The limitations of the work using the VinTS and RhoA FRET sensors 
have already been discussed both in general and when considering the 
CD98hc knockdown (4.4.3). Furthermore, the inability to image cells both for 
presence or absence of CD98hc and for FLIM of VinTS or RhoA constructs 
mean that results for cellular tension or RhoA activity for individual cells have 
to be assumed to be for CD98hc kd cells. The use of frequency domain FLIM 
will allow for a greater number of cells to be imaged in a shorter time, 
increasing the likelihood of the CD98hc kd population representing true 
knockdown. 
4.4.6 Future directions 
In addition to the optimisation steps discussed above, immediate future 
work would involve investigating the effect of CD98hc on signalling 
downstream of RhoA. RhoA activates myosin II through either 
phosphorylation of myosin light chain (Amano et al. 1996), or through 
inhibition, by phosphorylation, of myosin phosphatase (MYPT1) (Kawano et 
al. 1999). Brief attempts were made to ascertain the effect of CD98hc kd on 
ROCK-mediated activation of myosin II, via immunostaining for 
phosphorylation of myosin light chain 2 (pMLC2), but unfortunately without 
consistent results. Future investigations could focus on either pathway of 
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ROCK-mediated myosin regulation. Indeed, CD98hc deficiency decreased 
MYPT phosphorylation in murine epidermis (Estrach et al. 2014).   
Furthermore, given that the RhoGEFs LARG and GEFH1 regulate 
mechanical force-induced integrin signalling and subsequent RhoA activation 
(Guilluy et al. 2011), a prudent step would be to examine the effect of CD98hc 
kd and CMS on expression of these two activation factors by mRNA or protein 
analysis. Furthermore, although I have shown that inhibition of NMII activation 
using blebbistatin decreased CMS-induced IL-8 generation, RhoGTP-ROCK 
activity can also regulate YAP/TAZ signalling, which act as mechanosensors 
and nuclear relays to dictate cellular size, proliferation and transformation in 
response to the cellular microenvironment (Dupont et al. 2011). CD98hc 
depletion decreased expression of the YAP/TAZ target genes, mANKRD1 and 
mCTGF in murine epidermis (Estrach et al. 2014). Therefore, further work 
would aim to examine the effect of CMS on YAP/TAZ signalling and nuclear 
translocation, and the effect of CD98hc kd on this.  
One major aspect of CMS-induced mechanotransduction signalling that 
needs further exploration is the role of cell-cell adhesion and interactions. 
Silencing of CD98hc in HeLa cells triggered β-catenin degradation (Santiago-
Gómez et al. 2013). Therefore, cell-cell tension, pre-stress and subsequent 
injurious mechanotransduction may be decreased in CD98hc kd cells through 
this mechanism.  
Finally, silencing of CD98hc can be applied to more physiologically 
relevant models of CMS-induced injury. For example, blocking antibodies for 
CD98hc function were acquired with a view to application in PCLS subjected 
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to CMS, and although this was not possible in the lifetime of this thesis, it is 
still an option for future work in this field. Interestingly, siRNA technology was 
used to target CD98hc in intestinal cells in vivo. CD98hc siRNA complexed 
with polyethyeneimine (PEI), loaded into nanoparticles and administered as a 
hydrogel orally to mice decreased intestinal epithelial expression of CD98hc 
and reduced inflammatory colitis (Laroui et al. 2014). These exciting data 
demonstrate that CD98hc silencing can be realistically applied to in vivo, ex 
vivo or PCLS studies of injurious ventilation or CMS. 
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5 Chapter 5: Application of Cyclic Mechanical 
Strain (CMS) to Precision Cut Lung Slices 
(PCLS) 
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5.1 Introduction 
Results from preceding chapters were obtained from the application of 
CMS to a monolayer of cultured cells. These therefore must be interpreted in 
the context of the limitations of this method, described earlier (2.2.4.1, 3.4.6). 
Although such an approach is valuable for understanding mechanistic 
processes in the alveolar epithelium, different approaches are needed to 
develop understanding of mechanotransduction in alveolae in vivo. Alveolar 
epithelial cells not only exist as part of an interconnected 3D structure (Ochs 
et al. 2004), they function in concert with a variety of different cell types, 
including fibroblasts, macrophages, and endothelial cells (Bagnato & Harari 
2015). Therefore, to understand the effect of CMS on alveolar epithelial cell 
biology, a method incorporating these elements needs to be developed. 
The generation and culture of precision cut lung slices (PCLS) allow for 
investigation of viable animal or human lung tissue, with near physiological 
characteristics. Properties of the ECM, and contacts between cells and matrix 
are grossly preserved (Liberati et al. 2010; Song et al. 2016). Furthermore, 
multiple PCLS can be generated from a small amount of lung (Dassow et al. 
2010), enabling large-scale studies on valuable human lung material, and 
preservation of animal tissue. For these reasons, PCLS have been 
extensively used for toxicology, pharmacological and gene therapy studies 
(Sanderson 2011; Griesenbach et al. 2012; Liberati et al. 2010). 
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The work in this chapter is based on the hypothesis that PCLS can be 
used to investigate CMS-induced mechanotransduction in alveolar epithelial 
cells. Specifically, the aims of the work in this chapter are to determine 
whether: 
a. CMS can be applied to PCLS without adversely affecting PCLS 
architecture or viability 
b. application of CMS can induce cytokine generation in PCLS 
c. PCLS can be used to investigate CMS-induced cell signalling and 
mechanotransduction processes. 
To achieve these aims, I generated murine and human PCLS, and 
applied biaxial CMS using the Flexcell system. 
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5.2 Specific methods 
Human or murine samples of lung were agarose-inflated and PCLS 
generated as described (2.2.2). For all experiments, PCLS generated from 
contiguous sections of lung were used as control and treatment groups. In this 
way, differences in anatomy between PCLS could be minimised. PCLS were 
adhered to the silicone membrane and CMS applied using application of 
ethyl-cyanoacrylate (Henkel) at points around the periphery of the PCLS using 
a dissection microscope (Figure 5-1). CMS was either not applied (0%/static) 
applied at 5% (CMS low) or applied at over 15% (CMS high) for the durations 
specified.  
 
5.2.1 PCLS architecture following CMS 
PCLS subjected to either static or CMS conditions were detached from 
the membrane and fixed in 10% neutral buffered formalin for 30 minutes, then 
washed and incubated in 70% ethanol prior to xylene washes and embedding 
in paraffin wax. Paraffin blocks containing embedded tissue were sectioned at 
4µm thickness and stained for Haematoxylin and Eosin (H&E).  
Surfactant Protein C (Pro-SPC) staining of PCLS was performed as 
described for immunofluorescence of PCLS (2.2.5.1.4), with incubation in 
rabbit Pro-SPC primary antibody (1:1000, Millipore) (Table 2-3). 
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5.2.2 CMS-induced cytokine release 
Following CMS, PCLS were either left for specified durations or for 24 
hours, and the supernatant obtained, clarified and stored at -80°C. MSD 
analysis was performed as described (2.2.6.2) for KC/GRO (murine) or IL-8 
(human). 
5.2.3 Assessment of PCLS viability 
PCLS attached to silicone membranes were cut out, placed into ibidi 24-
well plates with coverslip bottom (Ibidi µ-plate), and incubated with 4µM 
ethidium/calcein as described (2.2.2.3). They were then imaged immediately 
using an inverted microscope. 
5.2.4 Cell proliferation in PCLS 
PCLS were subjected to either static or CMS conditions, then fixed and 
processed for immunostaining at 24 hours as described (2.2.5.1.4). PCLS 
were incubated in primary antibody (rabbit anti-PH3, 1:1000, Millipore) (Table 
2-3). The number of DAPI or PH3 positive nuclei was calculated using Imaris 
(Bitplane) software, and the ratio of the two determined. 
To characterise the proliferating cells, PLCS were co-incubated with 
mouse anti E-cadherin antibody (1:1000, CST) (Table 2-3). 
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5.2.5 Visualisation of cytokine release in PCLS 
PCLS were either untreated, or incubated with TNF-α at 10ng/ml or 
100ng/m for 4 hours. PCLS were then fixed, permeabilised and blocked as 
described (2.2.5.1.4), and immunostaining for GRO-α performed. (Table 2-3).  
Attempts were made to visualise intracellular GRO-α by adding brefeldin 
A (10µg/ml) with the TNF-α, and the above procedure was then followed. 
5.2.6 Cytokine gene regulation in PCLS 
To assess gene regulation in PCLS, slices were either untreated, or 
incubated with TNF-α at 10 or 100ng/ml. Following incubation for 4 hours, 3 
PCLS for each condition were lysed in Trizol and homogenised. RNA was 
extracted as described (2.2.3.1) and assessed for quantity and quality using 
the high sensitivity RNA Tapestation system (Agilent Genomics). RT-PCR 
was performed as described (2.2.3.3) using the primers listed in (Table 2-1). 
5.2.7 Assessment of ERK phosphorylation downstream of CMS 
PCLS were either incubated in EGF (20ng/ml) for 30 minutes, or 
exposed to 0% CMS (static) or CMS high for 10 minutes. PCLS were then 
fixed, permeabilised, blocked and stained and imaged as described 
(2.2.5.1.4). The ratio of p-ERK positive nuclei to total, DAPI-stained, nuclei 
was calculated using Imaris software. 
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Figure 5-1 Proposed workflow for investigating CMS-induced signalling using PCLS 
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5.3 Results 
5.3.1 PCLS architecture following CMS 
Initial experiments were performed to assess the integrity of alveolar 
epithelial architecture following generation of murine PCLS, and application of 
CMS. H+E staining demonstrated preservation of the architecture of lung 
parenchyma. The presence of cell nuclei within alveolar septal walls was 
noted (Figure 5-2 - a). 
Confocal immunofluorescence imaging of PCLS for cytoplasmic Pro-
SPC showed numerous positive cells at baseline conditions, indicating the 
presence of ATII cells (Figure 5-2 - b). 
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Figure 5-2 PCLS architecture following CMS 
Panel A shows murine PCLS either un-stretched (static) or exposed to CMS high for 2 hours. 
PCLS were detached from the silicone membrane, fixed, paraffin-embedded and stained for 
haematoxylin and eosin (H&E). Phase contrast images shown are at 20x (left) and 40x (right) 
original magnification. Arrowheads show nuclei of ATI, and arrows ATII. Panel B shows 
confocal immunofluorescence images for murine PCLS stained for nuclei with DAPI (cyan) 
and pro-surfactant protein C (red) indicated by arrows. Images show baseline, static 
conditions on the left, and secondary-antibody only conditions (right). Scale bar – 50 µm. 
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5.3.2 CMS-induced cytokine release in murine PCLS 
Murine PCLS were either unstretched, or subjected to CMS high for 2 
hours. Supernatant was sampled at 4, 8 and 24 hours following this and 
KC/GRO release assessed by MSD assay. At 24 hours, KC/GRO was 
approximately 2 times greater than static controls, and so this time point was 
used for future assessments of CMS-induced cytokine release (Figure 5-3). 
One outlier was removed from these results due to KC/GRO release over 100 
fold greater than other results.  
Further studies revealed a CMS-dependent increase in KC/GRO 
release, with CMS-high significantly increasing cytokine generation by 1.8 
times above static controls (Figure 5-3- b). The results for one experiment 
were removed due to grossly increased KC/GRO values across all conditions, 
attributed to technical anomalies. 
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Figure 5-3 CMS-induced cytokine release in murine PCLS 
Murine PCLS were subjected to either static conditions or CMS, and cytokine release 
assessed by MSD assay. Panel A shows fold changes in cytokine release at 4, 8 and 24 
hours following CMS high of 2 hours duration when compared to static controls at those time 
points. Data represented as median ± IQR from 4 PCLS per time point (n=1) (one outlier 
excluded at 4 hours). Panel B shows IL-8 release at 24 hours in PCLS subjected to CMS low 
and high (fold change over static controls). Data represented as median ± IQR from 19 PCLS 
(CMS low) and 18 PCLS (CMS high), from 5 individual experiments (n=5), ** = p<0.01, 
Kruskal Wallis test with Dunn’s post test. 
 
 
 
 
 
 239 
5.3.3 CMS-induced cytokine release in human PCLS 
          To determine whether CMS induced relevant cytokine release in human 
PCLS, hPCLS were generated and subjected to CMS as described for 1-2 
hours. 1 hour CMS induced a significant 5-fold increase in measured IL-8 
release over static controls (Figure 5-4 – a), whereas 2 hours CMS induced a 
75-fold increase (Figure 5-4 – b).  
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Figure 5-4 CMS-induced cytokine release in human PCLS 
Human PCLS were generated and subjected to either static conditions or CMS for 1-2 hours. 
IL-8 release was assessed at 24 hours by MSD assay. Panel A shows IL-8 values (left) and 
fold changes in IL-8 release (right) for PCLS subjected to 1 hour CMS high when compared to 
static controls. Data represented as median ± IQR from 9 PCLS per time point from two 
individual specimens of lung (n=2). Panel B shows IL-8 values (left) for PCLS subjected to 2 
hours CMS high when compared to static controls. Data represented as median ± IQR from 
12 PCLS from 2 individual specimens of lung (n=2), ** = p<0.01, Wilcoxon paired analysis. 
 
5.3.4 Viability of PCLS 
Viability as assessed by staining live murine PCLS with calcein and 
ethidium homodimer, demonstrated numerous dead, ethidium-stained nuclei 
in PCLS following static, and CMS low and high conditions. However, calcein 
staining revealed viable cells in all conditions. In contrast, PCLS incubated 
with methanol were replete with ethidium-stained nuclei, but no calcein-
stained cytoplasm (Figure 5-5).  
 241 
 
Figure 5-5 Viability of PCLS 
Murine PCLS subjected to either 0% CMS (static – top left), CMS low (top right) or CMS high 
(central two images) were incubated with calcein and ethidium homodimer, then imaged using 
an inverted confocal microscope. Green, calcein-stained cytoplasm represent live cells, 
whereas red, ethidium-stained nuclei represent dead cells. Conditions were compared with 
either un-stained PCLS (bottom left) or methanol-treated PCLS (bottom right). Images 
representative of two PCLS per condition, scale bar – 100 µm). 
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5.3.5 Cell proliferation in murine PCLS exposed to CMS 
To determine whether CMS affects alveolar epithelial cell proliferation, 
murine PCLS at either static, CMS low or CMS high conditions were fixed and 
imaged for the proliferation marker PH3 and the ratio of PH3-positive nuclei 
against total DAPI-stained nuclei calculated using Imaris software. CMS low 
conditions induced a 3-fold increase in proliferating cells compared to static 
controls, although a high SEM was observed. CMS high conditions induced a 
1.8 times increase (Figure 5-6).  
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Figure 5-6 Cell proliferation in murine PCLS exposed to CMS 
Murine PCLS subjected to either 0% CMS (static – left), CMS low (centre) or CMS high (right) 
were imaged for PH3 and the ratio of these cells against total nuclei assessed. Panel A 
shows PH3 stained nuclei (red) and phalloidin-stained actin architecture (green) for each 
condition. Arrowheads indicate PH3-stained nuclei, scale bar – 100 µm. Panel B shows fold 
change in PH3/total nuclei ratios for CMS low and high against static conditions. Data 
represented as median ± IQR for 3 PCLS from 2 individual mice (n=2) for CMS low and 6 
PCLS from 3 individual mice (n=3) for CMS high. 
CMS – cyclic mechanical strain, PH3 – phosphohistone H3 
 
5.3.6 Cell proliferation in human PCLS exposed to CMS 
To determine whether CMS-induced proliferation in human PCLS, slices 
were either un-stretched (static), or subjected to CMS-high, and the ratio of 
PH3-positive nuclei against total nuclei calculated as for murine PCLS. CMS-
high induced a non-significant increase in proliferating cells when compared 
to static controls (Figure 5-7). 
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Figure 5-7 Cell proliferation in human PCLS exposed to CMS 
Human PCLS subjected to either 0% CMS (static – left), or CMS high (right) were imaged for 
PH3 and the ratio of these cells against total nuclei assessed. Panel A shows PH3 stained 
nuclei (red) and phalloidin-stained actin architecture (green) for each condition. Arrowheads 
indicate PH3-stained nuclei, scale bar – 100 µm. Panel B shows fold change in PH3/total 
nuclei ratios for CMS high against static conditions. Data represented as median ± IQR for 5 
PCLS from 3 individual lung specimens (n=3), and analysed with Wilcoxon’s test. 
CMS – cyclic mechanical strain, PH3 – phosphohistone H3 
 
5.3.7 Characterisation of proliferating cells 
To characterise the proliferating cells, murine PCLS exposed to either 
static or CMS conditions were fixed and dual-stained for the epithelial-cell 
marker, E-cadherin, and PH3. PH3-positive nuclei were co-localised with E-
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cadherin-positive staining (Figure 5-8 - a). Furthermore, PH3 staining was 
visible throughout the slice thickness, rather than simply at the cut edges 
(Figure 5-8 – b). Brightfield images overlaid with PH3–stained nuclei indicated 
that PH3-positive nuclei were spatially located in the corners of alveoli, where 
ATII cells would be expected (Figure 5-8 - c). 
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Figure 5-8 Characterisation of proliferating cells 
Murine PCLS subjected to either 0% CMS (static) or CMS were imaged and stained for both 
PH3 and the epithelial cell marker E-cadherin. Panel A shows PH3 stained nuclei (red) and E-
cadherin-stained cytoplasm (green) for static vs. CMS. Panel B shows images throughout the 
z-stack thickness at the top, middle and bottom of the slice. Panel C shows brightfield and 
PH3 overlay. Arrowheads in all panels indicate PH3-stained nuclei, scale bar – 100 µm. 
 
5.3.8 Visualisation of cytokine release in PCLS 
To characterise which cells express GRO-α, trial experiments were 
conducted where murine PCLS were treated for 4 hours with TNF-α at either 
0 (untreated), 10 or 100ng/ml. PCLS were fixed and stained for GRO-α. Initial 
results demonstrated widespread GRO-α expression, even in untreated 
conditions, although image intensity was visibly greater in PCLS following 
TNF-α treatment (Figure 5-9 - a). In an attempt to visualise TNF- α –induced 
intracellular generation of GRO-α, PCLS were treated with brefeldin A 
(10µg/ml) to inhibit golgi-ER trafficking of GRO-α. Although all conditions 
again demonstrated widespread generation and release of GRO-α, discreet 
cellular generation was visible within alveolar septa, and in many cases, 
spatially correlated with ATII cells (Figure 5-9 – b). 
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Figure 5-9 Visualisation of cytokine release in murine PCLS 
Murine PCLS either untreated, or treated with TNF-α at either 10 or 100ng/ml were fixed and 
stained for GRO-α (red) and co-stained for phalloidin (green) and DAPI (cyan). Panel A 
shows murine PCLS treated in the absence of brefeldin (10µg/ml), stained for GRO-α, and 
imaged at 40x original magnification. Panel B shows PCLS treated in the presence of 
brefeldin, and imaged at 20x original magnification. Additional 2.5x digital magnification of 
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overlay is also shown to the right of each condition. Arrowheads indicate GRO-α -stained cells 
and arrows show GRO-α-expressing structures resembling macrophages. Scale bar – 100 
µm. 
 
5.3.9 Cytokine gene regulation in PCLS 
To determine whether cytokine generation could be determined at an 
RNA level in PCLS, trial experiments were undertaken where murine PLCS 
were treated with 0 (untreated), 10 or 100ng/ml of TNF-α for 1 hour, and lysed 
for quantification of CXCL1, CXCL2 and IL-6 mRNA. Quality of PCLS mRNA 
was assessed using the high sensitivity Agilent Genomics RNA Tapestation 
system. PCLS mRNA was of good quality, with RNA Integrity Number 
equivalent (RINe) values consistently above 8 (Figure 5-10 – a-b). Moreover, 
although TNF-α treatment at 10ng/ml did not induce a demonstrable fold 
change in cytokine gene expression over untreated controls, TNF-α at 
100ng/ml induced a four-fold increase in CXCL1, a 1.7-times increase in 
CXCL2, and a 1.6-times increase in IL-6 gene expression (Figure 5-10 – c). 
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Figure 5-10 Cytokine gene regulation in PCLS 
Murine PCLS were untreated, or exposed to TNF-α at 10 or 100 ng/ml for 1 hour, then 
lysed for mRNA quantification by RT-PCR. Panel A shows electropherogram of PCLS 
ribosomal (r)RNA showing 28s (right hand peak) and 18s (middle peak) and lower RNA 
(left-hand peak) at 5000,  2000 and <50 base pairs respectively, and compared to a ladder 
(top). Panel B shows these results as demonstrated on a gel. Black arrow indicates 28s 
bands and red arrow 18s bands. RINe values are shown below samples. Panel C shows 
fold change in mRNA expression over untreated PCLS for CXCL1 (top), CXCL2 (middle) 
and IL-6 (bottom) mRNA, for TNF-α at either 10 or 100ng/ml. mRNA quantified as ΔΔct 
where CT values are first normalised to that of two housekeeping genes (B2M and HPRT), 
then the average of these values normalised to that of untreated controls. 
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5.3.10 CMS-induced downstream signalling in PCLS 
To determine whether CMS of PCLS induced downstream signalling that 
correlated with that seen in A549 cells, murine PCLS treated with either 
20ng/ml epidermal growth factor (EGF) for 30 mins, or exposed to static 
conditions or CMS high for 10 minutes. The ratio of pERK-positive to total, 
DAPI-stained, nuclei in fixed and stained PCLS was calculated. EGF 
treatment induced a four-fold increase in p-ERK/total nuclei over static, 
untreated PCLS, and CMS induced a three-fold increase (Figure 5-11).  
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Figure 5-11 CMS-induced ERK phosphorylation in murine PCLS 
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Murine PCLS were either treated with epidermal growth factor (EGF), or exposed to static or 
CMS high conditions. Panel A shows confocal images of PCLS under different conditions, 
stained for p-ERK (red) and imaged by confocal immunofluorescence at 20x original 
magnification. Arrowheads show p-ERK positive nuclei. Scale bar – 100µm. Panel B shows 
the ratio of p-ERK positive nuclei to total nuclei for respective conditions. Data represented as 
mean for two images from one PCLS per condition (n=1). 
 
5.4 Discussion 
5.4.1 Summary of results 
The aims of the work in this chapter were to determine whether PCLS 
could be used to model CMS-induced cell signalling in alveolae. Specifically, I 
aimed to determine whether CMS could be applied to PCLS without adversely 
affecting architecture or viability, and if CMS could induce cytokine generation 
and downstream signalling in PCLS. 
Generation of murine PCLS preserved alveolar epithelial integrity, and 
nuclei spatially correlating with ATI and ATII were visible by H&E staining. 
Evidence of ATII was confirmed by confocal immunostaining for Pro-SPC. 
CMS-induced CXCL-1 release was found at 24 hours post-CMS in murine 
PCLS, and was dependent on the degree of CMS applied. Similarly, high 
degree CMS for over 1 hour induced significant IL-8 production by human 
PCLS at 24 hours. Basic ethidium and calcein staining of cells showed no 
gross differences in alveolar cell viability in PCLS exposed to CMS when 
compared to static controls, but a low degree of applied CMS induced 
proliferation of cells that spatially correlated with ATII, and a high degree of 
CMS induced a similar trend in human PCLS, although a statistically 
significant increase could not be determined in both cases. 
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I have shown from preliminary experiments that cytokine mRNA can be 
isolated from PCLS at good quality, and that TNF-α-induced increases in 
CXCL1 and CXCL2 mRNA can be detected. Finally, I have shown that CMS-
induced phosphorylation of ERK can be detected in PCLS. 
5.4.2 Application of CMS to PCLS 
I have successfully generated both murine and human PCLS that 
demonstrate preservation of cellular architecture in agreement with previous 
work from our group (Alçada et al. 2014; Ng-Blichfeldt et al. 2017) and also 
demonstrated reactivity to CMS without gross structural damage. I used 
400µm thickness for human PCLS, and 300µm for murine, correlating with 
thicknesses used in previous studies (Dassow et al. 2010), although 250µm 
thick slices have also been used (Song et al. 2016; N Davidovich et al. 2013).  
The application of adhesive and the method used to apply CMS also 
differs from that used in other studies. I found that application of 
cyanoacrylate in discrete areas along the periphery of the PCLS allowed 
adhesion to the silicone membrane of the Flexcell system, and biaxial stretch 
of the PCLS could be visualised. However, one group stitched the PCLS to a 
deformable silicone membrane and an indenter was then used to cyclically 
deform the membrane (J. Huang et al. 2012; N Davidovich et al. 2013). This 
generated consistent alveolar deformation to 30% of alveolar surface area. 
Another technique, although without a similar degree of uniformity of 
deformation, successfully stretched PCLS by clamping to a pliant PDMS 
membrane, which was then deformed by applying pressure beneath from 
compressed air (Dassow et al. 2010). Deformation of individual alveoli 
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increased linearly with applied pressure to approximately 35% original surface 
area. 
In my case, attempts were made to quantify the mean degree of stretch 
when pressures calibrated for stretch of cells to 5% original surface area 
(CMS low) and 15-20% (CMS high) were applied. This was done by live 
microscopy, and attempting to measure alveolar size at baseline and during a 
single stretch. Unfortunately, the onset of CMS moved the PCLS out of view 
in both the Z and XY directions, impeding our ability to successfully measure 
alveolar dimensions. For future studies, membrane stains will be used, and 
the average area of alveoli in a field of view at baseline compared with the 
average sizes during a period of tonic stretch. Therefore, at present, I cannot 
say with confidence by what degree application of CMS deforms individual 
PCLS, and how consistent that might be. 
Work from our group has previously shown that both ATI and ATII 
markers are visible in human PCLS for up to 7 days using markers for 
podoplanin and Pro-SPC respectively (Alçada et al. 2014). Moreover, both 
PECAM staining for endothelial cells within alveolar septal walls and larger 
vessels, and alpha smooth muscle actin (α-SMA) around vessels and airways 
have been described in human and porcine PCLS (Ng-Blichfeldt 2014). In rat 
PCLS, Pro-SPC staining is visible for up to 6 days in culture, at which point 
levels decline, suggesting possible de-differentiation to ATI cells (Dassow et 
al. 2010), whereas staining for the ATI marker, aquaporin-5 (AQP5), remained 
constant throughout the 6 day period. Type I and II alveolar epithelial cell 
phenotypes were similarly maintained in culture for up to 3 days in rat PCLS 
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(N Davidovich et al. 2013) and in murine PCLS for 5 days (Uhl et al. 2015). 
Therefore, it is assumed that, as CMS is applied to PCLS at 24 hours 
following slicing, tissue characteristics are well preserved. 
PCLS offer the advantage of generating a large sample size from a 
small amount of lung, therefore preserving animal and human tissue. 
However, when producing slices, significant variations can occur between 
PCLS in anatomy, such as the presence of large vessels or airways. 
Furthermore, both point-instillation of agarose to human PCLS, or tracheal 
instillation for murine PCLS, is likely to generate different distending forces 
throughout lung tissue, with some areas potentially exposed to high strain. In 
order to minimise heterogeneity between control and corresponding treatment 
PCLS, adjacent slices were used as control or treatment, and normalised for 
each other when calculating CMS-induced differences. 
5.4.3 CMS-induced cytokine release 
These results indicated that CMS promoted generation of KC/GRO-α 
(CXCL1) and IL-8 (CXCL8) from murine and human PCLS respectively. In 
previous murine studies, CXCL1 generation in adult mice was induced by high 
tidal volume ventilation, which paralleled neutrophil sequestration and lung 
injury scores and was sensitive to the degree of ventilation applied (Belperio 
et al. 2002). In adult studies, IL-8 generation in BAL fluid correlates with onset 
of ARDS (Donnelly et al. 1993), and low tidal volume (lung-protective) 
ventilation reduced BAL IL-8 concentration (Ranieri et al. 1999). These 
observations indicate that these cytokines are sensitive to the degree of 
mechanical strain applied to the lung. In vitro, application of CMS to human 
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alveolar epithelial cells promoted IL-8 generation (Vlahakis et al. 1999), and 
these cytokines have therefore been used as a ‘readout’ of CMS-induced 
injury in our models. 
The putative mechanism of CMS-induced cytokine release in ATII cells 
is dependent on ERK 1/2 signalling, and inhibition of ERK signalling using 
UO126 inhibits downstream IL-8 generation in A549 cells (Pinhu 2008). 
Furthermore, actin cytoskeletal tension is required for mechanotransduction-
induced cytokine release, as shown by earlier results using inhibition of ROCK 
and myosin II (3.3.4). Finally, A549 cells grown without mitochondria cannot 
generate cytokine in response to CMS (Pinhu 2008) correlating with 
observations suggesting that mitochondrial superoxide has a role in CMS-
induced mechanotransduction responses. Recent work demonstrated ROS 
generation in PCLS exposed to CMS, and that superoxide scavenging 
attenuated CMS-induced tight junction dissociation (Song et al. 2016). 
However, the benefit of using PCLS to investigate CMS-induced injury is 
the presence of all cell types normally resident in the alveolar epithelium. 
Increased nuclear translocation of p65 in ATI was seen in rat PCLS stretched 
to 37% (N Davidovich et al. 2013), and the authors stated their intent to also 
examine responses in other lung cells such as endothelial cells, and ATII. We 
attempted to visualise GRO-α in murine PCLS treated with TNF-α, in an 
attempt to localise cytokine release to cell type, but the diffuse staining seen 
in both control and TNF-α–treated PCLS made quantification and localisation 
difficult, even in the presence of the protein-transport inhibitor Brefeldin A. The 
concentration of Brefeldin A used in my experiments (10µg/ml) blocked 
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intracellular transport of proteins from hepatocytes by impedance of ER to 
golgi trafficking (Misumi et al. 1986). However, I could not confirm that this 
dose was effective in PCLS and therefore dosage and timing will need to be 
optimised when applied to PCLS in culture. 
Preliminary characterisation of ERK activation in PCLS was promising, 
suggesting a positive response to epidermal growth factor (EGF) and increase 
following 10 minutes CMS as observed with immunoblotting in A549 cells 
(4.3.3). However, as with other work in this chapter, the cells staining positive 
for phosphorylation need to be characterised fully when this work is repeated. 
Therefore, a mechanistic explanation for CMS-induced cytokine generation in 
PCLS cannot be provided at present, but this work suggests that this may be 
attainable. 
Finally, attempts to obtain cytokine mRNA expression profiles from 
PCLS exposed to injury were relatively successful. The RNA integrity number 
(RIN) scores RNA integrity based not only on the ratio of 28s:18s ribosomal 
RNA degradation bands, but also other factors including the height of the 28s 
peak and the fraction of the areas in the region of the peaks compared to the 
total area under the curve, and provides robust prediction of RNA integrity 
(Schroeder et al. 2006). Values over 7.4 are likely to be of acceptable quality 
for RNA sequencing analyses, although evidence suggests the effects of RNA 
degradation in these specimens can be controlled for (Gallego Romero et al. 
2014). Nonetheless, RIN values for all PCLS samples analysed fell over 8.5, 
suggesting that RNA expression profiles can be collated from pooled samples 
of 3 PCLS. A dose dependent increase in CXCL1, CXCL2 and IL-6 
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expression was seen in samples treated with TNF-α, suggesting that this can 
be used as a positive control in future studies of CMS-induced cytokine 
generation in PCLS. 
5.4.4 Viability of PCLS 
CMS-induced responses in PCLS tissue are dependent on the 
preservation of cell viability following the slicing, adhesion and CMS process. I 
used a variety of different methods, including MTT assay of PCLS tissue, 
determination of the ratio of ethidium-stained dead nuclei to total, DAPI or 
Hoechst-stained, nuclei. However, dual ethidium and calcein staining of PCLS 
to determine dead nuclei and cytoplasm of live cells respectively, was found 
to be quick and effective, and could be visualised in live cells allowing for real-
time viability studies during CMS in the future. Difficulties with this method 
result from the technical process of microscopy in adhered slices, and in 
quantifying viability from the images obtained. My preliminary data suggest 
that there are no gross differences in viability between PCLS exposed to static 
or CMS conditions at both low and high degrees of stretch when compared to 
methanol-treated PCLS. However, these conclusions are made cautiously, 
given both the large quantities of dead nuclei in all conditions, and the inability 
to derive quantifiable data from this work at present. 
Viability of lung slices as assessed by lactate dehydrogenase release, 
thymidine incorporation and MTT assay in rat (Martin et al. 1996) and guinea 
pig slices (Ressmeyer et al. 2006) have demonstrated that PCLS maintain 
viability in culture for at least 72 hours. Maintenance in culture beyond 7 days 
can affect physiological function, such as random twitching of airway smooth 
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muscle due to calcium store overloading and subsequent release (Bergner & 
Sanderson 2002; Sanderson 2011). Furthermore, previous work from our 
group suggests that human PCLS maintain viability in culture for up to one 
week as determined by the WST-1 metabolic assay (Alçada et al. 2014). 
The application of 4 hours CMS to rat PCLS clamped into a bioreactor 
did not significantly reduce viability as assessed by both ethidium/calcein 
staining and MTT assay (Dassow et al. 2010), although it must be noted that 
the PCLS appear better preserved in all conditions, with fewer dead cells 
evident compared with my data. This may be attributed to our use of ethyl-
cyanoacrylate to adhere PCLS to the silicone membrane. Indeed, stitching of 
the PCLS to a deformable membrane led to a similar viability profile to that 
obtained in our experiments (N Davidovich et al. 2013), indicating that both 
methods have an impact on PCLS viability without revealing an effect of CMS 
on cell viability.  
Recent data suggested that the short chain cyanoacrylate, ethyl-2-
cyanoacrylate, may reduce surgical and haemostasis time, and reduce 
inflammation when compared to the use of sutures in pulmonary partial 
lobectomy surgery (Szkudlarek et al. 2011), and a similar profile was obtained 
in vascular surgery studies (Kaplan et al. 2004). However, in general, shorter 
chain cyanoacrylates are known to induce local toxicity due to degradation of 
their alkyl chains into cyanoacetate and formaldehyde (García Cerdá et al. 
2015). Longer chain cyanoacrylates, such as n-butyl-2-cyanoacrylate 
(Indermil) have slower rates of degradation, with better toxicity profiles but 
with increased rates of dehiscence. My on-going and future work is using n-
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butyl-2-cyanoacrylate to reduce cell death in PCLS studies when compared to 
ethyl-2-cyanoacrylate, with PCLS that remain adhered during CMS. Another 
alternative currently being tested is ‘Cell-Tak’ (Corning) adhesive, which 
consists of polyphenolic proteins from the bivalve mollusc, Mytilus edulis, 
which enable it to adhere to structures (Waite 1983). The advantages of 
this compound in PCLS studies are that it has a low cytotoxicity profile, and 
can be subsequently degraded, facilitating detachment of the PCLS from 
the deformable membrane. However, optimisation is needed to identify the 
best concentration of this product to maintain PCLS adherence during 
CMS. 
Therefore, although preliminary work has demonstrated viability of PCLS 
following adhesion and CMS, further optimisation must be undertaken with 
both the type of adhesive and quantification of viability profiles. Imaris 
software (Bitplane, Zurich, Switzerland) can be used to ‘reconstruct’ and 
quantify the volume of tissue occupied by the calcein-stained cytoplasm, and 
count the number of ethidium-stained dead nuclei. A ratio can therefore be 
derived from the two measurements, allowing for some quantification of PCLS 
viability. In this way, we aim to determine whether CMS has an effect on 
PCLS viability. Finally, recent data suggest that murine PCLS maintain 
viability even following freeze-thawing (Rosner et al. 2014). Use of this 
technique in human PCLS could allow for long-term preservation and use of 
human tissue in CMS studies. 
 262 
5.4.5 CMS-induced proliferation 
Although not reaching statistical significance at present, these 
preliminary results suggest that CMS of murine and human PCLS induced an 
increase in the proliferation of cells that correlated spatially with ATII cells. 
These results support the hypothesis that lung re-growth following 
pneumonectomy in humans is driven by overdistension of the remaining lung 
(Butler et al. 2012), but repeat studies will determine if this trend in PCLS is 
consistent and significant. Furthermore, there is a growing body of evidence 
to suggest that lung development is driven by mechanical stretch. Foetal 
breath movements are necessary for the normal development of the lung 
(Wigglesworth & Desai 1979), exposure to continuous positive airways 
pressure (CPAP) promoted a 40% increase in total lung capacity in 6-week 
old ferrets when compared to controls (Zhang et al. 1996), and mechanical 
forces across epithelial tissues direct branching morphogenesis of the 
developing lung (Gjorevski & Nelson 2010; Varner et al. 2015).  
These observations correlate with increased alveolar cell proliferation 
both in vitro and in vivo. In both H441 and A549 pulmonary epithelial cells, low 
degree CMS over 24-72 hours increased cell numbers (Chaturvedi et al. 
2006), and mechanical ventilation of mice resulted in a 3-fold increase in the 
G1 and S-phase marker proliferating cell nuclear antigen (PCNA), and a 6.5-
fold increase in the cell cycle entry marker ki67 in cells identified 
morphologically as ATII (Chess et al. 2010). Furthermore, pneumonectomy is 
associated with a subsequent increase in alveolar cell density (Jain et al. 
2015) (Butler et al. 2012), and in murine lung induced a regression in 
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transcriptomic profile similar to late stages of development (alveolar stage), 
comprised of a small regression backwards (de-differentiation phase) then 
subsequent re-development phase (Kho et al. 2013).  
It is currently not clear by which mechanism mechanical stretch might 
induce epithelial cell proliferation, but in mammary epithelial cells, the Yorkie 
homologue proteins YAP and TAZ were activated in response to increasing 
ECM stiffness and corresponding RhoGTPase signalling (Dupont et al. 2011). 
In more recent studies, such stretch-induced YAP/TAZ activation promoted S-
phase re-entry (Aragona et al. 2013) and mechanical strain of MDCK 
epithelial cells induced cell cycle re-entry and progression through S phase 
(Benham-Pyle et al. 2015). This was dependent on Yap1 activation, and β-
catenin expression was necessary for S-phase progression. Furthermore, E-
cadherin extracellular engagement was required for strain-induced β-catenin 
transcriptional responses, suggesting its role as both a mechanical and 
signalling platform for mechanical strain-induced responses in epithelial cell 
monolayers. 
Recently, stretch-induced mitosis was also seen to be dependent on the 
transmembrane protein Piezo1, which activates in response to stretch to 
promote calcium-dependent phosphorylation of ERK 1/2, activating cyclin B 
transcription to drive cell cycle entry from G2 phase (Gudipaty et al. 2017). 
Piezo1 in this case may act as a mechanosensor and promote different 
responses to mechanical tension on epithelial cells, from extrusion of cells in 
response to overcrowding on one hand, to cell division in response to 
mechanical stretch on the other, depending on the magnitude of force applied. 
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Another possibility is that proliferation may be a regenerative response 
to CMS-induced injury or apoptosis. Although alveolar epithelial cell turnover 
in the quiescent adult lung is low (Barkauskas et al. 2013; Hogan et al. 2014), 
evidence suggests that the alveolar epithelium will regenerate with cell 
proliferation following injury. Bleomycin-induced fibrotic lung injury (Kawamoto 
& Fukuda 1990), and pulmonary fibrosis itself are associated with increased 
alveolar epithelial cell proliferation (Königshoff 2014; Weng et al. 2014). 
Cigarette smoke injury is associated with increased bronchial epithelial 
proliferation as demonstrated by ki-67 labelling (Lee et al. 2001; Hittelman et 
al. 2007). ATII proliferated 3 days after LPS and haemorrhagic shock in a 
rodent model of ALI, in a HGF and c-Met-dependent manner (Zeng et al. 
2016). These effects are thought to be secondary to cell apoptosis in fibrotic 
models of injury (Königshoff 2014), but whether this is the case in stretch-
mediated injury is not clear (Crosby et al. 2011). 
Although ATII self-renew and de-differentiate to repopulate the depleted 
alveolar epithelium following injury (Barkauskas et al. 2013), recent evidence 
suggests that the majority of ATII present following injury are not derived from 
self-renewal, but rather from differentiation and proliferation of club cells 
(Zheng et al. 2017). This may include previous candidates for alveolar 
epithelial stem cells, including lineage negative progenitor cells (Vaughan et 
al. 2014) and distal airway integrin α6β4+ cells (Chapman et al. 2011). 
Furthermore, the differentiation between ATII and ATI may be bi-directional, 
and ATI may be directly differentiated from Krt+ progenitor tracheal cells (Yee 
et al. 2017). These data suggest a significant degree of plasticity and 
complexity in the regeneration and self-renewal capacity of the alveolar 
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epithelium (Jain et al. 2015). Therefore, the cells identified as proliferating in 
response to CMS need extensive further characterisation. 
To identify cell proliferation, I used the G2/M-phase marker PH3, which 
was used in studies of CMS-induced alveolar epithelial cell proliferation 
(Gudipaty et al. 2017). Phosphorylation at ser10, 28 and thr11 of histone h3 
correlates with chromosome condensation during mitosis and meiosis 
(Hendzel et al. 1997; Goto et al. 1999), but I appreciate that the use of 
markers to identify cell cycle entry (ki67) and S-phase (EdU) would increase 
the robustness of these results.  
Additionally, although previous studies have both demonstrated (Crosby 
et al. 2011) and failed to identify (Chess et al. 2010) CMS-induced apoptosis 
in vitro and in vivo respectively, our results would benefit from a correlation 
with an apoptosis or necrosis profile as measured by terminal 
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), cleaved 
caspase 3 and propidium iodide staining. These were attempted, and require 
further work to fully elucidate the balance between cell death and proliferation 
stimulated by CMS. 
Finally, as with cytokine generation, attempts to characterise 
proliferating cells as epithelial were impeded by difficulties with combining 
ATII epithelial markers such as TTF-1 and Pro-SPC with proliferation markers. 
These may be overcome in future by the use of a Fluorescein isothiocyanate 
(FITC)-conjugated epithelial cell adhesion molecule (EPCAM) antibody, or by 
using PCLS from an epithelial-GFP tagged mouse line (Lee et al. 2013). 
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Although E-cadherin allowed for a preliminary identification of epithelial 
proliferating cells, the staining was diffuse and not definitive (5.3.7). 
5.4.6 Summary and limitations 
The aim of the work in this chapter was to determine whether PCLS 
could provide a platform to study mechanotransduction processes in the 
human alveolar epithelium with near in vivo conditions. To an extent, I have 
partly achieved this by demonstrating CMS-induced cytokine release in 
murine slices. Furthermore, I have described, to my knowledge, the first 
example of CMS-induced cytokine generation in human PCLS. I also made 
preliminary observations of TNF-α –induced cytokine mRNA expression to 
provide impetus for further work regarding CMS-induced injury, and of CMS-
induced proliferation and ERK activation. 
 However, the major limitation to this work has been my inability to 
characterise activated cells as epithelial and of any particular subtype. 
Attempts were made to co-stain with TTF-1, pancytokeratin, Pro-SPC, and E-
cadherin. Although some success was obtained with E-cadherin staining, 
results when using these markers were inconclusive. This was partly due to 
species incompatibility between proliferation or cytokine antibody and 
epithelial marker, but also due to poor penetration into the lung slice itself, and 
488-channel auto-fluorescence from elastin. Improvements have been made 
since this work, with EPCAM providing a consistent and specific epithelial cell 
stain, and the use of alveolar-epithelial–GFP expressing mice to generate 
PCLS.  
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Similarly, optimisation of PCLS viability studies will help ensure optimal 
conditions for further mechanotransduction work in PCLS. One issue with the 
work presented here is the high index of ethidium-stained dead nuclei, and 
this has been attributed to the use of ethyl-cyanoacrylate adhesive. Although 
there were no gross differences observed in the ratio of ethidium and calcein 
– stained cells between static and CMS conditions, this method to assess cell 
viability does not allow for easy quantification of cell viability parameters. 
Other methods were attempted, including measurement of the ratio of 
ethidium-positive to Hoechst-positive nuclei, but without consistent and 
reliable results. Two improvements have therefore been made to progress this 
work. The first is substitution of n-butyl-cyanoacrylate for ethyl-cyanoacrylate 
to reduce the adhesive-related toxicity to PLCS. The second is use of the 
MTT assay, which has now been optimised and validated in PCLS by work 
from our group. 
Finally, a better characterisation of the degree of CMS experienced by 
PCLS is required. Although PCLS were observed to stretch, our previous 
attempts at calculating the degree of CMS applied by measuring alveoli in 
relaxed and stretched states was inhibited by movement of the PCLS in and 
out of focus. One possibility in future work is to film PCLS undergoing stretch, 
and calculate change in surface area of the PCLS itself. 
5.4.7 Future directions 
The aim of the work in this chapter was to advance my model of 
mechanotransduction in the alveolar epithelium to near in vivo conditions in 
the human lung. Therefore, I hoped to assess the role of RhoGTPases and 
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CD98hc in CMS-induced injury in PCLS. Although further optimisation of the 
model is required as described above, the long-term aim is to be able to 
characterise cytokine generation, apoptosis and proliferation on a cell-by-cell 
basis in the PCLS. Inhibitors of the Rho-ROCK-NMII pathway, CD98hc 
blocking antibodies (Bhuyan et al. 2014) and ERK inhibitors can then be used 
to assess response. 
One of the key benefits of the PCLS model is the potential to assess 
alveolar epithelial function in a near physiological cellular environment. 
Therefore, the interaction of alveolar epithelial cells with other cell types in 
response to CMS can be assessed. Interestingly, flow cytometric profiling of 
murine lung following high tidal volume ventilation indicated that endothelial 
cells responded with inflammatory signalling most rapidly (within 1 minute), 
followed by epithelial cells and then macrophages (Woods et al. 2015). These 
results indicate that the kinetic profiling of inflammatory responses to stretch 
of different lung cells is important, and the use of PCLS provides an 
opportunity to examine the role of the epithelium in what is likely to be 
complex and dynamic inter-dependent signalling between different cells. 
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6 Chapter 6: Discussion and further work 
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6.1 Summary of important results from this thesis 
The work in this thesis demonstrated that CMS induced actin 
cytoskeletal remodelling, promoting a reduction in cell size, an increase in the 
cell-free area between cells, and redistribution of focal adhesions to, what 
appeared to be, damaged stress fibres within the cell. Furthermore, inhibition 
of ROCK and NMII abrogated CMS-induced cytokine release, and CMS 
induced early increases in RhoA activation, suggesting that Rho-ROCK-NMII 
is critical for CMS-induced injurious signalling in alveolar epithelial cells. 
I also found that knockdown of the transmembrane integrin-associated 
protein, CD98hc, abrogated CMS-induced cytokine release and was 
associated with loss of CMS-induced autophosphorylation of FAK. 
Significantly, knockdown of CD98hc reduced baseline RhoA activity. 
Preliminary results using a FRET probe to indicate tension across focal 
adhesions suggested that knockdown may be associated with lower tension 
at baseline, with increased tension following CMS. Finally, knockdown was 
associated with a decreased rate of migration of cells to recover a wound in 
the epithelial monolayer, as indicated by an impedance-based assay. 
Although the application of CMS to a monolayer of epithelial cells in vitro 
is useful for understanding mechanistic responses, it is vital to understand the 
mechanobiology of the in vivo alveolar epithelium, as affected by cellular 
repertoire, cell-matrix and cell-cell interactions. I developed a method by 
which CMS could be applied to precision cut lung slices (PCLS). These PCLS 
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demonstrated preserved alveolar epithelial integrity. CMS-induced cytokine 
release was evident in both murine and human PCLS, and was dependent on 
the degree of CMS applied. A low degree of applied CMS was associated with 
cell proliferation that spatially correlated with ATII in murine PCLS, and a high 
degree of CMS induced a similar trend in human PCLS, although a 
statistically significant increase could not be determined in both cases.  
Finally, I demonstrated that cytokine mRNA can be isolated from PCLS, 
and that PCLS increased expression of CXCL1 and CXCL2 mRNA in 
response to TNF-α. Preliminary work also demonstrated that it is possible to 
detect CMS-induced phosphorylation of ERK in PCLS. I believe that this work 
in PCLS opens the door to further, more physiologically relevant, 
investigations of mechanobiology in the alveolar epithelium, using live human 
tissue. 
6.2 The role of the CD98hc-RhoA-NMII axis in alveolar 
epithelial mechanobiology 
6.2.1 Cellular tension and pre-stress 
The findings that inhibition of ROCK, NMII or CD98hc abrogated CMS-
induced cytokine release led me to hypothesise that baseline pre-stress 
affects the response of alveolar epithelial cells to CMS. Although I was unable 
to confirm the effect of these treatments on the dynamics of cellular tension 
before and during CMS, this is to form the basis of on-going work. The data 
presented in this thesis suggest that cells with lower pre-stress, such as from 
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inhibition of ROCK or NMII, may be less susceptible to the sensation and 
transduction of mechanical force into injurious biological signalling.  
Pre-treatment of animals with Y27632 protected animals from lung injury 
in models of sepsis-induced injury (Cinel et al. 2012; Birukova et al. 2012). 
Moreover, hyperoxia-induced increases in cell stiffness were Rho kinase 
dependent and associated with CMS-induced cell detachment, which was 
abrogated by inhibition of ROCK (Wilhelm et al. 2014).  
Patients with chronic interstitial lung disease, who have lungs with less 
elasticity and greater stiffness (Liu et al. 2010), have poor tolerability of 
mechanical ventilation with a subsequent increased mortality (Saydain et al. 
2002; Fernández-Pérez et al. 2008). Although there are many reasons why 
patients with the gross pathological changes observed in interstitial lung 
disease may have poor outcomes following mechanical ventilation, it would be 
interesting to ascertain if this was due to increased VALI in this cohort of 
patients, and if this in turn was due to higher baseline pre-stress in alveolar 
epithelial cells. Use of ex vivo lung perfusion (EVLP) or PCLS studies may be 
helpful in this regard. Interestingly, Rho-ROCK signalling has been 
demonstrated to regulate fibroblast to myofibroblast differentiation in the 
pathogenesis of pulmonary fibrosis, and its inhibition using a ROCK inhibitor, 
fasudil, protected animals from experimental fibrosis (Zhou et al. 2013). 
The tensegrity model of the cell as a pre-stressed structure predicts that 
the transmission of force throughout the cell is dependent on the degree of 
baseline pre-stress (Wang & Ingber 1994; Hu et al. 2005; Matthews et al. 
2006). Evidence for the effect of increased cellular pre-stress on susceptibility 
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to high tidal volume stretch may be seen in hyperoxia, which increased the 
elastic modulus of alveolar epithelial cells (Wilhelm et al. 2014; Roan et al. 
2012), and worsened VALI (Makena et al. 2010; Li et al. 2007). Furthermore, 
these effects of hyperoxia-induced cell stiffening, and CMS-induced cell 
detachment following hyperoxia were abrogated by inhibition of ROCK 
signalling using Y27632 (Wilhelm et al. 2014).  
6.2.2 Mitochondrial ROS and ERK signalling 
My finding that ablation of F-actin polymerisation using cytochalasin D 
did not reduce CMS-induced IL-8 release suggests an additional factor of the 
Rho-ROCK-NMII signalling pathway integral to mechanotransduction in CMS, 
beyond mechanical integrity of the pre-stressed actin cytoskeleton. Physical 
forces may directly influence nuclear mechanotransduction of cytokine 
signalling (Lammerding et al. 2004). Furthermore, the generation of 
mitochondrial ROS has been associated with CMS-induced cytokine 
generation in the lung, and A549 cells grown without mitochondria do not 
generate cytokine in response to CMS (although they do in response to 
chemical stimulation) (Pinhu 2008). PCLS exposed to CMS generated ROS, 
the attenuation of which abrogated CMS-induced tight junction disruption 
(Song et al. 2016).  
There are also data to suggest that mitochondrial ROS activate ROCK 
and MLC-mediated remodelling of the cytoskeleton in drosophila (Muliyil & 
Narasimha 2014), suggesting a direct interaction between the Rho-ROCK and 
mitochondrial ROS pathways. Activation of the NF-κB pathway mediated 
CMS-induced ROS release in monolayers of alveolar epithelial cells and in 
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ATI and ATII in PCLS (Nurit Davidovich et al. 2013; N Davidovich et al. 2013). 
That hyperoxia is associated with mitochondrial ROS generation (Kallet & 
Matthay 2013), and that hyperoxia-induced cell stiffening and increased 
susceptibility to CMS-induced injury were abrogated by inhibition of ROCK 
(Wilhelm et al. 2014), lends further evidence of an interaction between 
mitochondrial ROS, ROCK signalling, cellular pre-stress and susceptibility to 
CMS-induced injury.  
Moreover, inhibition of ERK signalling also abrogated CMS-induced 
cytokine responses (Pinhu 2008), and CMS-induced p65 nuclear translocation 
in PCLS was prevented by ERK inhibition (Song et al. 2016), suggesting a 
possible overlap between mitochondrial ROS and ERK pathways. CMS of 
human lung endothelial cells was associated with the formation of a paxillin-
ERK-GEF-H1 complex to stimulate Rho signalling with subsequent 
actomyosin contraction and endothelial permeability. Formation of this 
complex was abolished by inhibition of ERK by UO126 (Gawlak et al. 2014).  
Therefore, given that NF-κB and mitochondrial ROS-induced cytoskeletal 
remodelling occurs via ROCK, I would suggest ROCK as the point of overlap 
between these pathways in CMS-induced injury. This could be tested by the 
use of LPA or other Rho and NMII ‘rescue’ of mechanotransduction following 
ERK inhibition. 
6.2.3 CD98hc signalling 
I have shown that CD98hc kd is associated with lower baseline RhoA 
activation in a preliminary FRET-based assay, suggesting that CD98hc-
mediated alteration of baseline RhoA activity, and possibly pre-stress, has a 
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role in the regulation of CMS-induced mechanotransduction. This correlates 
with previous observations that CD98hc-deficient cells demonstrate reduced 
RhoA (Féral et al. 2007; Boulter et al. 2013) and ROCK (Estrach et al. 2014) 
activity. Furthermore, overexpression studies of CD98hc demonstrated 
increased ERK and p38 MAPK signalling, and proliferation, in a mechanism 
dependent both on CD98-mediated-amino acid transport, and the CD98hc 
cytoplasmic tail (Bulus et al. 2012). Although this was in the context of serum-
dependent proliferation responses, it would be interesting to determine 
whether CD98hc overexpression stimulated RhoA activity, as my hypothesis 
would suggest (Figure 6-1). 
Although this thesis has focussed on the cytoplasmic CD98hc 
association with β1-integrins, the ectodomain of the heavy chain associates 
with any of 6 light chain subunits LAT1, LAT2, xCT, y+LAT1, y+LAT2, asc1 
(Fotiadis et al. 2013) responsible for amino acid transport across the cell. 
Inhibition of the light-chain binding capacity of CD98hc leads to accumulation 
of ROS, indicating the role of CD98 in regulating redox balance (de la Ballina 
et al. 2016). How this might relate to mechanobiology pathways remains to be 
seen. Finally, an actin bundling protein Fascin-1 was observed to target 
SLC3A2 (CD98hc) gene expression and transcription to regulate mTor activity 
to affect cell growth and survival via aberrant amino acid transport (Saad et al. 
2016). That the actin-fascin interaction may be dependent on Rho-ROCK 
signalling (Jayo et al. 2012) and that CD98hc activation might lie downstream 
of fascin suggests the exciting possibility of a force-sensing feedback loop 
mediated in part by CD98hc.  
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Figure 6-1 Proposed CMS-induced mechanotransduction pathway in alveolar epithelial 
cells 
CMS induces β1-integrin activation (Guilluy et al. 2011), and both phosphorylation of focal 
adhesion kinase (FAK) at tyrosine 397, and of extracellular related kinase (ERK) p44/42 (1/2). 
FAK-dependent phosphorylation of paxillin leads to ERK-paxillin complex formation which 
recruits and activates guanine exchange factor H1, stimulating RhoA activity (Gawlak et al. 
2014). I have shown that ROCK and NMII are necessary for CMS-induced cytokine release, 
and that CD98hc both mediates CMS-induced cytokine release and may affect RhoA activity, 
although whether this is through regulation of β1-integrin signalling remains to be seen. 
Mitochondrial ROS activated by CMS (Pinhu 2008) may directly induce ROCK signalling 
(Muliyil & Narasimha 2014) and ROCK may be a point of overlap between ERK and 
mitochondrial ROS pathways. CMS may also promote direct nuclear mechanotransduction of 
IL-8 signalling. 
 
6.3 Targetting CD98hc-RhoA-NMII signalling in clinical 
practice 
The work in this thesis demonstrates that both Rho-ROCK and CD98hc 
signalling are required for CMS-induced injurious signalling in alveolar 
epithelial cells in vitro. Although this is a small step in understanding the 
mechanobiology of the alveolar epithelium, an interesting aspect is that 
inhibitors of Rho-ROCK signalling are already in clinical use. Fasudil is a 
selective ROCK inhibitor in use in Japan for the prevention of cerebral 
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vasospasm (Veldeman et al. 2016), and is thought to reduce vasoconstriction 
through a combination of decreased MLC phosphatase activity (Takagi et al. 
2011) and ERK nuclear translocation (Wang et al. 2011), and increased 
angiotensin-converting enzyme (ACE) activity (Ocaranza et al. 2011).  
Another, more potent, ROCK inhibitor, Ripasudil hydrochloride hydrate 
(K-115) is also in use in Japan as a treatment for ocular hypertension and 
glaucoma (Kaneko et al. 2016). Rapasudil-induced cytoskeletal changes, 
including rounding and retraction of cells, reduced the compaction of 
trabecular meshwork tissue, reducing resistance to aqueous outflow (Koga et 
al. 2006). The overexpression of CD98 in solid and haematological 
malignancies has led to the generation of a CD98-specific mouse monoclonal 
antibody (IGN523), which has demonstrated inhibition of tumour growth in 
patient-derived cancer xenographs and tumour cell apoptosis (Hayes et al. 
2015). This compound was found to be safe and associated with anti-
leukaemic activity when administered in a phase I clinical trial for acute 
myeloid leukaemia (Bixby et al. 2015). Finally, CD98hc siRNA, complexed in 
nanoparticles and administered as an oral hydrogel, reduced inflammatory 
colitis in mice (Laroui et al. 2014). Therefore, two clinically approved inhibitors 
of ROCK, an anti-CD98hc monoclonal antibody, and a novel method to 
administer CD98hc siRNA to patients may be amenable to future testing in 
models of VALI, either using ex vivo lung perfusion or PCLS technology. 
6.4 Future work 
I have attempted to measure both RhoA activity and cellular tension 
using FRET probes before and after 1 minute of CMS (3.3.9 3.3.10). 
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However, responses to CMS are likely to be dynamic and cellular rheology 
may follow a biphasic pattern of initial softening followed by reinforcement 
(1.6.2). Therefore, my on-going work aims to measure cellular tension and 
RhoA activity over a range of time points after the onset of CMS, using 
frequency domain FLIM to increase the rate of data acquisition. Furthermore, 
preliminary imaging of stress fibres indicated potential ‘breaks’ following CMS 
with realignment of focal adhesions to damaged ends of stress fibres (3.3.2). 
My aims for future work include staining for the focal adhesion protein zyxin, 
to determine whether this protein is mobilised to stress fibres in a possible 
repair process. This work will also consolidate evidence of CMS-induced 
cellular ‘hardening’ with longer time courses of strain. 
With regards to investigating CMS-induced RhoA activity, and the effect 
of CD98hc kd on this process, future work will aim to establish expression 
profiles of the RhoGEFs LARG and GEFH1, and phosphorylation of the 
myosin light chain MLC2 under these conditions. This will help establish the 
regulation of signalling upstream of RhoA and downstream of ROCK 
respectively. Furthermore, effects on downstream YAP/TAZ expression will be 
helpful to better characterise CMS and CD98hc-Rho mediated signalling. 
CD98 itself is composed of the integrin-associated component of the heavy 
chain, and light chains, which enable amino acid transport. Use of previously 
described mutations composed of only the cytoplasmic, transmembrane or 
extracellular domains (Feral et al. 2005) will help clarify the role of CD98hc in 
CMS-induced mechanotransduction.  
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The work in this thesis has been based on CMS-induced and β1-
integrin-mediated cell signalling in a monolayer of epithelial cells, However, 
CMS induced gap formations between cells (3.3.1) and it is likely that cell-cell 
interactions play a major role in CMS-induced mechanoresponses. Therefore, 
future investigation of the expression and localisation of, for example, α and β 
catenin, would help improve understanding of the interplay between cell-cell 
and cell-matrix adhesions in response to CMS. This is particularly relevant 
given evidence that CMS-induced YAP/TAZ signalling is mediated via β-
catenin, and that CD98hc silencing induced β-catenin degradation (Santiago-
Gómez et al. 2013).  
Finally, I attempted to develop a more physiologically relevant model of 
CMS-induced mechanotransduction in alveolar epithelial cells using PCLS. 
Further optimisation is needed to characterise cells involved in CMS-induced 
proliferation and cytokine release, and the dynamic interplay between cells 
over a time course of CMS. However, providing this can be achieved, the 
effect of ROCK and CD98hc inhibition on CMS-induced injurious signalling 
can be ascertained using clinically approved and validated inhibitors as 
discussed above.  
6.5 Overall conclusions 
ROCK-NMII activity and CD98hc expression are necessary for CMS-
induced cytokine release in alveolar epithelial cells in vitro. However, it is 
likely that CMS-induced injury is a result of dynamic interplay between 
different cell types, cell-matrix and cell-cell interactions. The use of bridge 
platforms between in vitro and in vivo conditions, such as PCLS, will allow 
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further investigation of this important and exciting, but still poorly understood, 
discipline of alveolar epithelial biology. 
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